<table><tr><td>Degenerative Vascular</td></tr><tr><td>Toxic</td></tr><tr><td>Metabolic</td></tr><tr><td>Inherited</td></tr><tr><td>Acquired</td></tr><tr><td>Neoplastic</td></tr><tr><td>Inflammatory—immune</td></tr></table>
======================================
<table><thead><th>INCIDENCE IN GENERAL PRACTICE</th><th>PREVALENCE IN THE COMMUNITY</th></thead><tr><td>Stroke (all types) Carpal tunnel syndrome</td><td>Migraine Chronic tension headache</td></tr><tr><td>Epilepsy</td><td>Stroke</td></tr><tr><td>Bell’s palsy</td><td>Alzheimer disease</td></tr><tr><td>Essential tremor</td><td>Epilepsy</td></tr><tr><td>Giant cell arteritis</td><td>Unexplained motor symptoms</td></tr><tr><td>Migraine</td><td>Neurofibromatosis</td></tr></table>
======================================
<table><thead><th></th><th>APPROXIMATE PREVALENC</th></thead><tr><td colspan="2">Degenerative diseases</td></tr><tr><td>Amyotrophic lateral sclerosis</td><td>5x10</td></tr><tr><td>Huntington disease</td><td>5x10</td></tr><tr><td>Parkinson disease</td><td>5x 10°</td></tr><tr><td>Alzheimer disease</td><td>5x 10°</td></tr><tr><td>Macular degeneration</td><td>5x10"</td></tr><tr><td colspan="2">Autoimmune neurologic diseases</td></tr><tr><td>Multiple sclerosis</td><td>4x 10°</td></tr><tr><td>Stroke, all types</td><td>5x 10°</td></tr><tr><td colspan="2">Central nervous system trauma</td></tr><tr><td>Head</td><td>2x 10°</td></tr><tr><td>Spinal cord</td><td>2.5 X 10°</td></tr><tr><td colspan="2">Metabolic</td></tr><tr><td>Diabetic retinopathy</td><td>2x 10°</td></tr><tr><td>Headache</td><td></td></tr><tr><td>Epilepsy</td><td></td></tr><tr><td>Back pain</td><td></td></tr><tr><td colspan="2">Peripheral neuropathy</td></tr><tr><td>Total</td><td></td></tr><tr><td>Inherited</td><td></td></tr><tr><td>Diabetic neuropathy</td><td></td></tr><tr><td colspan="2">Mental retardation</td></tr><tr><td>Severe</td><td></td></tr><tr><td>Moderate</td><td></td></tr><tr><td>Schizophrenia</td><td></td></tr><tr><td>Manic depressive illness</td><td></td></tr></table>
======================================
<table><thead><th colspan="5">CHARACTERISTIC CSF FORMULAS</th></thead><thead><th>CONDITION</th><th>CELLS</th><th>PROTEIN</th><th>GLUCOSE</th><th>OTHER FEATURES</th></thead><tr><td>Bacterial infection</td><td>WBC &gt;50/mm%, often greatly increased</td><td>100-250 mg%</td><td>20-50 mg%; usually lower than half of blood level</td><td>Gram stain shows organisms; pressure increased</td></tr><tr><td>Viral, fungal, spirochetal infection</td><td>WBC 10-100/mm?</td><td>50-200 mg%</td><td>glucose Normal or slightly reduced</td><td>Special culture techniques required; pressure normal or</td></tr><tr><td>Tuberculous infection</td><td>WBC &gt;25/mm?</td><td>100-1,000 mg%</td><td>&lt;50, often markedly reduced</td><td>slightly increased Special culture techniques and PCR may be needed to detect</td></tr><tr><td>Subarachnoid hemorrhage</td><td>RBC &gt;500/mm/; slight increase in WBC</td><td>60-150 mg%</td><td>Normal</td><td>organisms Must be distinguished from traumatic lumbar puncture by presence of xanthochromia of spun sample; greatly</td></tr><tr><td>Cerebral hemorrhage, trauma</td><td>RBC 50-200/mm3; higher if ventricular rupture of blood</td><td>50-150 mg%</td><td>Normal</td><td>increased pressure Pressure may be elevated</td></tr><tr><td>Ischemic stroke</td><td>Normal or few WBC</td><td>Normal</td><td>Normal</td><td>Normal pressure unless brain swelling</td></tr><tr><td>Multiple sclerosis</td><td>Normal or few WBC</td><td>Normal or slightly increased</td><td>Normal</td><td>Increased IgG fraction and oligoclonal bands</td></tr><tr><td>Meningeal cancer</td><td>WBC 10-100/mm?</td><td>Usually elevated</td><td>Normal or depressed.</td><td>Neoplastic cells in CSF; elevation of certain protein markers (e.g., B&gt;- microglobulin)</td></tr></table>
======================================
<table><thead><th></th><th>CEREBROSPINAL FLUID</th><th>SERUM</th></thead><tr><td>Osmolarity</td><td>295 mOsm/L</td><td>295 mOsm/L</td></tr><tr><td>Sodium</td><td>138.0 mEq/L</td><td>138.0 mEq/L</td></tr><tr><td>Potassium</td><td>2.8 mEq/L</td><td>4.1 mEq/L</td></tr><tr><td>Calcium</td><td>2.1 mEq/L</td><td>4.8 mEq/L</td></tr><tr><td>Magnesium</td><td>2.3 mEq/L</td><td>1.9 mEq/L</td></tr><tr><td>Chloride</td><td>119 mEq/L</td><td>101.0 mEq/L</td></tr><tr><td>Bicarbonate</td><td>23.0 mEq/L</td><td>23.0 mEq/L</td></tr><tr><td>Carbon dioxide tension</td><td>48 mm Hg</td><td>38 mm Hg (arterial)</td></tr><tr><td>pH</td><td>7.31-7.33</td><td>7A] (arterial)</td></tr><tr><td>Nonprotein nitrogen</td><td>19.0 mg/dL</td><td>27.0 mg/dL</td></tr><tr><td>Ammonia</td><td>30.0 g/dL</td><td>70.0 g/dL</td></tr><tr><td>Uric acid</td><td>0.24 mg/dL</td><td>5.5 mg/dL</td></tr><tr><td>Urea</td><td>4.7 mmol/L</td><td>5.4 mmol/L</td></tr><tr><td>Creatinine</td><td>1.1mg/dL</td><td>1.8 mg/dL</td></tr><tr><td>Phosphorus</td><td>1.6 mg/dL</td><td>4.0 mg/dL</td></tr><tr><td>Total lipid</td><td>1.5 mg/dL</td><td>750.0 mg/dL.</td></tr><tr><td>Total cholesterol</td><td>0.4mg/dL</td><td>180.0 mg/dL</td></tr><tr><td>Cholesterol esters</td><td>0.3 mg/dL</td><td>126.0 mg/dL</td></tr><tr><td>Glucose</td><td>60 mg/dL</td><td>90.0 mg/dL</td></tr><tr><td>Lactate</td><td>1.6 mEq/L</td><td>1.0 mEq/L</td></tr><tr><td>Total protein</td><td>15-50 mg/dL</td><td>6.5-8.4 g/100 dL</td></tr><tr><td>Prealbumin</td><td>1-7%</td><td>Trace</td></tr><tr><td>Albumin</td><td>49-73%</td><td>56%</td></tr><tr><td>Alpha, globulin</td><td>3-7%</td><td>4%</td></tr><tr><td>Alphay globulin</td><td>6-13%</td><td>10%</td></tr><tr><td>Beta globulin (beta,</td><td>9-19%</td><td>12%</td></tr><tr><td>plus tau) Gamma globulin</td><td>3-12%</td><td>14%</td></tr></table>
======================================
<table><thead><th>TYPE OF EVOKED POTENTIAL</th><th>MEAN</th><th>UPPER LIMIT (MEAN + 3 SD)</th></thead><tr><td colspan="3">PSVER (70-min check size)</td></tr><tr><td>P100 absolute latency</td><td>104</td><td>118</td></tr><tr><td>Intereye difference</td><td>2</td><td>8</td></tr><tr><td colspan="3">BAER (60 dBSL, 10/s monaural stimuli)</td></tr><tr><td colspan="3">Interwave latency</td></tr><tr><td>Il</td><td>2.1</td><td>2.6</td></tr><tr><td>Ill-V</td><td>1.9</td><td>24</td></tr><tr><td>LV</td><td>4.0</td><td>47</td></tr><tr><td>Interside difference for most</td><td>0.1</td><td>0.4</td></tr><tr><td colspan="3" rowspan="3">latencies SEP—median nerve (wrist stimulation)</td></tr><tr><td colspan="3" rowspan="2">Absolute latency</td><td colspan="3" rowspan="2"></td><td colspan="3"></td></tr><tr><td colspan="3"></td><td colspan="3"></td><td colspan="3"></td></tr><tr><td>Erb’s point</td><td>9.7</td><td>12.0</td></tr><tr><td>P/N 13 (cervicomedullary)</td><td>13.5</td><td>16.3</td></tr><tr><td>N 19/P 21</td><td>19.0</td><td>22.1</td></tr><tr><td>(cortical) Interwave</td><td></td><td></td></tr><tr><td>latency 13</td><td>3.8</td><td>5.2</td></tr><tr><td>Erb’s-P/N</td><td></td><td></td></tr><tr><td colspan="3">P/N 13-N 19 5.5 6.8 Interside difference</td></tr><tr><td colspan="3">P/N 13-N 19 0.3 11 SEP—tibial nerve (ankle stimulation; Fz-Cz recording; 165-cm height; absolute latencies are shorter for stimulation at the knee) Absolute latency</td></tr><tr><td>Lumbar point (cauda equina)</td><td>20</td><td>25</td></tr><tr><td colspan="3">N/P 37 (cortex) 36 42.5</td></tr><tr><td>Interwave latency Lumbar-N/P 37 Interside difference</td><td>16.4</td><td>21.6</td></tr><tr><td>Lumbar-N /P 37</td><td>0.7</td><td>19</td></tr></table>
======================================
<table><thead><th>UPPER MOTOR NEURON OR SUPRANUCLEAR PARALYSIS</th><th>LOWER MOTOR NEURON OR NUCLEAR-INFRANUCLEAR PARALYSIS</th></thead><tr><td>Muscles affected in groups; never individual muscles</td><td>Individual muscles may be affected</td></tr><tr><td>of disuse Spasticity with hyperactivity of the tendon reflexes and</td><td>of total bulk Flaccidity and hypotonia of affected muscles with loss of</td></tr><tr><td>potentials in EMG</td><td>studies; denervation potentials (fibrillations, fasciculations, positive sharp waves) in EMG</td></tr></table>
======================================
<table><thead><th></th><th>CORTICOSPINAL</th><th>EXTRAPYRAMIDAL</th></thead><tr><td>Character of the alteration of muscle tone</td><td>Clasp-knife effect (spasticity)</td><td>Plastic, equal throughout passive movement (rigidity), or intermittent (cogwheel rigidity)</td></tr><tr><td>Distribution of hypertonus</td><td>Flexors of arms, extensors of legs</td><td>Generalized but predominates in flexors of limbs and of trunk</td></tr><tr><td>Involuntary movements</td><td>Absent</td><td>Presence of tremor, chorea, athetosis, dystonia</td></tr><tr><td>Tendon reflexes</td><td>Increased</td><td>Normal or slightly increased</td></tr><tr><td>Babinski sign</td><td>Present</td><td>Absent</td></tr><tr><td>Paralysis of voluntary movement</td><td>Present</td><td>Absent or slight</td></tr></table>
======================================
<table><thead><th></th><th colspan="5">Classes of Dopaminergic Receptors</th></thead><thead><th></th><th>D1</th><th>D2</th><th>D3</th><th>D4</th><th>DS</th></thead><tr><td colspan="6">Within basal ganglia</td></tr><tr><td>Striatum</td><td>+</td><td>+b</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Lateral GP</td><td></td><td>+</td><td></td><td>+</td><td></td></tr><tr><td>Subthalamic nucleus</td><td>+</td><td>+</td><td>+</td><td></td><td></td></tr><tr><td>Medial GP/SN pars reticulata</td><td>+</td><td></td><td></td><td></td><td></td></tr><tr><td>SN pars compacta</td><td>+</td><td>+</td><td>+</td><td></td><td></td></tr><tr><td colspan="6">Outside basal ganglia</td></tr><tr><td>Nucleus accumbens</td><td>+</td><td></td><td>+</td><td></td><td></td></tr><tr><td>Frontal cortex</td><td>+</td><td></td><td></td><td>+</td><td></td></tr><tr><td>Limbic structures</td><td></td><td></td><td></td><td>+</td><td></td></tr><tr><td>Hippocampus</td><td></td><td></td><td></td><td>+</td><td></td></tr><tr><td>Hypothalamus</td><td></td><td></td><td>+</td><td></td><td>+</td></tr><tr><td>Olfactory tubercle</td><td></td><td></td><td>+</td><td></td><td></td></tr><tr><td>Pituitary</td><td></td><td>+</td><td></td><td></td><td></td></tr><tr><td colspan="6">Brainstem. +</td></tr><tr><td colspan="6">Drug affinities</td></tr><tr><td>Dopamine</td><td>++</td><td>+44</td><td>+444</td><td></td><td></td></tr><tr><td>Bromocriptine</td><td>—</td><td>++</td><td>++</td><td></td><td></td></tr><tr><td>Pergolide</td><td>+</td><td>+444</td><td>+44</td><td></td><td></td></tr><tr><td>Ropinirole</td><td>0</td><td>+44</td><td>+444</td><td></td><td></td></tr><tr><td>Pramipexole</td><td>0</td><td>+44</td><td>+444</td><td></td><td></td></tr></table>
======================================
<table><thead><th>SYMPTOMS</th><th>PRINCIPAL LOCATION OF MORBID ANATOMY</th></thead><tr><td>Unilateral plastic rigidity with rest tremor (Parkinson disease) Unilatral hemiballismus and hemichorea</td><td>Contralateral substantia nigra plus (?) other mesencephalic structures Contralateral subthalamic nucleus of Luys or luysial—pallidal connections</td></tr><tr><td>Chronic chorea of Huntington type Athetosis and dystonia</td><td>Caudate nucleus and putamen Contralateral striatum (pathology of dystonia musculorum deformans unknown)</td></tr><tr><td>Cerebellar incoordination, intention tremor, and hypotonia</td><td>Ipsilateral cerebellar hemisphere; ipsilateral middle or inferior cerebellar peduncle; brachium conjunctivum (ipsilateral if below decussation, contralateral if</td></tr><tr><td>Decerebrate rigidity, i.e., extension of arms and legs, opisthotonos</td><td>above) Usually bilateral in tegmentum of upper brainstem at level of red nucleus or between red and vestibular nuclei</td></tr><tr><td>Palatal and facial myoclonus (rhythmic)</td><td>Ipsilateral central tegmental tract with denervation of inferior olivary nucleus and nucleus ambiguus</td></tr><tr><td>Diffuse myoclonus</td><td>Neuronal degeneration, usually diffuse or predominating in cerebral or cerebellar cortex and dentate nuclei</td></tr></table>
======================================
<table><thead><th>DIAGNOSIS OF GENERALIZED</th><th>CEREBELLAR ATAXIA</th></thead><tr><td>MODE OF DEVELOPMENT</td><td>CAUSES</td></tr><tr><td>Acute-transitory</td><td>Intoxication with alcohol, lithium, barbiturate, phenytoin or other antiepileptics (associated with dysarthria, nystagmus; Chaps. 42 and 43) Diamox-responsive episodic ataxia (Chap. 37) Childhood hyperammonemias (Chap. 37)</td></tr><tr><td>Acute and usually reversible</td><td>Postinfectious, with inflammatory changes in CSF (Chap. 36) Viral cerebellar encephalitis (Chap. 33) Myxedema</td></tr><tr><td>Acute-enduring</td><td>Extreme hyperthermia with coma at onset (Chap. 17) Intoxication with mercury compounds or toluene (glue sniffing; spray painting; Chap. 43) Postanoxic with intention myoclonus</td></tr><tr><td rowspan="3">Subacute (over weeks)</td><td>headache and papilledema; Chap. 31) Alcoholic-nutritional (Chaps. 41 and 42) Paraneoplastic, often with opsoclonus and specific anticerebellar antibodies (particularly with breast and ovarian carcinoma; Chap. 31) Creutzfeldt-Jakob disease (Chap. 33) Cerebellar abscess (Chap. 32) disease with and</td></tr><tr><td></td><td>Adulterated heroin (“chasing the dragon”) Brain tumors such as medulloblastoma, astrocytoma, hemangioblastoma metastasis (usually with Whipple (often myoclonus oculomasticatory movements) Sprue (gluten enteropathy)</td></tr><tr><td></td><td>Multiple sclerosis</td></tr><tr><td>Chronic (months to years)</td><td>Friedreich ataxia and other spinocerebellar degenerations; other hereditary cerebellar degenerations (olivopontocerebellar degenerations; cerebellar cortical degenerations [Chap. 39]) Adult form of X 38 and</td></tr><tr><td></td><td>fragile premutation syndrome (Chaps. 39) Hereditary metabolic diseases, often with myoclonus (Chap. 37) Childhood ataxias, including ataxia telangiectasia, cerebellar agenesis</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr></table>
======================================
<table><thead><th colspan="5">MAIN TYPES OF TREMOR</th></thead><thead><th>TYPE OF TREMOR</th><th>FREQUENCY, HZ</th><th>PREDOMINANT LOCATION</th><th>ENHANCING AGENTS</th><th>ATTENUATING AGENTS</th></thead><tr><td>Physiologic</td><td>8-13</td><td>Hands</td><td>Epinephrine, B-adrenergics</td><td>Alcohol, B-adrenergic</td></tr><tr><td>(enhanced) Parkinson (rest)</td><td>3-5</td><td>Hands and forearms, fingers, feet, lips,</td><td>Emotional stress</td><td>antagonists L-Dopa, anticholinergics</td></tr><tr><td>Cerebellar (intention, ataxic, “rubral”)</td><td>24</td><td>tongue Limbs, trunk, head</td><td>Emotional stress</td><td></td></tr><tr><td>Postural, or action</td><td>5-8</td><td>Hands</td><td>Anxiety, fright, B- adrenergics, alcohol withdrawal, xanthines,</td><td>B- Adrenergic antagonists in some cases</td></tr><tr><td>Essential (familial,</td><td>4-8</td><td>Hands, head, vocal cords</td><td>lithium, exercise, fatigue Same as above</td><td>Alcohol, propanolol,</td></tr><tr><td>senile) Alternate beat</td><td>3.5-6</td><td>Hands, head</td><td>Same as above</td><td>primidone Clonazepam, alcohol, B-</td></tr><tr><td>Orthostatic</td><td>4-8, irregular</td><td>Legs</td><td>Quiet standing</td><td>adrenergic antagonists Repose, walking,</td></tr><tr><td>Tremor of neuropathy</td><td>47</td><td>Hands</td><td></td><td>clonazepam, valproate</td></tr><tr><td>Palatal tremor</td><td>60-100/min</td><td>Palate, sometimes facial, pharyngeal, proximal limb muscles</td><td></td><td>Clonazepam, valproate</td></tr><tr><td>Dystonic</td><td>Irregular</td><td>Concordant with focal dystonia</td><td></td><td>Local botulinum toxin, gestes</td></tr></table>
======================================
<table><thead><th></th><th>CADENCE</th><th>STEP LENGTH</th><th>BASE</th><th>OTHER ASSOCIATED SIGNS</th></thead><tr><td>Cerebellar Sensory ataxic (tabetic)</td><td>Irregular | Normal</td><td>Slightly short Short</td><td>Wide Slightly wide</td><td>Erratic shifting of weight and step Excessive force in step resulting in</td></tr><tr><td>Steppage</td><td>Normal</td><td>Normal</td><td>Normal</td><td>stamping of feet; Romberg sign Overlifting and slapping of feet</td></tr><tr><td>Plegic</td><td>Slow</td><td>Short</td><td>Narrow</td><td>Circumduction and scraping of affected leg(s)</td></tr><tr><td>Dystonic</td><td>Slow</td><td>Normal</td><td>Erratic</td><td>Twisting athetoid movements</td></tr><tr><td>Parkinsonian- festinating</td><td>Slow until festination</td><td>Short</td><td>Normal</td><td>interrupt walking Quickening step, forward leaning, shuffling, may have trouble with</td></tr><tr><td>Waddling-myopathic Toppling Normal pressure hydrocephalus</td><td>Normal Slow until fall Slow</td><td>Normal Short Short</td><td>Slightly wide Widened (protective) Slightly wide</td><td>gait initiation Overlifting of hip(s) Sudden loss of balance Numerous problems with axial body movement</td></tr><tr><td>Frontal lobe</td><td>Slow</td><td>Greatly shortened</td><td>Slightly wide (protective)</td><td>Difficulty starting and stopping; tendency for feet to “stick” to floor</td></tr><tr><td>Aging and marche a petit pas</td><td>Slow</td><td>Slightly shortened</td><td>_—_ Slightly widened</td><td>Cautious, slight forward lean</td></tr></table>
======================================
<table><thead><th>FIBER TYPE</th><th>ALTERNATIVE DESIGNATION</th><th>FIBER DIAMETER</th><th>CONDUCTION VELOCITY (M/S)</th><th>FUNCTION AND SYMPTOMS OF DYSFUNCTION</th></thead><tr><td>A-aand -B Large, heavily myelinated</td><td>Il</td><td>5-20</td><td>30-70</td><td>Touch, pressure</td></tr><tr><td>A-yY A-6</td><td>la Il</td><td>3-6 5</td><td>15-30 12-30</td><td>Spindle afferents Pain and temperature, soma touch</td></tr><tr><td>Small, thinly myelinated B</td><td></td><td>13</td><td>3-15</td><td>(sharp, lancinating, prickly pain)</td></tr><tr><td>Cc Small, unmyelinated; polymodal</td><td>IV</td><td>0.3-1.</td><td>0.5-2</td><td>Slow pain and temperature (dull, burning, poorly localized pain)</td></tr></table>
======================================
<table><thead><th>NOMENCLATURE IN THE DESCRIPTION OF PAIN ABNORMAL SENSATION (SEE ALSO TABLE 9-1)</th><th>AND</th></thead><tr><td colspan="2">Dysesthesia: Any abnormal sensation described as unpleasant by the patient</td></tr><tr><td>Hyperalgesia: Exaggerated pain response from a stimulus; usually includes aspects of summation with stimulus of constant intensity and aftersensation</td><td>normally painful repeated</td></tr><tr><td>painful stimulus; related to hyperalgesia Hyperesthesia (hypesthesia): Exaggerated perception of</td><td>touch</td></tr><tr><td>stimulus</td><td></td></tr><tr><td>Allodynia: Abnormal perception of pain from a normally nonpainful mechanical or thermal stimulus; usually elements of delay in perception and of aftersensation Hypoalgesia (hypalgesia): Decreased sensitivity and</td><td>has raised</td></tr><tr><td>threshold to painful stimuli Anesthesia: Reduced of all sensation,</td><td>touch</td></tr><tr><td>perception mainly Pallanesthesia: Loss of perception of vibration</td><td></td></tr><tr><td>Analgesia: Reduced perception of pain stimulus</td><td></td></tr><tr><td>Paresthesia: Mainly spontaneous abnormal sensation that unpleasant; usually described as “pins and needles”</td><td>is not</td></tr><tr><td>Causalgia: Burning pain in the distribution of one or peripheral nerves</td><td>more</td></tr></table>
======================================
<table><thead><th>GENERIC NAME</th><th>ORAL DOSE, MG</th><th>INTERVAL</th><th>COMMENTS</th></thead><tr><td colspan="4">Nonopioid analgesics</td></tr><tr><td>Aspirin</td><td>650</td><td>q4h</td><td>Enteric-coated preparations available</td></tr><tr><td>Acetaminophen</td><td>650</td><td>q4h</td><td>Side effects uncommon</td></tr><tr><td>Ibuprofen</td><td>400</td><td>q4-6h</td><td></td></tr><tr><td>Naproxen</td><td>250-500</td><td>qi2h</td><td>Delayed effects may be due to long half-life</td></tr><tr><td>Ketorolac</td><td>10-20</td><td>q4-6h</td><td>Useful postoperatively and for weaning from narcotics. Can be used</td></tr><tr><td>Trisalicylate</td><td>1,000-1,500</td><td>qi2h</td><td>intramuscularly Fewer gastrointestinal or platelet effects than aspirin</td></tr><tr><td>Indomethacin</td><td>25-50</td><td>q8h</td><td>Gastrointestinal side effects common</td></tr><tr><td colspan="4" rowspan="4">Tramadol 50 qoh Potent nonnarcotic with similar side effects but less respiratory depression Narcotic analgesics 30-60 Nausea</td></tr><tr><td colspan="4"></td></tr><tr><td colspan="4"></td></tr><tr><td colspan="4"></td></tr><tr><td>Codeine</td><td></td><td>q4h</td><td>common</td></tr><tr><td>Oxycodone</td><td>—</td><td>5-10 q4-6h</td><td>Usually available combined with acetaminophen or aspirin</td></tr><tr><td>Morphine</td><td>10 q4h</td><td>60 q4h</td><td></td></tr><tr><td>Morphine, sustained release</td><td>—</td><td>90 q12h</td><td>Oral slow-release preparation</td></tr><tr><td>Hydromorphone</td><td>1-2 q4h</td><td>2-4 q4h</td><td>Shorter acting than morphine sulfate</td></tr><tr><td>Levorphanol</td><td>2 q6-8h</td><td>4 q6-8h</td><td>Longer acting than morphine sulfate; absorbed well orally</td></tr><tr><td>Methadone</td><td>10 q6-8h</td><td>20 q6-8h</td><td>Delayed sedation because of long half-life</td></tr><tr><td>Meperidine</td><td>75-100 q3—4h</td><td>300 q4h</td><td>Poorly absorbed orally; normeperidine is a toxic metabolite</td></tr><tr><td>Fentanyl</td><td>25 to 100 ug</td><td>apply q72h</td><td>Parenteral and transcutaneous (“patch”) use</td></tr><tr><td colspan="4">Antiepileptic and related drugs</td></tr><tr><td>Phenytoin</td><td>100</td><td>q6-8h</td><td>Side effects of drowsiness, ataxia, nystagmus</td></tr><tr><td>Carbamazepine</td><td>200-300</td><td>qoh</td><td></td></tr><tr><td>Gabapentin</td><td>300-2,700</td><td>q8h</td><td></td></tr><tr><td colspan="4">Pregabalin 25-100 q8h</td></tr><tr><td>Special Agents Mexiletine Ketamine</td><td>150-200 _</td><td>q4-6h 10-25 ug/kg/hIV</td><td>Heart block Dysphoria, confusion</td></tr></table>
======================================
<table><thead><th>SYMPTOMS</th><th>STRUCTURES AFFECTED</th></thead><tr><td>Paresthesia, tingling, buzzing Burning, heat, cold</td><td>Large fibers (in nerve or posterior columns) Small fibers</td></tr><tr><td>Band tightness Lancinating pain</td><td>Lemniscal system of cord Small-fiber neuropathy and</td></tr><tr><td>Hyperalgesia</td><td>radiculopathy Partial peripheral nerve damage</td></tr></table>
======================================
<table><thead><th>TYPE</th><th>SITE</th><th>AGE AND SEX</th><th>CLINICAL CHARACTERISTICS</th><th>DIURNAL PATTERN</th><th>LIFE PROFILE</th><th>PROVOKING FACTORS</th><th>ASSOCIATED FEATURES</th><th>TREATMENT</th></thead><tr><td>Migraine without aura (common migraine)</td><td>Frontotempo- ral Uni- or bilateral</td><td>Adolescents, young to mid- dle-aged adults, sometimes chil- dren, morecom- mon in women</td><td>Throbbing (pulsa- tile); worse behind one eye or ear Becomes dull ache and generalized. Scalp sensitive</td><td>Upon awaken- ing or later in day Duration:4-24h in most cases, sometimes longer</td><td>Irregular inter- vals, weeks to months —Tendstodecrease in middle age and during pregnancy</td><td>Bright light, noise, ten- sion, alcohol Relieved by darkness and sleep</td><td>Nausea and vomit- ing in some cases</td><td>_Triptans, ergota- mine,nonsteroida antiinflammatory agents Propranolol or amitriptyline for prevention</td></tr><tr><td>Migraine with aura (neuro- logic migraine) Cluster (histamine</td><td>Same as above Orbitotempo-</td><td>Same as above Adolescent and.</td><td>Same as above Family history fre- quent nonthrob-</td><td>Same as above Usually</td><td>Same as above Nightly daily</td><td>Same as above Alcohol</td><td>Scintillating lights, visual loss, and scotomas Unilateral paresthe- sias, weakness, dysphasia, ver- tigo, rarely con- fusion</td><td>Same as above Op,</td></tr><tr><td>Tension headaches</td><td>Generalized</td><td>Mainly adults, both sexes, more common, in women,</td><td>Pressure (nonthrob- bing), tightness, aching</td><td>Continuous, variable intensity, for days, weeks, or months</td><td>or years One or more peri- ods of months to years</td><td>Fatigue and nervous strain</td><td>Depression, worry, anxiety</td><td>recalcitrant cases Antianxiety and antidepressant drugs</td></tr><tr><td>Meningeal irrita- tion (meningitis, subarachnoid hemorrhage)</td><td>Generalized, or bioccipi- tal, or bifrontal</td><td>Any age, both sexes</td><td>Intense, steady deep pain, may be worse in neck</td><td>Rapid evolu- tion—min- utes to hours</td><td>Single episode</td><td></td><td>Neck stiff on for- ward bending Kernig and Bru- dzinski signs</td><td>For meningitis or bleeding (see text</td></tr><tr><td>Brain tumor</td><td>Unilateral or generalized</td><td>Any age, both sexes</td><td>Variable intensity May awaken patient Steady pain</td><td>Lasts minutes to hours; worse in early A.M., increasing severity</td><td>Once in a life- time: weeks to months</td><td>Sometimes position</td><td>Papilledema Vomiting Impaired menta- tion Seizures Focal signs</td><td>Corticosteroids Mannitol Treatment of tumor</td></tr><tr><td>Temporal arteritis</td><td>Unilateral or bilateral, usually tem- poral</td><td>Older than 50 years, either sex</td><td>Throbbing, then persistent ach- ing and burning, arteries thick- ened and tender</td><td>Intermittent, then continu- ous</td><td>Persists for weeks to months</td><td></td><td>Loss of vision Polymyalgia rheu- matica Fever, weight loss, increased sedi-</td><td>Corticosteroids</td></tr></table>
======================================
<table><thead><th>TYPES OF FACIAL</th><th>PAIN</th><th></th><th>AGGRAVATING/</th><th></th><th></th></thead><tr><td>TYPE Trigeminal neural- gia (tic dou- loureux)</td><td>SITE Second and third divisions of tri- geminal nerve, unilateral</td><td>CLINICAL CHARACTERISTICS Men:women = 1:3 Older than age 50 years Paroxysms (10-30 s) of stabbing, burn- ing pain; persis- tent for weeks or longer Trigger points</td><td>RELIEVING FACTORS Touching trigger points, chewing, smiling, talking, blowing nose, yawning</td><td>ASSOCIATED DISEASES Idiopathic If in young adults, multiple sclerosis Vascular anomaly Tumor of fifth cra- nial nerve</td><td>TREATMENT Carbamazepine, phen- ytoin, gabapentin, alcohol injection, coagulation, or sur- gical (vascular) decompression of root</td></tr><tr><td>Postzoster neuralgia</td><td>Unilateral</td><td>No sensory or motor paralysis History of zoster</td><td>Contact, movement</td><td>Herpes zoster</td><td>Carbamazepine, anti-</td></tr><tr><td>Costen syndrome (temporomandib- ular joint syn- drome)</td><td>Unilateral, behind or front of ear, temple, face</td><td>slight sensory loss Dermal scars Severe aching pain, intensified by chewing Tenderness over temporomandib- ular joints</td><td>Chewing, pressure over temporo- mandibular joints</td><td>Loss of teeth, rheu- matoid arthritis</td><td>Correction of bite Surgery in some</td></tr><tr><td>Tolosa-Hunt syn- drome (see Chap. 47)</td><td>Unilateral, mainly retroorbital</td><td>ing molars Intense sharp, ach- ing pain, associ- ated with ophthalmople- gias and sensory loss over fore- head; pupil</td><td></td><td>Granulomatous lesion of cavern- ous sinus or superior orbital fissure</td><td>Corticosteroids</td></tr><tr><td>Raeder paratrigemi- nal syndrome</td><td>Unilateral, fronto- temporal and maxilla</td><td>ally spared Intense sharp or aching pain, pto- sis, miosis, pre-</td><td></td><td>Parasellar tumors, granulomatous lesions, trauma,</td><td>Depends on type of lesion</td></tr><tr><td>“Migrainous neu- ralgia” (migraine cluster crossover)</td><td>Orbitofrontal, tem- ple, upper jaw, angle of nose and cheek</td><td>served sweating See cluster head- ache, Table 10-1</td><td>Alcohol in some</td><td>idiopathic</td><td>Indomethacin, triptan, or ergotamine before anticipated attack</td></tr><tr><td>Carotidynia, lower- half headache, sphenopalatine neuralgia, etc.</td><td>Unilateral face, ear, jaws, teeth, upper neck</td><td>Both sexes, con- stant dull ache 24h</td><td>Compression of common carotid at or below bifur- cationreproduces pain in some</td><td>Occasionally with cranial arteritis, carotid tumor, migraine and cluster headache</td><td>Corticosteroid acutely; triptans Calcium channel blockers</td></tr><tr><td>Atypical facial neu- ralgia (facial pain of indeterminate cause)</td><td>Unilateral or bilat- eral; cheek or angle of cheek and nose; deep in nose</td><td>Predominantly female 30-50 years of age Continuous intoler- able pain Mainly maxillary areas</td><td></td><td>Depressive and anx- iety states Idiopathic</td><td>Antidepressant and antianxiety medica- tion,</td></tr></table>
======================================
<table><thead><th>INTERVERTEBRAL DISC SPACE</th><th>ROOT AFFECTED</th><th>PAIN REFERRAL</th><th>WEAKNESS</th><th>REFLEX CHANGE</th><th>ADDITIONAL FEATURES</th></thead><tr><td>C4-C5</td><td>C5</td><td>Shoulder, trapezius</td><td>Supra- and infraspina- tus deltoid, slight biceps weakness</td><td>Slightly diminished. biceps jerk</td><td></td></tr><tr><td>C5-C6</td><td>C6</td><td>Trapezius ridge and tip of shoulder, radi- ation to anterior upper arm, thumb, and index finger</td><td>Biceps, brachioradia- lis, extensor carpi radialis</td><td>Diminished bicepsand supinator jerk</td><td>Tenderness over spine or scapula and supras- capular region; pares- thesias in thumb and index finger</td></tr><tr><td>C6-C7</td><td>C7</td><td>Shoulder, axilla, pos- terolateral arm, elbow, and middle finger</td><td>Triceps, wrist exten- sors</td><td>Diminished or absent triceps jerk</td><td>Tenderness over medial scapula and supracla- vicular region or tri- ceps. May complain of paresthesias in most of the</td></tr><tr><td>C7-T1</td><td>C8</td><td>Medial forearm</td><td>Intrinsic hand muscles</td><td>__ Slight or no decrease in triceps jerk</td><td>fingers Mimics ulnar palsy</td></tr><tr><td>L2-L3</td><td>L3</td><td>Anterior thigh, over knee</td><td>Thigh adductor, quad- riceps</td><td>—_ Absent or diminished knee jerk</td><td></td></tr><tr><td>L3-L4</td><td>L4</td><td>Anterolateral thigh, medial foreleg</td><td>Anterior tibial, some- times with partial foot drop</td><td>Diminished or normal knee jerk</td><td></td></tr><tr><td>L4-L5</td><td>L5</td><td>Posterolateral gluteal sciatica; lateral thigh, anterolateral foreleg, dorsal foot, lateral malleolus and great or second and third toe</td><td>Extensor hallucis lon- gus and extensor digitorum brevis; some weakness of anterior tibialis, sometimes with foot drop</td><td>Unaffected (except posterior tibial)</td><td>Pain with straight-leg raising and variant tests; tenderness over fourth lumbar lateral process and lateral gluteal region</td></tr><tr><td>L5-S1</td><td>S1</td><td>Midgluteal sciatica; posterior thigh, pos- terolateral leg, lat- eral foot, heel, or lateral toes</td><td>Plantar-flexor and hamstring weak- ness</td><td>Absent or diminished ankle jerk</td><td>Pain with straight-leg raising and variant tests; tenderness over lumbosacral (L5-S1) joint and sciatic notch; discomfort walking on. heels</td></tr></table>
======================================
<table><thead><th>CAUSES OF OPTIC</th><th>DISC SWELLING</th><th></th><th></th><th></th></thead><thead><th>OPHTHALMIC ABNORMALITY</th><th>UNDERLYING CAUSE</th><th>VISUAL LOSS</th><th>ASSOCIATED SYMPTOMS</th><th>PUPILS</th></thead><tr><td>Papilledema</td><td>Increased intracranial pressure</td><td>or transient blurring; constriction of visual fields and enlargement of blind spot; findings almost always binocular</td><td>Headache; signs of intracranial mass</td><td>Normal unless suc- ceeded by optic atrophy</td></tr><tr><td>Anterior ischemic optic neuropathy</td><td>Infarction of disc and intraorbital optic nerve due to atherosclerosis arteritis</td><td>Acute visual loss, monocular (usually); may be an altitu- dinal defect</td><td>Headache with tempo- ral arteritis</td><td>—_ Afferent pupillary defect</td></tr><tr><td>Optic neuritis’ (“papil- litis”)</td><td>or temporal Inflammatory changes in disc and intraorbital part of optic nerve— usually due to MS,</td><td>Rapidly progressive visual loss; usually monocular</td><td>Tender globe, pain on ocular movement</td><td>Afferent pupillary defect</td></tr><tr><td>Hyaline bodies? (drusen)</td><td>sometimes to ADEM Congenital, familial</td><td>Usually none but may be slowly progressive Enlargement of blind spot or arcuate inferior nasal defect</td><td>Usually none; rarely transient visual obscurations</td><td>Normal</td></tr></table>
======================================
<table><thead><th colspan="4">ACTIONS OF THE EXTRAOCULAR MUSCLES</th></thead><thead><th>MUSCLE</th><th>PRIMARY ACTION</th><th>SECONDARY ACTION</th><th>OCULOMOTOR NERVE</th></thead><tr><td>Medial rectus</td><td>Adduction</td><td>_</td><td>Il</td></tr><tr><td>Lateral rectus</td><td>Abduction</td><td>_</td><td>VI</td></tr><tr><td>Superior rectus</td><td>Elevation</td><td>Intorsion</td><td>Tl</td></tr><tr><td>Inferior rectus</td><td>Depression</td><td>__Extorsion</td><td>Tl</td></tr><tr><td>Superior</td><td>Intorsion</td><td>Depression</td><td>IV</td></tr><tr><td>oblique Inferior oblique</td><td>— Extorsion</td><td>Elevation</td><td>Il</td></tr></table>
======================================
<table><thead><th></th><th>SIZE AND SIDE</th><th colspan="3">ACCOMMODATIVE LIGHT REACTION REACTION SPECIAL FEATURES</th></thead><tr><td rowspan="2">Argyll Robertson pupil Adie tonic pupil</td><td>Small, irregular,</td><td>No</td><td>Yes</td><td>Syphilitic, but also diabetic</td></tr><tr><td></td><td>asymmetrical Initially fixed, later enlarged to medium size; bilateral</td><td>No or poor; only with sustained bright light</td><td>Yes, with tonic reaction</td><td>—_ Tonic contraction to prolonged accommodation; associated areflexia</td></tr></table>
======================================
<table><thead><th>DESIGNATION</th><th>INHERITANCE</th><th>GENE DEFECT</th><th>TYPE OF HEARING LOSS</th><th>ASSOCIATED DEFECTS.</th><th>FREQUENCY</th></thead><tr><td>IFN A IFN B</td><td>AD AR (most common)</td><td>GJB2 (connexin), MYO7, USH, SLC26A4, and allelic variants of these genes; GJB2 accounts for half of cases in most populations (AD)</td><td>Progressive sensorineural</td><td>Same loci as cause syndromic hearing loss such as Usher and Pendred syndromes, as noted below; 80% of hereditary deafness from recessive gene</td><td>Accounts for half of nonsyndromic recess deafness (connexin)</td></tr><tr><td>DEN X familial otosclerosis I. Syndromic</td><td>X-linked AD with reduced penetrance</td><td>COLIA1</td><td>Conductive</td><td></td><td></td></tr><tr><td>Naardenburg Typel</td><td>AD</td><td>PAX3 and some due to SOX, WSIV (transcription factors)</td><td>Variable sensorineural</td><td>Dystopic canthi, heterochromia, iritis, poliosis</td><td>Most common dominat syndromic hearing Ic accounts for 3% of childhood hearing lo</td></tr><tr><td>Type II</td><td></td><td></td><td></td><td>Same as type I but no</td><td></td></tr><tr><td>Ill</td><td></td><td></td><td></td><td>dystopia limb defects</td><td></td></tr><tr><td>Type Type IV</td><td></td><td>EDN (receptors in</td><td></td><td>Upper Pigmentary defects and</td><td></td></tr><tr><td>3rachio-oto-renal syndrome</td><td>AD</td><td>endothelin pathways) EYA1 in half (transcription factor involved in development of inner ear and kidney)</td><td>Conductive (75%), sensorineural and mixed</td><td>Hirschsprung disease Second most common dominant form of hearing loss. Brachial cleft cysts, cleft palate, malformations of external ear and of</td><td>2%</td></tr><tr><td>stickler</td><td>AD</td><td>STL1-3</td><td>Progressive sensorineural hearing loss</td><td>kidney Cleft palate, epiphyseal dysplasia; severe myopia and retinal detachment in 1 and 3</td><td></td></tr><tr><td>Neurofibromatosis type 2</td><td>AD</td><td>NF2</td><td>Acoustic neuromas</td><td>types Evident on MRI; proclivity to other tumors</td><td></td></tr><tr><td>Jsher Typel</td><td>AR</td><td>USH genes (unconventional myosin and adhesion molecules)</td><td>Severe congenital sensorineural hearing loss, vestibular dysfunction; retinitis pigmentosa</td><td>Most common recessive types; retinitis pigmentosa after first decade; type 1 has abnormal vestibular function</td><td>3-6%</td></tr><tr><td>Type Il</td><td></td><td></td><td>Moderate to severe hearing loss, late retinitis</td><td></td><td></td></tr><tr><td>Type Hl</td><td></td><td></td><td>Progressive hearing loss and variable</td><td></td><td></td></tr></table>
======================================
<table><thead><th>endred</th><th>AR</th><th>SLC13A4 in half (same mutation causes nonsyndromic hearing loss)</th><th>Profound congenital sensorineural hearing loss; abnormal bony labyrinth (Mondini dysplasia)</th><th>Euthyroid goiter</th><th>4%</th></thead><tr><td>ervell and Lange-Nielsen</td><td>AR</td><td>KVQT, KCNE (delayed potassium rectifier inner ear)</td><td>Congenital deafness</td><td>Prolonged QT interval on ECG; syncope, sudden death</td><td>&lt;1%</td></tr><tr><td>cefsum</td><td>AR</td><td></td><td>Progressive sensorineural deafness</td><td>Retinitis pigmentosa, sensory polyneuropathy; elevated phytanic acid</td><td></td></tr><tr><td>\lport</td><td>X-linked</td><td>X-linked in 85% but also autosomal dominant and recessive forms (basement membrane formation in cochlea, eye, and kidney)</td><td>Progressive sensorineural hearing loss</td><td>Glomerulonephritis and renal failure</td><td>1%</td></tr><tr><td>Mohr-Tranebjerg</td><td>X-linked</td><td>TIMMBA (a translocation protein from cyutopsol to mitochondria)</td><td>Progressive childhood deafness</td><td>Visual disability, dystonia, mild retardation</td><td></td></tr><tr><td>‘earns-Sayre</td><td>Mitochondrial</td><td>MTRNT lat 3243 site and MTTS 1 of mitochondrial genome</td><td>Late-onset progressive sensorineural hearing loss</td><td>Diabetes, other features typically associated with mitochondrial mutations—see Chap. 37</td><td></td></tr><tr><td>artter IV</td><td></td><td>BSND; CI channel</td><td>Congenital, severe</td><td>Salt wasting</td><td></td></tr></table>
======================================
<table><thead><th colspan="3">DIFFERENTIATION OF PERIPHERAL FROM CENTRAL NYSTAGMUS (SEE TEXT)</th></thead><thead><th></th><th>PERIPHERAL</th><th>CENTRAL</th></thead><tr><td>Vertigo and nausea Direction of nystagmus</td><td>Pronounced ¢ Mixed torsional- vertical e Mixed torsional- horizontal ¢ May be pure</td><td>Mild e Pure horizontal ¢ Pure vertical e Pure torsional</td></tr><tr><td>Influence of gaze</td><td>horizontal Does not change direction with</td><td>Direction changes with gaze</td></tr><tr><td>Visual fixation</td><td>gaze Inhibits nystagmus</td><td>Does not affect nystagmus</td></tr><tr><td>Latency following repositioning, maneuver</td><td>Up to 20s</td><td>Brief</td></tr><tr><td>Direction changing with reversal of head position</td><td>Present and characteristic</td><td>Absent</td></tr><tr><td>Hearing loss/ tinnitus</td><td>Variably present</td><td>Absent</td></tr><tr><td>Signs of brainstem or cerebellar disease</td><td>Absent</td><td>Generally present</td></tr></table>
======================================
<table><thead><th>SYNDROME</th><th>NEUROLOGIC FINDINGS</th><th>DISORDERS OF EQUILIBRIUM</th><th>TYPE OF NYSTAGMUS?</th><th>HEARING</th><th>LABORATORY EXAM</th></thead><tr><td>Labyrinths (postural vertigo, trauma, Méniére disease, aminoglycoside toxicity, labyrinthitis)</td><td>|</td><td>Ipsilateral past pointing and lateral propulsion to side of lesion</td><td>Horizontal or rotary to side opposite lesion, positional and position changing, fatigable</td><td>— Normal or conduction or neurosensory deafness with recruitment</td><td>Vestibular paresis by caloric testing, directional preponderance</td></tr><tr><td>Vestibular nerve and ganglia (vestibular neuronitis, herpes zoster)</td><td>Auditory eighth and seventh cranial nerve abnormalities; abnormal head impulse test to affected side</td><td>Ipsilateral past pointing and lateral propulsion to side of lesion</td><td>Unidirectional positional</td><td>Sometimes sensorineural deafness, without recruitment (vestibulo- labyrinthitis)</td><td>Radiography and CT may be normal or abnormal Vestibular paresis on caloric testing Directional preponderance</td></tr><tr><td>Cerebellopontine angle (acoustic neuroma, glomus and other tumors)</td><td>Ipsilateral fifth, seventh, ninth, tenth cranial nerves, cerebellar ataxia Increased intracranial</td><td>Ataxia and falling ipsilaterally</td><td>Gaze-paretic, positional, coarser to side of lesion</td><td>Sensorineural deafness without recruitment</td><td>CT and MRI abnormal Vestibular paresis on caloric testing BAEPs abnormal Increased CSF protein</td></tr><tr><td>Brainstem and cerebellum (infarcts, tumors, viral infections)</td><td>pressure (late) Multiple cranial nerves, brainstem tract signs, cerebellar ataxia</td><td>Ataxia present with eyes open</td><td>Coarse horizontal and vertical, gaze-paretic</td><td>Usually normal</td><td>Hyperactive labyrinths or directional preponderance on caloric testing CT, MRI, and BAEPs abnormal</td></tr><tr><td>Higher (cerebral) connections</td><td>Aphasia, visual field, hemimotor, hemisensory, and other cerebral abnormalities, seizures</td><td>No change</td><td>Usually absent</td><td>Normal</td><td>in most cases No change in caloric responses CT and electro- encephalogram may be abnormal</td></tr></table>
======================================
<table><tr><td colspan="2">I. Generalized seizures (bilaterally symmetrical and without local</td></tr><tr><td colspan="2">onset) A. Tonic, clonic, or tonic-clonic (grand mal)</td></tr><tr><td>B. Absence (petit mal) 1. With loss of consciousness only 2. brief automatic</td><td></td></tr><tr><td>Complex—with tonic, clonic, or</td><td></td></tr><tr><td>movements</td><td></td></tr><tr><td>C. Lennox-Gastaut syndrome D. Juvenile myoclonic epilepsy</td><td></td></tr><tr><td>spasms (West syndrome) F. Atonic (astatic, akinetic) seizures (sometimes with jerks)</td><td>myoclonic</td></tr><tr><td>IL. Partial, or focal, seizures (seizures beginning locally) A. Simple (without loss of consciousness or alteration in</td><td>psychic</td></tr><tr><td>function) 1. Motor-frontal lobe origin (tonic, clonic, jacksonian; benign childhood epilepsy; epilepsia continua) 2. Somatosensory special (visual,</td><td>tonic-clonic; partialis auditory,</td></tr><tr><td>Beginning simple partial impairment of consciousness</td><td>progressing</td></tr><tr><td>2. With impairment of consciousness at onset</td><td></td></tr><tr><td>IIL. Special epileptic syndromes</td><td></td></tr><tr><td>A. Myoclonus and myoclonic seizures</td><td></td></tr><tr><td>epilepsy C. Acquired aphasia with convulsive disorder</td><td></td></tr><tr><td>D. Febrile and other seizures of infancy and childhood</td><td></td></tr></table>
======================================
<table><thead><th colspan="2">COMMON PARTIAL SEIZURE PATTERNS</th></thead><thead><th>CLINICAL TYPE</th><th>LOCALIZATION</th></thead><tr><td>Somatic motor Jacksonian (focal motor) Masticatory, salivation, speech arrest</td><td>Prerolandic gyrus Amygdaloid nuclei, opercular</td></tr><tr><td>Simple contraversive Head and</td><td>Frontal motor cortex</td></tr><tr><td>eye turning associated with arm</td><td>Supplementary</td></tr><tr><td>dystonic postures Somatic and special sensory (auras) Somatosensory Unformed images, lights,</td><td>Contralateral postrolandic Occipital</td></tr><tr><td>patterns Auditory</td><td>Heschl gyri</td></tr><tr><td>Olfactory Gustatory</td><td>temporal Insula</td></tr><tr><td>Visceral: autonomic Complex partial seizures</td><td>Insular-orbital-frontal cortex</td></tr><tr><td>Formed hallucinations</td><td>Temporal neocortex or amygdaloid-hippocampal complex</td></tr><tr><td colspan="2">Illusions —</td></tr><tr><td>Dyscognitive experiences (déja vu, dreamy states,</td><td>_</td></tr><tr><td>depersonalization) Affective states (fear, elation)</td><td>Temporal</td></tr><tr><td>depression, or Automatism (ictal and postictal)</td><td>Temporal and frontal</td></tr><tr><td>Absence</td><td>Frontal cortex, amygdaloid— hippocampal complex, reticular—cortical system</td></tr></table>
======================================
<table><thead><th></th><th>GENE</th><th>PROTEIN INVOLVED</th></thead><tr><td colspan="3">Channelopathies</td></tr><tr><td>Sodium channels Familial generalized seizures with febrile</td><td>SCN1A,B, (GABA)</td><td>Sodium channel subunits; less often, GABA receptor</td></tr><tr><td>seizures “plus”; see text Benign familial neonatal convulsions</td><td>SCN2A</td><td>Sodium channel subunits</td></tr><tr><td>Potassium channels Benign infantile epilepsy</td><td>KCNQ23</td><td>Potassium channel subunits</td></tr><tr><td>Episodic ataxia type 1 with partial epilepsy Ligand-gated channels Autosomal dominant nocturnal frontal</td><td>KCNA1 CHRNA 2,4</td><td>Nicotinic acetylcholine receptor subunits</td></tr><tr><td>seizures Familial generalized and febrile seizures Juvenile myoclonic epilepsy</td><td>GABRG2 GABRAI1 (CACNB4)</td><td>GABA g receptor subunit GABA g receptor subunit; less often, calcium channel</td></tr><tr><td>Calcium channels Episodic ataxia type 2 with spike-wave</td><td>CACNA1A</td><td>subunit Calcium channel subunit</td></tr><tr><td>seizures Malformations of cortical development</td><td></td><td></td></tr><tr><td>Holoprosencephaly, generalized epilepsy</td><td>SHH, PTCH, ZIC2, SIX3, TGIF EMX2</td><td>Sonic hedgehog, SHH receptor, transcription factors Homeodomain</td></tr><tr><td>Schizencephaly, generalized epilepsy Tuberous sclerosis, generalized epilepsy</td><td>TSC1, 2</td><td>protein Hamartin, tuberin</td></tr><tr><td></td><td>LIS1</td><td>factor acid</td></tr><tr><td>Lissencephaly, generalized epilepsy</td><td></td><td>Platelet-activating hydrolase</td></tr><tr><td>Double-cortex syndrome, generalized epilepsy</td><td>DCX</td><td>Doublecortin</td></tr><tr><td>Heterotopia, focal epilepsy</td><td>FLN1</td><td>Filamin1</td></tr><tr><td>Fukuyama muscular dystrophy, lissencephaly, generalized epilepsy</td><td>FCMD</td><td>Fukutin</td></tr><tr><td>Walker-Warburg syndrome, generalized</td><td>POMT1</td><td>O-mannosy] transferase</td></tr><tr><td>epilepsy</td><td></td><td></td></tr><tr><td>disease,</td><td>MEB</td><td>PMGnT1</td></tr><tr><td>Muscle-eye-brain generalized epilepsy</td><td></td><td>Lycosyltransferase,</td></tr><tr><td>Progressive myoclonic epilepsies (PME) Unverricht-Lundborg disease with PME</td><td>EPM1</td><td>Cystatin B</td></tr><tr><td>Lafora body disease with PME Myoclonic epilepsy with ragged red fibers with</td><td>EPM2A tRNAlys DRPLA</td><td>Laforin, protein tyrosine phosphatase Mitochondrial lysine tRNA</td></tr><tr><td>Dentatorubro-pallidoluysian atrophy PME</td><td></td><td>Atrophin-1</td></tr><tr><td>Gaucher disease</td><td>PSAP</td><td>B-Glucocerebrosidase</td></tr><tr><td>Sialidosis I</td><td>NEU1</td><td>Sialidase</td></tr><tr><td>type Ceroid lipofuscinosis (CLN) and PME</td><td>CLN</td><td>CLN2, CLN3, CLN5, CLN6 also cause generalized, atonic and atypical absence seizures</td></tr><tr><td colspan="3">Mixed seizure types</td></tr><tr><td>Lipoid proteinosis and temporal lobe epilepsy Autosomal dominant lateral temporal lobe epilepsy</td><td>ECM1 LGI1</td><td>Extracellular matrix protein 1 Leucine-rich glioma inactivated protein</td></tr><tr><td>CLNS8; progressive nonmyoclonic epilepsy with retardation</td><td>CLN8</td><td>Membrane protein in endoplasmic reticulum</td></tr></table>
======================================
<table><thead><th>DIFFERENT AGE</th><th>GROUPS</th></thead><tr><td>AGE OF ONSET</td><td>PROBABLE CAUSE?</td></tr><tr><td>Neonatal</td><td>Congenital maldevelopment, birth injury, anoxia, metabolic disorders (hypo- calcemia, hypoglycemia, vitamin Bg deficiency, biotinidase deficiency, phenylketonuria, and others)</td></tr><tr><td>Infancy (1-6 months)</td><td>As above; infantile spasms (West syndrome)</td></tr><tr><td>Early childhood (6 months-3 years)</td><td>Infantile spasms, febrile convulsions, birth injury and anoxia, infections, trauma, metabolic disorders, cortical dysgenesis,</td></tr><tr><td>Childhood (3-10 years)</td><td>drug poisoning Perinatal anoxia, injury at birth or later, infections, thrombosis of cerebral arteries or veins, metabolic disorders, cortical malformations, Lennox-Gastaut syndrome, “idiopathic,” probably inherited, epilepsy (Rolandic epilepsy)</td></tr><tr><td>Adolescence (10- 18 years)</td><td>Idiopathic epilepsy, including genetically transmitted types, juvenile myoclonic epilepsy, trauma, drugs</td></tr><tr><td>Early adulthood (18-25 years)</td><td>Idiopathic epilepsy, trauma, neoplasm, withdrawal from alcohol or other sedative drugs</td></tr><tr><td>Middle age (35-60 years) Late life (older than 60 years)</td><td>Trauma, neoplasm, vascular disease, alcohol or other drug withdrawal Vascular disease (usually postinfarction), tumor, abscess, degenerative disease, trauma</td></tr></table>
======================================
<table><thead><th rowspan="2">GENERIC NAME</th><th rowspan="2">TRADE NAME</th><th colspan="2">USUAL DOSAGE</th><th rowspan="2">PRINCIPAL THERAPEUTIC INDICATIONS</th><th rowspan="2">SERUM HALF-LIFE, H</th><th rowspan="2">EFFECTIVE BLOOD LEVEL,? UG/ML</th></thead><thead><th></th><th></th><th>a CHILDREN, MG/KG</th><th>ADULTS, MG/D</th><th></th><th></th><th></th></thead><tr><td colspan="7">Major anticonvulsants used as monotherapy</td></tr><tr><td>Valproic acid</td><td>Depakote</td><td>30-60</td><td>1,000-3,000.</td><td>Generalized tonic- clonic, partial, absence, myoclonic</td><td>6-15</td><td>50-100</td></tr><tr><td>Phenytoin</td><td>Dilantin</td><td>47</td><td>300-400</td><td>Generalized tonic- clonic, partial, absence, myoclonic</td><td>12-36</td><td>10-20</td></tr><tr><td>Carbamazepine</td><td>_ Tegretol</td><td>20-30</td><td>600-1,200°</td><td>Generalized tonic- clonic, partial</td><td>14-25</td><td>4-12</td></tr><tr><td>Oxcarbazepine Phenobarbital</td><td>Trileptal Luminal</td><td>10-40 3-5 (8 for</td><td>900-2,400 90-200</td><td>Partial Generalized tonic-</td><td>1-5 40-120</td><td>_ 15-40</td></tr><tr><td>Lamotrigine</td><td>Lamictal</td><td>infants) 0.5</td><td>300-500</td><td>clonic, partial Generalized, partial</td><td>15-60</td><td>2-7</td></tr><tr><td>Levetiracetam Adjuvant and special-use</td><td>Keppra anticonvulsants</td><td>20-60</td><td>500-3,000°</td><td>Partial, myoclonic</td><td>6-8</td><td>_</td></tr><tr><td>Topiramate</td><td>Topamax</td><td>_</td><td>400</td><td>Generalized tonic- clonic, atypical absence, myoclonic, partial</td><td>20-30</td><td>_</td></tr><tr><td>Tiagabine</td><td>Gabitril</td><td>_</td><td>30-60</td><td>Partial and secondary</td><td>= 7-9</td><td>_</td></tr><tr><td></td><td></td><td></td><td></td><td>generalized</td><td></td><td>_</td></tr><tr><td>Gabapentin</td><td>Neurontin</td><td>30-60</td><td>900-1,800°</td><td>Partial and secondary</td><td>= 5-7</td><td></td></tr><tr><td></td><td></td><td></td><td></td><td>generalized</td><td></td><td></td></tr><tr><td>Primidone</td><td>Mysoline</td><td>10-25</td><td>750-1,5008</td><td>Generalized tonic-</td><td>6-18</td><td>5-12</td></tr><tr><td></td><td></td><td></td><td></td><td>clonic, partial</td><td></td><td></td></tr><tr><td>Ethosuximide</td><td>Zarontin</td><td>20-40</td><td>750-1,500</td><td>Absence</td><td>20-60</td><td>50-100</td></tr><tr><td>Methsuximide ACTH</td><td>Celontin _</td><td>10-20 40-60 Units</td><td>500-1,000 _</td><td>Absence Infantile spasms</td><td>28-50 _</td><td>40-100 _</td></tr><tr><td>Clonazepam</td><td>Klonopin</td><td>daily 0.01-0.2</td><td>2-10</td><td>Absence, myoclonus</td><td>18-50</td><td>0.01-0.07</td></tr><tr><td colspan="7">Anticonvulsants for status epilepticus (initial loading or continuous infusion doses shown)‘—phenytoin and phenobarbital used in doses</td></tr><tr><td colspan="7">higher than shown above</td></tr><tr><td>Diazepam</td><td>Valium</td><td>0.15-2</td><td>2-20</td><td>Status epilepticus</td><td>_</td><td>_</td></tr><tr><td>Lorazepam</td><td>Ativan</td><td>0.03-0.22</td><td>2-20</td><td>Status epilepticus</td><td>_</td><td>_</td></tr><tr><td>Midazolam.</td><td>Versed</td><td>_</td><td>0.1-0.4 mg/ kg/h</td><td>Status epilepticus</td><td>_</td><td>_</td></tr><tr><td>Propofol</td><td>Diprivan</td><td>2.5-3.5</td><td>2-8 mg/kg/h</td><td>Status epilepticus</td><td>_</td><td></td></tr><tr><td>Fosphenytoin</td><td>Cerebyx</td><td>30-50 mg</td><td>1,000-1,500</td><td>Status epilepticus</td><td>_</td><td>10-20</td></tr></table>
======================================
<table><thead><th>SEIZURE TYPE</th><th>__ INITIAL CHOICE</th><th>SECOND LINE</th></thead><tr><td>Tonic-clonic</td><td>Carbamazepine, valproate,</td><td>Lamotrigine, oxcarbazepine</td></tr><tr><td>Myoclonic</td><td>phenytoin Valproate</td><td>Topiramate, levetiracetam, zonisamide</td></tr><tr><td>Partial</td><td>Carbamazepine, phenytoin</td><td>Valporate, lamotrigine, oxcarbazine, levetiracetam</td></tr><tr><td>Absence Unclassifiable</td><td>Valproate Valproate</td><td>Ethosuximide, lamotrigine Lamotrigine</td></tr></table>
======================================
<table><thead><th colspan="4">CHOICES OF ANTIEPILEPTIC DRUGS IN CHILDHOOD SEIZURE DISORDERS</th></thead><thead><th>SEIZURE TYPE</th><th>INITIAL CHOICE</th><th>SECOND</th><th>THIRD</th></thead><tr><td>Tonic- clonic</td><td>Valproate, carba- mazepine</td><td>_— Lamotrigine, oxcarbazine</td><td>Phenytoin</td></tr><tr><td>Myoclonic</td><td>Valproate</td><td>Lamotrigine</td><td>Phenobarbital, clobazam</td></tr><tr><td>Absence</td><td>Valproate</td><td>Topiramate, levetiracetam,</td><td>Lamotrigine</td></tr><tr><td>Partial</td><td>Carbamazepine, phenytoin</td><td>ethosuximide Valproate, levetiracetam, gabapentin,</td><td>Lamotrigine, vigabatrin, topiramate</td></tr><tr><td>Infantle</td><td>Vigabatrin, corticosteroids</td><td>oxcarbazine Valproate</td><td>Lamotrigine</td></tr><tr><td>spasms Lennox- Gastaut</td><td>Valproate</td><td>Topiramate, lamotrigine</td><td>Felbamate</td></tr></table>
======================================
<table><thead><th colspan="2">COMBINATION ANTIEPILEPTIC REGIMENS FOR REFRACTORY SEIZURES</th></thead><thead><th colspan="2">COMBINATION INDICATION</th></thead><tr><td>Valproate and lamotrigine or levetiracetam</td><td>Partial or generalized seizures</td></tr><tr><td>Carbamazepine and valproate Levetiracetam and lamotrigine or tiagabine</td><td>Complex partial seizures Partial seizures</td></tr><tr><td>Topiramate and lamotrigine or levetiracetam</td><td>Numerous types</td></tr></table>
======================================
<table><tr><td colspan="2">Initial assessment</td></tr><tr><td colspan="2">Ensure adequate ventilation, oxygenation, blood pressure</td></tr><tr><td colspan="2">Intubate if necessary, based on low oxygen saturation and labored breathing</td></tr><tr><td>Insert intravenous line</td><td></td></tr><tr><td>Administer glucose and thiamine in appropriate</td><td>cirumstances</td></tr><tr><td>Send toxic screen</td><td></td></tr><tr><td>Immediate suppression of convulsions Lorazepam or diazepam, 2 to 4 mg/min IV to a total to 15 mg with blood pressure monitoring when</td><td>dose of 10 higher rates</td></tr><tr><td>Phenytoin 15-20 mg/kg IV at 25-50 mg/min in normal or fosphenytoin at 50 to 75 mg/min</td><td>saline</td></tr><tr><td>General anesthetic doses of medication for persistent epilepticus</td><td>status</td></tr><tr><td>Midazolam 0.2 mg/kg loading dose followed by to 0.4 mg/kg/h or propofol 2 mg/kg/h Further treatment</td><td>infusion at 0.1 seizures</td></tr><tr><td>if convulsions or electrographic persist after several hours</td><td></td></tr><tr><td>May add valproate or phenobarbital 10 mg/min to of 20 mg/kg as additional anticonvulsants carbamazepine or levetiracetam by nasogastric tube is gastric and bowel activity</td><td>total dose intravenously, or if there</td></tr><tr><td>Consider neuromuscular paralysis with EEG convulsions persist</td><td>monitoring if</td></tr><tr><td>Pentobarbital 10 mg/kg/h</td><td></td></tr><tr><td>Inhalational anesthetics (isoflurane)</td><td></td></tr></table>
======================================
<table><thead><th colspan="2">HOSPITAL WITH “COMA OF UNKNOWN ETIOLOGY”</th></thead><thead><th>Metabolic and other diffuse disorders</th><th>326 (65%)</th></thead><tr><td>Drug poisoning</td><td>149</td></tr><tr><td>Anoxia or ischemia</td><td></td></tr><tr><td>Hepatic encephalopathy</td><td></td></tr><tr><td>Encephalomyelitis and encephalitis</td><td></td></tr><tr><td>Subarachnoid hemorrhage</td><td></td></tr><tr><td>Endocrine disorders (including diabetes)</td><td></td></tr><tr><td>Acid-base disorders</td><td></td></tr><tr><td>Temperature regulation</td><td></td></tr><tr><td>Uremic encephalopathy</td><td></td></tr><tr><td>Pulmonary disease</td><td></td></tr><tr><td>Nutritional</td><td></td></tr><tr><td>Nonspecific metabolic coma</td><td></td></tr><tr><td>Supratentorial mass lesions</td><td></td></tr><tr><td>Intracerebral hematoma</td><td></td></tr><tr><td>Subdural hematoma</td><td></td></tr><tr><td>Cerebral infarct</td><td></td></tr><tr><td>Brain tumor</td><td></td></tr><tr><td>Brain abscess</td><td></td></tr><tr><td>Epidural hematoma</td><td></td></tr><tr><td>Thalamic infarct</td><td></td></tr><tr><td>Pituitary apoplexy</td><td></td></tr><tr><td>Closed head injury</td><td></td></tr><tr><td>Subtentorial lesions</td><td>65 (13%)</td></tr><tr><td>Brainstem infarct</td><td>40</td></tr><tr><td>Pontine hemorrhage</td><td></td></tr><tr><td>Cerebellar hemorrhage</td><td></td></tr><tr><td>Cerebellar tumor</td><td></td></tr><tr><td>Cerebellar infarct</td><td></td></tr><tr><td>Brainstem demyelination</td><td></td></tr><tr><td>Cerebellar abscess</td><td></td></tr><tr><td>Posterior fossa subdural hemorrhage</td><td></td></tr><tr><td>Basilar migraine</td><td></td></tr><tr><td>Psychiatric disorders</td><td></td></tr></table>
======================================
<table><thead><th>PATHOLOGIC CHANGE</th><th>MECHANISM</th><th>CLINICAL DISORDERS</th></thead><tr><td>Injury to outer fibers of ipsilateral oculomotor nerve</td><td>Strangulation of nerve between herniating tissue and medial petroclinoid ligament; stretching of nerve over clivus from lateral displacement of midbrain; entrapment of nerve between posterior cerebral and superior cerebellar arteries from downward displacement of midbrain</td><td>Pupillary dilatation (Hutchinson pupil), ophthalmoplegia later</td></tr><tr><td>Creasing of contralateral cerebral peduncle (Kernohan notch)</td><td>Pressure of laterally displaced midbrain against sharp edge of tentorium</td><td>Hemiplegia ipsilateral to herniation (false localizing sign) and bilateral corticospinal tract signs</td></tr><tr><td>Lateral flattening of midbrain and zones of necrosis and secondary hemorrhages in tegmentum and base of subthalamus, midbrain, and upper pons (Duret hemorrhages)</td><td>Crushing of midbrain between herniating temporal lobe and opposite leaf of tentorium and vascular occlusion (hemorrhages around arterioles and veins)</td><td>Cheyne-Stokes respirations; stupor; coma; bipyramidal signs; decerebration; dilated, fixed pupils and alterations of gaze (facilitated oculocephalic reflex movement giving way to loss of all response to head movement and stimulation)</td></tr><tr><td>Unilateral or bilateral infarction (hemorrhagic) of occipital lobes</td><td>Compression of posterior cerebral artery against the tentorium by herniating temporal lobe</td><td>labyrinthine Usually none detectable during coma; hemianopia (unilateral or bilateral) with recovery</td></tr><tr><td>Rising intracranial pressure and hydrocephalus</td><td>Lateral flattening of aqueduct and third ventricle and blockage of perimesencephalic subarachnoid space</td><td>Increasing coma, rising blood pressure, bradycardia</td></tr></table>
======================================
<table><thead><th>ENERAL GROUP</th><th>SPECIFIC DISORDER</th><th>IMPORTANT CLINICAL FINDINGS</th><th>IMPORTANT LABORATORY FINDINGS</th><th>REMARKS</th></thead><tr><td rowspan="8">ma with focal or lateralizing signs</td><td>Cerebral hemorrhage</td><td>Hemiplegia, hypertension, cyclic breathing, spe- cific ocular signs (See Chaps. 14 and 33)</td><td>CT scan +</td><td>Sudden onset, often with headache, vor history of chronic hypertension; late lary enlargement</td></tr><tr><td></td><td>Basilar artery occlusion (throm- botic or embolic)</td><td>Extensor posturing and bilateral Babinski signs; early loss of oculocephalic responses; ocular bobbing</td><td>Normal early CT; MRI shows cerebellar and brainstem or thalamic infarction; normal CSF</td><td>Onset subacute (thrombosis), or sudder tral basilar embolism)</td></tr><tr><td></td><td>Massive infarction and edema in carotid territory Subdural hematoma</td><td>Hemiplegia, unilateral unresponsive or enlarged pupil Slow or cyclic respiration, rising blood pressure, unilateral</td><td>CT and MRI show massive edema of hemi- sphere CT scan; CSF xanthochromic with relatively low</td><td>Coma preceded by drowsiness for seve days after stroke Signs or history of trauma, headache, cx drowsiness</td></tr><tr><td></td><td>Trauma</td><td>hemiparesis, enlarged pupil Signs of cranial and facial injury</td><td>protein CT and MRI show brain contusions and other</td><td>sion, progressive Unstable blood pressure, associated sys</td></tr><tr><td></td><td>Brain abscess</td><td>Neurologic signs depending on location</td><td>injuries CT scan and MRI +</td><td>injuries Systemic infection or neurosurgical pro dure, fever</td></tr><tr><td></td><td>Hypertensive encephalopathy; eclampsia</td><td>Blood pressure &gt;210/110 mm Hg (lower in eclampsia and in children), headache, sei- zures, hypertensive retinal changes</td><td>CT +; CSF pressure elevated</td><td>Acute or subacute evolution, use of ami phylline or catecholamine medicatio:</td></tr><tr><td rowspan="13">ma without focal or lateralizing signs, with signs of meningeal irrita- tion ma without focal neurologic signs or meningeal irri- tation; CT scan and CSF normal</td><td></td><td>Thrombotic thrombocytopenic (TTP)</td><td>Petechiae, seizures shifting focal signs</td><td>Multiple small cortical infarctions; thrombo-</td><td>Similar to fat embolism; multifocal mict culopathy</td></tr><tr><td></td><td></td><td>purpura Meningitis and encephalitis</td><td>Stiff neck, Kernig sign, fever, headache</td><td>cytopenia CT scan +; pleocytosis, increased protein, low glucose in CSF</td><td>Subacute or acute onset</td></tr><tr><td></td><td>Subarachnoid hemorrhage</td><td>Stertorous breathing, hypertension, stiff neck, Kernig sign</td><td>CT scan may show blood and aneurysm; bloody or xanthochromic CSF under increased pressure</td><td>Sudden onset with severe headache</td></tr><tr><td></td><td>Alcohol intoxication</td><td>Hypothermia, hypotension, flushed skin, alcohol breath</td><td>Elevated blood alcohol</td><td>May be combined with head injury, infe or hepatic failure</td></tr><tr><td></td><td>Sedative intoxication</td><td>Hypothermia, hypotension</td><td>Drug in urine and blood; EEG often shows fast</td><td>History of intake of drug; suicide attem</td></tr><tr><td></td><td>Opioid intoxication</td><td>Slow respiration, cyanosis, constricted pupils</td><td>activity</td><td>Administration of naloxone causes awa ing and withdrawal signs</td></tr><tr><td></td><td>Carbon monoxide intoxication Global ischemia—anoxia</td><td>Cherry-red skin Rigidity, decerebrate postures, fever, seizures, myoclonus</td><td>Carboxyhemoglobin CSF normal; EEG may be isoelectric or show high-voltage delta</td><td>Pallidal necrosis Abrupt onset following cardiopulmona arrest; damage permanent if anoxia e 35 min</td></tr><tr><td></td><td>Hypoglycemia</td><td>Same as in anoxia</td><td>Low blood and CSF glucose</td><td>Characteristic slow evolution through s of nervousness, hunger, sweating, flu 
======================================
face; then pallor, shallow respiration: seizures</td></tr><tr><td></td><td>Diabetic coma</td><td>Signs of extracellular fluid deficit, hyperventila- tion with Kussmaul respiration, “fruity” breath</td><td>Glycosuria, hyperglycemia, acidosis; reduced serum bicarbonate; ketonemia and ketonuria, or hyperosmolarity</td><td>History of polyuria, polydipsia, weight or diabetes</td></tr><tr><td></td><td>Uremia</td><td>Hypertension; sallow, dry skin, uriniferous breath, twitch-convulsive syndrome</td><td>Protein and casts in urine; elevated blood urea nitrogen and serum creatinine; ane- mia, acidosis, hypocalcemia</td><td>Progressive apathy, confusion, and aste precede coma</td></tr><tr><td></td><td>Hepatic coma</td><td>Jaundice, ascites, and other signs of portal hyper- tension; asterixis</td><td>Elevated blood NHs3 levels; CSF yellow (bili- rubin) with normal or slightly elevated protein</td><td>Onset over a few days or after paracent hemorrhage from varices; confusion, por, asterixis, and characteristic EEG changes precede coma</td></tr><tr><td></td><td>Hypercapnia</td><td>Papilledema, diffuse myoclonus, asterixis</td><td>Increased CSF pressure; PCO may exceed 75 mm Hg; EEG theta and delta activity</td><td>Advanced pulmonary disease; profoun coma and brain damage uncommon</td></tr><tr><td></td><td>Severe infections (septic shock); heat stroke Seizures</td><td>Extreme hyperthermia, rapid respiration Episodic disturbance of behavior or convulsive</td><td>Vary according to cause Characteristic EEG changes</td><td>Evidence of a specific infection or expo: extreme heat History of previous attacks</td></tr></table>
======================================
<table><thead><th>AMERICAN ACADEMY OF SLEEP MEDICINE</th><th>FORMER NOMENCLATURE</th><th>EEG CHARACTERISTICS</th><th>BEHAVIORAL STATE</th></thead><tr><td>Ww</td><td>_</td><td>Posterior reactive alpha rhythm</td><td>Awake</td></tr><tr><td>N1</td><td>Stage 1</td><td>Diffuse theta and loss of alpha</td><td>Drowsy</td></tr><tr><td>N2</td><td>Stage 2</td><td>Sleep spindles and K complexes</td><td>Light sleep</td></tr><tr><td>N3</td><td>Stages 3 and 4</td><td>High-voltage theta and delta activity</td><td>Deep sleep</td></tr><tr><td>R</td><td>REM</td><td>Diffuse theta</td><td>Predominance of dreaming (see text)</td></tr></table>
======================================
<table><thead><th>DEMENTING DISEASE</th><th>RELATIVE FREQUENCY, %</th></thead><tr><td>Cerebral atrophy, mainly Alzheimer but including Lewy-body, Parkinson, frontotemporal, and Pick diseases</td><td>50</td></tr><tr><td>Multiinfarct dementia</td><td>=</td></tr><tr><td>Alcoholic dementia</td><td>AWNUANS</td></tr><tr><td>Intracranial tumors</td><td></td></tr><tr><td>Normal-pressure hydrocephalus</td><td></td></tr><tr><td>Huntington chorea</td><td></td></tr><tr><td>Cerebral trauma</td><td></td></tr><tr><td>AIDS dementia</td><td>eNN</td></tr><tr><td>Pseudodementias (depression, hypomania, schizophrenia, hysteria, undiagnosed)</td><td></td></tr></table>
======================================
<table><thead><th>NEUROPATHOLOGIC DIAGNOSIS</th><th>NUMBER OF CASES</th><th>PERCENT</th></thead><tr><td>Alzheimer disease</td><td>218</td><td>83.5</td></tr><tr><td>Parkinson and Alzheimer diseases</td><td>16</td><td>6.1</td></tr><tr><td>Lewy-body disease</td><td>8</td><td>3.1</td></tr><tr><td>Pick disease</td><td>6</td><td>2.3</td></tr><tr><td>Multiple infarcts</td><td>5</td><td>19</td></tr><tr><td>Binswanger disease</td><td>1</td><td>0.4</td></tr><tr><td>Corticobasal ganglionic</td><td>1</td><td>0.4</td></tr><tr><td>degeneration</td><td></td><td></td></tr><tr><td>Mixed dementia</td><td>1</td><td>0.4</td></tr><tr><td>Other</td><td>5</td><td>19</td></tr><tr><td>Total</td><td>261</td><td>100</td></tr></table>
======================================
<table><thead><th></th><th rowspan="3">IMMEDIATE RECALL</th><th rowspan="3">WORKING MEMORY</th><th></th><th>LONG-TERM</th><th>MEMORY</th><th></th></thead><thead><th></th><th></th><th></th><th></th><th colspan="3">EXPLICIT IMPLICIT</th></thead><thead><th></th><th></th><th></th><th>SEMANTIC</th><th>EPISODIC</th><th>PROCEDURAL</th><th>VISUAL</th></thead><tr><td>Function</td><td>Repetition</td><td>Short-term recall of objects, plans, names,</td><td>— Recall for facts and their rela- tionships</td><td>Recall for tem- porally orga- nized events</td><td>Operational recall (“how to do”)</td><td>Recall of visual representa- tions</td></tr><tr><td>Conscious access</td><td>Yes</td><td>sequencing Yes</td><td>Yes</td><td>Yes</td><td>Usually</td><td>No</td></tr><tr><td>Anatomic regions involved</td><td>Perisylvian cor- tex of domi- nant hemisphere</td><td>Prefrontal cor- tex, medial temporal lobes, dorso- medial thala-</td><td>Anterior,inferior temporal lobes; frontal lobes</td><td>Association cor- tex</td><td>—_ Premotor and motor cortex, basal ganglia, cerebellum</td><td>Occipital lobes</td></tr><tr><td>Conditions that disturb memory</td><td>_—_ Agitation, confusion (impaired attention)</td><td>mus Wernicke-Korsa- koff syn- drome, herpes encephalitis, infarction of hippocampi, dorsomedial thalamus</td><td>AD, fronto- temporal dementia, encephalitis, chronic tox- ins, tumors</td><td>Hippocampal infarction, alcoholic Kor- sakoff syn- drome, AD and other CNS degenerative disorders, encephalitis, chronic toxic exposure, tumors</td><td>AD and other CNS degener- ative disor- ders, encephalitis, chronic toxic exposure, tumors</td><td>AD, other CNS degenerative disorders, encephalitis, tumors</td></tr></table>
======================================
<table><thead><th colspan="4">AINI-MIENTAL” STATUS TEST OF FOLSTEIN, FOLSTEIN, AND McHUGH</th></thead><thead><th>TASK</th><th>INSTRUCTIONS</th><th>SCORING</th><th></th></thead><tr><td>ite orientation</td><td>“Tell me the date?” Ask for omitted items.</td><td>One point each for year, season, date, day of week, and month</td><td></td></tr><tr><td>vce orientation</td><td>“Where are you?” Ask for omitted items.</td><td>One point each for state, county, town, building, and floor or room</td><td></td></tr><tr><td>gister three objects</td><td>Name three objects slowly and clearly. Ask the patient to them.</td><td>One point for each item correctly repeated</td><td></td></tr><tr><td>rial sevens</td><td>repeat Ask the patient to count backwards from 100 by 7. Stop after 5 answers. (Or ask them to spell world</td><td>One point for each correct answer (or letter)</td><td></td></tr><tr><td>call three objects ming</td><td>backwards.) Ask the patient to recall the objects mentioned above. Point to your watch and ask the patient “What is this?” Repeat with a pencil.</td><td>One point for each item correctly remembered. One point for each correct answer</td><td></td></tr><tr><td>peating a phrase rbal commands</td><td>Ask the patient to say “no ifs, ands, or buts.” Give the patient a plain piece of paper and say “Take this paper in your right hand, fold it in half, and put it on the floor.”</td><td>One point if successful on first try One point for each correct action</td><td></td></tr><tr><td>‘itten commands</td><td>Show the patient a piece of paper with CLOSE YOUR EYES printed on it.</td><td>One point if the patient’s eyes close</td><td></td></tr><tr><td>‘iting</td><td>Ask the patient to write a sentence.</td><td>One point if sentence has a subject, a verb, and makes sense</td><td></td></tr><tr><td>awing</td><td>Ask the patient to copy a pair of intersecting pentagons onto a piece of paper.</td><td>One point if the figure has 10 corners and 2 intersecting lines</td><td></td></tr><tr><td>oring</td><td>A score of 24 or above is considered normal.</td><td></td><td>30</td></tr></table>
======================================
<table><thead><th colspan="6">THE MAIN APHASIC SYNDROMES</th></thead><thead><th>TYPE OF APHASIA</th><th>SPEECH</th><th>COMPREHENSION</th><th>REPETITION</th><th>ASSOCIATED SIGNS</th><th>LOCALIZATION?</th></thead><tr><td>Broca’s</td><td>Nonfluent, effortful, agrammatical, paucity of output but transmits ideas</td><td>Relatively preserved</td><td>Impaired</td><td>Right arm and face weakness</td><td>Frontal suprasylvian</td></tr><tr><td>Wernicke’s</td><td>Fluent, voluble, well articulated but lacking meaning</td><td>Greatly impaired</td><td></td><td>Hemi- or quadrantanopia, no paresis</td><td>Temporal, infrasylvian including angular and supramarginal gyri</td></tr><tr><td>Conduction</td><td>Fluent</td><td>Relatively preserved</td><td></td><td>Usually none</td><td>Supramarginal gyrus or insula</td></tr><tr><td>Global</td><td>Scant, nonfluent</td><td>Very impaired</td><td></td><td>Hemiplegia usual</td><td>_ Large perisylvian or separate frontal and temporal</td></tr><tr><td>Transcortical</td><td>Nonfluent</td><td>Good</td><td>Largely</td><td>Variable</td><td>Anterior or superior to Broca</td></tr><tr><td>motor Transcortical</td><td>Fluent</td><td>Impaired as</td><td>preserved Largely</td><td>Variable</td><td>area Surrounding Wernicke area</td></tr><tr><td>sensory Pure word</td><td>Mildly paraphasicor</td><td>Wernicke’s — Impaired</td><td>preserved Impaired</td><td>or</td><td>Bilateral (or left) middle of</td></tr><tr><td>deafness Pure word blind- ness (and alexia without</td><td>normal Normal but unable to read aloud</td><td>Normal</td><td>Normal</td><td>quadrantanopia Righthemianopia; unable to read own writing</td><td>superior temporal gyrus — Calcarine and white matter or callosum (or angular gyrus)</td></tr><tr><td>agraphia) Pure word mutism</td><td>Mute, but able to write</td><td>Normal</td><td></td><td></td><td>Region of Broca area</td></tr><tr><td>(aphemia) Anomic aphasia</td><td>Isolated word- finding difficulty</td><td>Normal various sites</td><td>Normal</td><td>Variable</td><td>Deep temporal lobe</td></tr></table>
======================================
<table><tr><td>I. Disturbances of emotionality because of: A. Perceptual abnormalities (illusions and</td><td>hallucinations)</td></tr><tr><td colspan="2">B. Cognitive derangements (delusions) I. Disinhibition of emotional expression</td></tr><tr><td>A. Emotional lability B. Pathologic laughing and crying</td><td></td></tr><tr><td colspan="2">A. Kliiver-Bucy syndrome B. Other syndromes (frontal and thalamic) V. Altered sexuality</td></tr><tr><td>VI. Endogenous fear, anxiety, depression, and</td><td>euphoria</td></tr></table>
======================================
<table><tr><td>Bilateral strokes (lacunes in the cerebral hemispheres or</td></tr><tr><td>most often after several strokes in succession</td></tr><tr><td>Binswanger diffuse leukoencephalopathy (Chap. 34)</td></tr><tr><td>Amyotrophic lateral scerlosis with pseudobulbar palsy</td></tr><tr><td>Progressive supranuclear palsy Multiple sclerosis with bilateral corticobulbar demyelinative</td></tr><tr><td>Gliomatosis cerebri Hypoxic—ischemic encephalopathy</td></tr><tr><td>myelinolysis Wilson disease</td></tr></table>
======================================
<table><thead><th>TEST</th><th colspan="2">NORMAL RESPONSE</th><th>MAIN PART OF REFLEX ARC TESTED</th></thead><tr><td colspan="4">NONINVASIVE BEDSIDE TESTS</td></tr><tr><td>Blood-pressure response to standing or vertical tilt</td><td colspan="2">Fall in BP &lt;30/15 mm Hg</td><td>Afferent and sympathetic efferent limbs</td></tr><tr><td>Heart rate response to standing</td><td colspan="2">Increase 11-90 beats/min; 30:15 ratio 21.04</td><td>Vagal afferent and efferent limbs</td></tr><tr><td>Isometric exercise</td><td colspan="2">Increase in diastolic BP, 15 mm Hg</td><td>Sympathetic efferent limb</td></tr><tr><td>Heart rate variation with respiration</td><td>E:I</td><td>Maximum-minimum heart rate &gt;15 beats/min; ratio 1.2"</td><td>Vagal afferent and efferent limbs</td></tr><tr><td>Valsalva ratio (see text)</td><td colspan="2">21.4"</td><td colspan="2" rowspan="2">Sweating over all body and limbs</td><td>Afferent and efferent limbs</td></tr><tr><td>Sweat tests</td><td colspan="2"></td><td>Sympathetic efferent limb</td></tr><tr><td>Axon reflex</td><td colspan="2" rowspan="2">Local piloerection, sweating Rises from horizontal vertical</td><td>Postganglionic sympathetic efferent fibers</td></tr><tr><td>Plasma noradrenaline level</td><td colspan="2"></td><td>efferent limb</td></tr><tr><td rowspan="4">Plasma vasopressin level Valsalva maneuver (BP response with</td><td colspan="2" rowspan="2">on tilting to Rise with induced hypotension</td><td>Sympathetic</td></tr><tr><td></td><td colspan="2"></td><td>Afferent limb</td></tr><tr><td></td><td colspan="2">INVASIVE TESTS</td><td></td></tr><tr><td></td><td colspan="2" rowspan="3">Phase I: Rise in BP Phase II: Gradual reduction of BP to plateau; tachycardia Phase III: Fall in BP Phase IV: Overshoot of BP, bradycardia® of heart rate with induced rise of BP“</td><td>Afferent and sympathetic efferent limbs</td></tr><tr><td>indwelling arterial catheter or continuous noninvasive BP measurement)</td><td colspan="2"></td><td></td></tr><tr><td>Baroreflex</td><td colspan="2" rowspan="5">(1) Slowing (2) Steady-state responses to induced rise and fall of BP (1) Rise in BP (2) Slowing of heart rate</td><td colspan="2"></td><td colspan="2"></td><td>afferent and efferent</td></tr><tr><td>sensitivity</td><td>(1) Parasympathetic limbs (2) Afferent and efferent limbs</td></tr><tr><td>Infusion of</td><td colspan="2"></td><td></td></tr><tr><td>pressor drugs</td><td colspan="2"></td><td>(1) Adrenergic receptors (2) Afferent and efferent parasympathetic</td></tr><tr><td></td><td colspan="2"></td><td>limbs</td></tr><tr><td></td><td colspan="2" rowspan="2">OTHER TESTS OF VASOMOTOR CONTROL Increased hand blood flow</td><td></td></tr><tr><td>Radiant heating of trunk</td><td colspan="2"></td><td>Sympathetic efferent limb</td></tr><tr><td rowspan="5">Immersion of hand in hot water Cold pressor test Emotional stress 4% cocaine</td><td colspan="2" rowspan="3">Increased blood flow of opposite hand Reduced blood flow, rise in BP Increased BP</td><td colspan="2"></td><td>Sympathetic efferent limb</td></tr><tr><td></td><td colspan="2"></td><td>Sympathetic efferent limb</td></tr><tr><td></td><td>Sympathetic efferent limb</td></tr><tr><td></td><td></td><td>TESTS OF PUPILLARY INNERVATION</td><td></td></tr><tr><td></td><td>Pupil</td><td>dilates</td><td>Sympathetic innervation</td></tr><tr><td>0.1% adrenaline</td><td>No</td><td></td><td>innervation</td></tr><tr><td></td><td></td><td></td><td>Postganglionic sympathetic</td></tr><tr><td></td><td></td><td>response</td><td></td></tr><tr><td>1% hydroxyamphetamine</td><td>Pupil</td><td>dilates</td><td>Postganglionic sympathetic innervation</td></tr><tr><td>hydrobromide</td><td></td><td></td><td></td></tr><tr><td>2.5% methacholine 0.125%</td><td>No</td><td>response</td><td>Parasympathetic innervation</td></tr><tr><td>pilocarpine</td><td></td><td></td><td></td></tr><tr><td>0.5% apraclonidine</td><td>Pupil</td><td>dilates and ptosis resolves in Horner syndrome</td><td>Parasympathetic i
======================================
nnervation</td></tr></table>
======================================
<table><thead><th colspan="2">TIMESCALE OF STAGES IN HUMAN GROWTH AND DEVELOPMENT</th></thead><thead><th>GROWTH PERIOD</th><th>APPROXIMATE AGE</th></thead><tr><td>Prenatal</td><td>From 0 to 280 days</td></tr><tr><td>Ovum</td><td>From 0 to 14 days</td></tr><tr><td>Embryo</td><td>From 14 days to 9 weeks</td></tr><tr><td>Fetus</td><td>From 9 weeks to birth</td></tr><tr><td>Premature infant</td><td>From 27 to 37 weeks</td></tr><tr><td>Birth</td><td>Average 280 days</td></tr><tr><td>Neonate</td><td>First 4 weeks after birth</td></tr><tr><td>Infancy</td><td>First year</td></tr><tr><td>Early childhood (preschool)</td><td>From 1 to 6 years</td></tr><tr><td>Later childhood (prepubertal)</td><td>From 6 to 10 years</td></tr><tr><td>Adolescence</td><td>Girls, 8 or 10 to 18 years 10 12 to 20</td></tr><tr><td>Puberty (average)</td><td>Boys, or years Girls, 13 years Boys, 15 years</td></tr></table>
======================================
<table><thead><th>AGE, DAYS</th><th>SIZE (CROWN-RUMP. LENGTH), MM</th><th>NERVOUS SYSTEM DEVELOPMENT</th></thead><tr><td>18</td><td>15</td><td>Neural groove and tube</td></tr><tr><td>21</td><td>3.0</td><td>Optic vesicles</td></tr><tr><td>26</td><td>3.0</td><td>Closure of anterior neuropore</td></tr><tr><td>27</td><td>3.3</td><td>Closure of posterior neuropore; ventral horn cells appear</td></tr><tr><td>31</td><td>43</td><td>Anterior and posterior roots</td></tr><tr><td>35</td><td>5.0</td><td>Five cerebral vesicles</td></tr><tr><td>42</td><td>13.0</td><td>Primordium of cerebellum</td></tr><tr><td>56</td><td>25.0</td><td>Differentiation of cerebral cortex and</td></tr><tr><td>150</td><td>225.0</td><td>meninges Primary cerebral fissures</td></tr><tr><td>180</td><td>230.0</td><td>appear Secondary cerebral sulci and first myelination appear in</td></tr><tr><td>8-9 months</td><td>240.0</td><td>brain Further myelination and growth of brain (see text)</td></tr></table>
======================================
<table><thead><th>APGAR SCORING</th><th>SYSTEM</th></thead><tr><td colspan="2">Heart rate</td></tr><tr><td>0 No heart rate</td><td></td></tr><tr><td>1 Fewer than</td><td>100 beats per minute—the baby is not very</td></tr><tr><td>responsive 2 More than 100</td><td>beats per minute—the baby is obviously</td></tr><tr><td>vigorous Respiration</td><td></td></tr><tr><td>0 Not</td><td></td></tr><tr><td>breathing Weak</td><td>sound like</td></tr><tr><td>1 cry;</td><td>may wimpering or grunting</td></tr><tr><td colspan="2" rowspan="2">2 Good strong cry Muscle tone</td><td colspan="2" rowspan="2"></td></tr><tr><td colspan="2"></td><td colspan="2"></td></tr><tr><td>Limp 1 Some flexing</td><td>(bending) of arms and legs</td></tr><tr><td>2 Active motion</td><td></td></tr><tr><td>Reflex response</td><td></td></tr><tr><td>0 No response</td><td>to airways being suctioned</td></tr><tr><td>1 Grimace</td><td>during suctioning</td></tr><tr><td>2 Grimace and</td><td>cough or sneeze during suctioning</td></tr><tr><td colspan="2">Color</td></tr><tr><td colspan="2">0 The baby's whole body is completely blue or pale</td></tr><tr><td>1 Good color in</td><td>body with blue hands or feet</td></tr><tr><td>2 Completely</td><td>pink or good color</td></tr></table>
======================================
<table><thead><th colspan="3">NEUROLOGIC FUNCTIONS AND DISTURBANCES IN INFANCY AND EARLY CHILDHOOD</th></thead><thead><th>AGE</th><th>NORMAL FUNCTIONS</th><th>PATHOLOGIC SIGNS</th></thead><tr><td>Newborn period</td><td>Blinking, tonic deviation of eyes on turning head, sucking, rooting, swallowing, yawning, grasping, brief extension of neck in prone position, incurvation response, Moro response, flexion postures of limbs Biceps reflexes present and others variable; infantile type of flexor plantar reflex; stable temperature, respirations, and blood pressure; periods of sleep and arousal: vigorous cry</td><td>Lack of arousal (stupor or coma) High-pitched or weak cry Abnormal (incomplete or absent) Moro response Opisthotonus Flaccidity or hypertonia Convulsions Tremulous limbs Failure of tonic deviation of eyes on passive movement of head or of head and body</td></tr><tr><td>—3 months months</td><td>Supports head Smiles Makes vowel sounds Adopts tonic asymmetrical neck postures (tonic neck reflexes) Large range of movements of limbs, tendon reflexes usually present Fixates on and follows a dangling toy Suckles vigorously Period of sleep sharply differentiated from awake periods Support and stepping unelicitable Vertical suspension—legs flex, head up Optokinetic nystagmus elicitable Good head support, minimal head lag Coos and chuckles</td><td>Absence of any or all of the normal functions Convulsions Hypotonia or hypertonia of neck and limbs Vertical suspension—legs extend and adduct Lack of head support Motor deficits</td></tr><tr><td>6 months</td><td>Inspects hands Tone of limbs moderate or diminished Turns to sounds Rolls over from prone to supine Grasping, sucking, and tonic neck reflexes subservient to volition Babbles Reaches and grasps Vocalizes in social play Discriminates between family and strangers Moro and grasp reflexes disappear Tries to recover lost object Begins to sit; no head lag on pull to sit Positive support reaction Tonic neck reflexes gone Landau response (holds head above horizontal, arches</td><td>Hypertonia Lack of social reactions Tonic neck reflexes present Strong Moro response Absence of symmetrical attitude Altered tone Obligatory postures Cannot sit or roll over Hypo- or hypertonia Persistent Moro and grasp Persistent tonic neck reflexes No Landau response</td></tr><tr><td>months</td><td>back when held horizontally) Begins to grasp objects with one hand; holds bottle Creeps and pulls to stand; stands holding on Sits securely Babbles “Mama,” “Dada,” or equivalent Sociable; plays “pat-a-cake,” seeks attention Drinks from cup Landau response present Parachute response present</td><td>Fails to attain these motor, verbal, and social milestones Persistent automatisms and tonic neck reflexes or hypo- or hypertonia</td></tr><tr><td>months</td><td>Grasps with thumb to forefinger Stands alone May walk, or walks if led Tries to feed self May say several single words, echoes sounds Plantar reflexes definitely flexor</td><td>Failure to attain 12-month milestones Persistence of automatisms</td></tr><tr><td rowspan="2">months</td><td></td><td>Throws objects Walks independently (9-16 months), falls easily Moves arms steadily Says several words; scribbles with crayon Requests by pointing Interest in and animal</td><td>Retardation in reaching milestones expected at this age Persistent abnormalities of tone and posture Sensory discriminations defective</td></tr><tr><td>sounds, music, pictures, toys</td><td>(continued)</td></tr></table>
======================================
<table><thead><th colspan="3">EVELOPMENTAL ACHIEVEMENTS OF THE NORMAL PRESCHOOL CHILD</th></thead><thead><th>AGE</th><th>OBSERVED ITEMS</th><th>USEFUL CLINICAL TESTS</th></thead><tr><td>years</td><td>Runs well Goes up and down stairs, 1 step at a time Climbs on furniture Opens doors Helps to undress Feeds well with spoon Puts 3 words together</td><td>Pencil-paper test: scribbles, imitates horizontal stroke Folds paper once Builds tower of 6 blocks</td></tr><tr><td>5 years</td><td>Listens to stories with pictures Jumps on both feet; walks on tiptoes if asked Knows full name; asks questions Refers to self as “I” Helps put away toys and clothes Names animals in book, knows 1 to 3 colors</td><td>Pencil-paper test: copies horizontal and vertical line Builds tower of 8 blocks</td></tr><tr><td>years</td><td>Can complete 3-piece form board Climbs stairs, alternating feet Talks constantly; recites nursery rhymes Rides tricycle Stands on one foot momentarily Plays simple games Helps in dressing Washes hands</td><td>Builds 9-cube tower Builds bridge with 3 cubes Imitates circle and cross with pencil</td></tr><tr><td>years</td><td>Identifies 5 colors Climbs well; hops and skips on one foot; throws ball overhand; kicks ball Cuts out pictures with scissors Counts 4 pennies Tells a story; plays with other children Goes to toilet alone</td><td>Copies cross and circle Builds gate with 5 cubes Builds a bridge from model Draws a human figure with 2 to 4 parts other than head Distinguishes short and long line</td></tr><tr><td>years</td><td>Skips Names 4 colors; counts 10 pennies Dresses and undresses Asks questions about meaning of words</td><td>Copies square and triangle Distinguishes heavier of 2 weights More detailed drawing of a human figure</td></tr></table>
======================================
<table><thead><th>DEFICIT</th><th>TEST</th></thead><tr><td>Development</td><td>Denver Developmental Test; Vine- Jand Social Maturity Test; Leiter International Performance Scale; Otis Group Intelligence Test</td></tr><tr><td>Achievement</td><td>Wide Range Achievement Test; Gates Primary Reading Test</td></tr><tr><td>Attentiveness Calculation</td><td>Dehoit Test of hearing aptitude Key Math Diagnostic Arithmetic</td></tr><tr><td></td><td>Test Picture</td></tr><tr><td>Vocabulary</td><td>Peabody Vocabulary</td></tr><tr><td>Developmental Gerstmann</td><td>Finger Order Tests; Benton Right— Left Discrimination Test</td></tr><tr><td>syndrome (finger agnosia, right—left disorientation)</td><td></td></tr><tr><td>Figure copying</td><td>Visual—Motor Integration Test</td></tr><tr><td>Visual memory</td><td>Benton Visual Retention Test</td></tr><tr><td>Error patterns</td><td>Boder Test of Reading-Spelling Patterns</td></tr><tr><td>Impulsiveness</td><td>Matching Familiar Figures Test</td></tr></table>
======================================
<table><thead><th>MEN</th><th></th><th>WOMEN</th><th></th></thead><tr><td colspan="4">1. Weight loss Greater than 10 lbs or 5% of weight loss in the last year 2. 15-Foot walk time</td></tr><tr><td>Height &lt;173cm =</td><td>27s</td><td>Height $159 cm</td><td>27s</td></tr><tr><td>Height &gt;173cm 3. Grip strength (Ibs)</td><td>26s</td><td>Height &gt;159 cm</td><td>26s</td></tr><tr><td>BMI &lt;24</td><td>&lt;29</td><td>BMI &lt;23</td><td>&lt;17</td></tr><tr><td>BMI 24.1-26</td><td>&lt;30</td><td>BMI 23.1-26</td><td>&lt;17.3</td></tr><tr><td>BMI 26.1-28</td><td>&lt;30</td><td>BMI 26.1-29</td><td>&lt;18</td></tr><tr><td>BMI &gt;28</td><td>&lt;32</td><td>BMI &gt;29</td><td>&lt;21</td></tr><tr><td>4. Physical activity &lt;383 kcal/wk</td><td></td><td>&lt;270 kcal/wk</td><td></td></tr><tr><td>5. Exhaustion</td><td></td><td></td><td></td></tr></table>
======================================
<table><thead><th></th><th>PERCENT DECREASE</th></thead><tr><td>Brain weight</td><td>10-15</td></tr><tr><td>Blood flow to brain</td><td>20</td></tr><tr><td>Speed of return of blood acidity to equilibrium</td><td>83</td></tr><tr><td colspan="2">after exercise</td></tr><tr><td>Cardiac output at rest</td><td>35</td></tr><tr><td>Number of glomeruli in kidney</td><td>44</td></tr><tr><td>Glomerular filtration rate</td><td>31</td></tr><tr><td>Number of fibers in nerves</td><td>37</td></tr><tr><td>Nerve conduction velocity</td><td>10</td></tr><tr><td>Number of taste buds</td><td>64</td></tr><tr><td>Maximum O, utilization with exercise</td><td>60</td></tr><tr><td>Maximum ventilation volume</td><td>47</td></tr><tr><td>Maximum breathing capacity</td><td>44</td></tr><tr><td>Power of hand grip</td><td>45</td></tr><tr><td>Maximum work rate</td><td>30</td></tr><tr><td>Basal metabolic rate</td><td>16</td></tr><tr><td>Body water content</td><td>18</td></tr><tr><td>Body weight (males)</td><td>12</td></tr></table>
======================================
<table><thead><th rowspan="2">sae: SIGN</th><th colspan="4">, eee_—oOoOoVoe_V—oa—eee eee AGE (YEARS)</th></thead><thead><th></th><th>65-69</th><th>70-74</th><th>75-79</th><th>&gt;80</th></thead><tr><td>Glabellar sign (inability to inhibit blink)</td><td>10</td><td>15</td><td>27</td><td>37</td></tr><tr><td>Snout reflex</td><td>3</td><td>8</td><td>7</td><td>26</td></tr><tr><td>Limited upgaze</td><td>6</td><td>15</td><td>27</td><td>29</td></tr><tr><td>Limited downgaze</td><td>8</td><td>15</td><td>26</td><td>34</td></tr><tr><td>Abnormal visual tracking</td><td>8</td><td>18</td><td>22</td><td>32</td></tr><tr><td>Paratonic rigidity</td><td>6</td><td>10</td><td>12</td><td>21</td></tr><tr><td>Unable to recall 3 words</td><td>24</td><td>28</td><td>25</td><td>55</td></tr><tr><td>Unable to spell world backward</td><td>10</td><td>12</td><td>18</td><td>21</td></tr></table>
======================================
<table><thead><th>CAUSES AND ASSOCIATIONS OF PSEUDOTUMOR CEREBRI</th><th></th></thead><tr><td colspan="2">I. Idiopathic (“benign”) intracranial hypertension II. Cerebral venous hypertension (diagnosis by imaging of cerebral vasculature)</td></tr><tr><td>A. Occlusion of superior sagittal or lateral venous 1. Hypercoagulable states (cancer, birth control dehydration, antiphospholipid antibody) 2. Traumatic</td><td>sinus: pills,</td></tr><tr><td>3. Postsurgical 4. Infectious (mainly of transverse venous sinus</td><td>due to</td></tr><tr><td>mastoiditis) B. Increased blood volume due to</td><td>arteriovenous</td></tr><tr><td>high-flow</td><td></td></tr><tr><td>malformation, dural fistulas, and other vascular III. Meningeal diseases (diagnosis by examination of</td><td>anomalies CSF)</td></tr><tr><td>A. Carcinomatous and lymphomatous meningitis B. Chronic infectious and granulomatous meningitis tuberculous, spirochetal, sarcoidosis)</td><td>(fungal,</td></tr><tr><td>A. Administration or withdrawal of corticosteroids</td><td></td></tr><tr><td colspan="2">B. Hyper- and hypoadrenalism</td></tr><tr><td colspan="2">C. Myxedema</td></tr><tr><td>D. Hypoparathyroidism</td><td></td></tr><tr><td colspan="2">VIL Greatly elevated protein concentration in the CSF</td></tr><tr><td>A. Guillain-Barré syndrome</td><td></td></tr><tr><td colspan="2">B. Spinal oligodendroglioma</td></tr><tr><td>C. Systemic lupus erythematosus</td><td></td></tr></table>
======================================
<table><thead><th>SERIES OF ZULCH, CUSHING, AND OLIVECRONA, EXPRESSED IN PERCENTAGE OF TOTAL (APPROXIMATELY 15,000 CASES)</th><th></th></thead><thead><th>TUMOR</th><th>PERCENT OF TOTAL</th></thead><tr><td colspan="2">Gliomas*</td></tr><tr><td>Glioblastoma multiforme</td><td>20</td></tr><tr><td>Astrocytoma</td><td>10</td></tr><tr><td>Ependymoma</td><td></td></tr><tr><td>Medulloblastoma</td><td>RANNGTAARD</td></tr><tr><td>Oligodendroglioma</td><td></td></tr><tr><td>Meningioma</td><td>=</td></tr><tr><td>Pituitary adenoma</td><td></td></tr><tr><td>Neurinoma (schwannoma)</td><td></td></tr><tr><td>Metastatic carcinoma</td><td></td></tr><tr><td>Craniopharyngioma, dermoid, epidermoid,</td><td></td></tr><tr><td colspan="2">teratoma</td></tr><tr><td>Angiomas</td><td></td></tr><tr><td>Sarcomas</td><td>OR</td></tr><tr><td>Unclassified (mostly gliomas)</td><td></td></tr><tr><td>Miscellaneous (pinealoma, chordoma, granuloma, lymphoma)?</td><td></td></tr><tr><td>Total</td><td>100</td></tr></table>
======================================
<table><thead><th>TUMOR</th><th>CHILDHOOD, PERCENT</th><th>ADULT, PERCENT</th><th>OLDER ADULT, = PERCENT</th></thead><tr><td>Neuroepithelial tumors (glial origin)</td><td>78.1</td><td>44.6</td><td>419</td></tr><tr><td>Pilocytic astrocytoma</td><td>19.8</td><td>0.7</td><td>0</td></tr><tr><td>Glioblastoma</td><td>3.8</td><td>23.2</td><td>29.3</td></tr><tr><td>Malignant glioma</td><td>8.9</td><td>15</td><td>3.1</td></tr><tr><td>Diffuse astrocytoma</td><td>15</td><td>0.8</td><td>0.6</td></tr><tr><td>Anaplastic</td><td>25</td><td>44</td><td>2.7</td></tr><tr><td colspan="4">astrocytoma</td></tr><tr><td>Other astrocytoma</td><td>9.2</td><td>41</td><td>3.8</td></tr><tr><td>Oligodendroglioma</td><td>2.3</td><td>3.4</td><td>0.7</td></tr><tr><td>Anaplastic</td><td>0.8</td><td>15</td><td>0.4</td></tr><tr><td>oligodendroglioma</td><td></td><td></td><td></td></tr><tr><td>Ependymomas</td><td>64</td><td>0.5</td><td>0.4</td></tr><tr><td>Mixed glioma</td><td>0.8</td><td>11</td><td>0.2</td></tr><tr><td>Embryonal/</td><td>16.0</td><td>0.5</td><td>0</td></tr><tr><td>Meningeal tumors</td><td>43</td><td>29.9</td><td>39.6</td></tr><tr><td>Meningioma</td><td>3.1</td><td>28.4</td><td>39.1</td></tr><tr><td>Hemangioblastoma</td><td>0.8</td><td>12</td><td>0.4</td></tr><tr><td>Lymphoma</td><td>0.5</td><td>24</td><td>2.7</td></tr><tr><td>Sellar tumors</td><td>64</td><td>8.7</td><td>3.9</td></tr><tr><td>Pituitary adenoma</td><td>0.8</td><td>8.0</td><td>3.8</td></tr><tr><td>Craniopharyngioma</td><td>3.6</td><td>0.6</td><td>0</td></tr><tr><td>Cranial and spinal</td><td>2.0</td><td>11.3</td><td>34</td></tr><tr><td>nerve tumors</td><td></td><td></td><td></td></tr><tr><td>Germ cell tumors</td><td>43</td><td>0</td><td>0</td></tr><tr><td>Local extension from.</td><td>0.5</td><td>0.2</td><td>0</td></tr><tr><td>regional tumors Unclassified Total</td><td>3.8 100.0</td><td>28 100.0</td><td>8.5 100.0</td></tr></table>
======================================
<table><tr><td colspan="3"></td><td colspan="3" rowspan="2">astrocytomas</td><td colspan="2" rowspan="11">Other CNS Neoplasms I. Tumors of the sellar region A. Pituitary adenoma B. Pituitary carcinoma C. Craniopharyngioma II. Hematopoietic tumors A. Primary malignant lymphomas B. Plasmacytoma C. Granulocytic sarcoma</td><td colspan="2"></td></tr><tr><td colspan="3"></td><td colspan="2"></td></tr><tr><td>I)</td><td></td><td></td><td colspan="2"></td></tr><tr><td>I Astrocytic tumors A. Noninvasive: Pilocytic and subependymal pleomorphic xanthoastrocytoma (grade B. Diffuse astrocytoma (grade II) C. Anaplastic astrocytoma (grade III) D. Glioblastoma multiforme (grade IV)</td><td>giant cell</td><td>and</td><td colspan="2"></td></tr><tr><td></td><td></td><td></td><td colspan="2"></td></tr><tr><td></td><td></td><td></td><td colspan="2" rowspan="19">III. Germ cell tumors A. Germinoma B. Embryonal carcinoma C. Yolk sac tumor (endodermal sinus tumor) D. Choriocarcinoma E. Teratoma F. Mixed germ cell tumors IV. Tumors of the meninges A. Meningioma B. Atypical meningioma C. Anaplastic (malignant) meningioma V. Nonmeningothelial tumors of the meninges A. Benign mesenchymal including lipoma B. Malignant mesenchymal including hemangiopericytoma C. Primary melanocytic lesions</td><td colspan="2"></td></tr><tr><td></td><td></td><td></td><td colspan="2"></td><td colspan="2"></td></tr><tr><td>I. Oligodendroglial tumors</td><td></td><td></td><td colspan="2"></td><td colspan="2"></td></tr><tr><td>A. Oligodendroglioma (grade II)</td><td></td><td></td><td colspan="2"></td><td colspan="2"></td></tr><tr><td>B. Anaplastic (malignant) oligodendroglioma</td><td>(grade III)</td><td></td><td colspan="2"></td><td colspan="2"></td></tr><tr><td>III. Ependymal cell tumors</td><td></td><td></td><td colspan="2"></td><td colspan="2"></td></tr><tr><td>A. Ependymoma (grade II)</td><td></td><td></td><td colspan="2"></td></tr><tr><td>B. Anaplastic ependymoma (grade III) C. Myxopapillary ependymoma</td><td></td><td></td><td colspan="2"></td></tr><tr><td>D. Subependymoma (grade I)</td><td></td><td></td><td colspan="2"></td></tr><tr><td>IV. Mixed gliomas A. Mixed</td><td></td><td></td><td colspan="2"></td></tr><tr><td>oligoastrocytoma (grade II)</td><td></td><td></td><td colspan="2"></td></tr><tr><td>B. Anaplastic (malignant) oligoastrocytoma</td><td>(grade III)</td><td></td><td colspan="2"></td></tr><tr><td>C. Others (e.g., ependymoastrocytoma)</td><td></td><td></td><td colspan="2"></td></tr><tr><td>V. Neuroepithelial tumors of uncertain origin A. Polar IV)</td><td></td><td></td><td colspan="2"></td></tr><tr><td>spongioblastoma (grade B. Astroblastoma</td><td></td><td></td><td colspan="2"></td></tr><tr><td>(grade IV)</td><td></td><td></td><td colspan="2"></td></tr><tr><td>C. Gliomatosis cerebri (grade IV)</td><td></td><td></td><td colspan="2"></td></tr><tr><td colspan="3">VI. Tumors of the choroid plexus</td><td colspan="2"></td></tr><tr><td>VII. Neuronal and mixed neuronal-glial tumors A. Gangliocytoma</td><td></td><td></td><td colspan="2"></td></tr><tr><td>B. Dysplastic gangliocytoma of cerebellum C. Ganglioma</td><td>(Lhermitte-Duclos)</td><td></td><td>D. E.</td><td>Hemopoietic neoplasms—malignant lymphoma Tumors of uncertain histogenesis</td></tr><tr><td colspan="3" rowspan="2">D. Anaplastic (malignant) ganglioglioma E. Desmoplastic infantile ganglioglioma</td><td colspan="2" rowspan="4">1. Hemangioblastoma (capillary hemangioblastoma) VI. Tumors of cranial and spinal nerves A. Schwannoma (neurinoma, neurilemoma) B. Neurofibroma</td></tr><tr><td colspan="3"></td><td colspan="2"></td></tr><tr><td colspan="3" rowspan="4">F. Central neurocytoma G. Olfactory neuroblastoma (esthesioneuroblastoma) VIII. Pineal parenchyma tumors A.</td><td colspan="2"></td></tr><tr><td colspan="3"></td><td colspan="2"></td></tr><tr><td colspan="3"></td><td>C.</td><td>Malignant peripheral nerve sheath tumor</td></tr><tr><td colspan="3"></td><td colspan="2" rowspan="2">(malignant schwannoma
======================================
)</td></tr><tr><td colspan="3" rowspan="6">Pineocytoma B. Pineoblastoma C. Mixed pineocytoma/pineoblastoma IX. Tumors with neuroblastic or glioblastic elements (embryonal tumors) A. Primitive neuroectodermal tumors with multipotent differentiation 1. Medulloblastoma 2. Cerebral primitive neuroectodermal tumor</td><td colspan="3"></td><td colspan="2" rowspan="4">VII. Local extensions from regional tumors A. Paraganglioma (chemodectoma) B. Chordoma C. Chondroma</td><td colspan="2"></td><td colspan="2"></td></tr><tr><td colspan="3"></td><td colspan="2"></td></tr><tr><td colspan="3"></td><td colspan="2"></td></tr><tr><td colspan="3"></td><td colspan="2" rowspan="3">D. Chondrosarcoma E. Carcinoma VIII. Metastatic tumors IX. Cysts and tumor-like lesions A. Rathke cleft cyst</td></tr><tr><td colspan="3"></td><td colspan="2"></td></tr><tr><td colspan="3" rowspan="4">B. Neuroblastoma C. Retinoblastoma D. Ependymoblastoma</td><td colspan="2"></td></tr><tr><td colspan="3"></td><td>B. C.</td><td>Epidermoid Dermoid</td></tr><tr><td colspan="3"></td><td>D. E.</td><td>Colloid cyst of the third ventricle neuronal hamartoma</td></tr><tr><td colspan="3"></td><td></td><td>Hypothalamic</td></tr><tr><td>GRADE</td><td>!</td><td>i</td><td>ul</td><td>IV</td></tr><tr><td colspan="5">Astrocytic tumors</td><td colspan="2"></td></tr><tr><td>Subependymal giant cell astrocytoma</td><td>.</td><td></td><td></td><td></td></tr><tr><td>Pilocytic astrocytoma</td><td>.</td><td></td><td></td><td></td></tr><tr><td>Pilomyxoid astrocytoma</td><td></td><td></td><td></td><td></td></tr><tr><td>Diffuse astrocytoma</td><td></td><td></td><td></td><td></td></tr><tr><td>Pleomorphic xanthoastrocytoma</td><td></td><td></td><td></td><td></td></tr><tr><td>Anaplastic astrocytoma</td><td></td><td></td><td></td><td></td></tr><tr><td>Glioblastoma</td><td></td><td></td><td></td><td></td></tr><tr><td>Giant cell</td><td></td><td></td><td></td><td></td></tr><tr><td>glioblastoma Gliosarcoma</td><td></td><td></td><td></td><td></td></tr><tr><td>Oligodendroglial tumors</td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5">Oligodendroglioma</td></tr><tr><td colspan="5">Anaplastic oligodendroglioma</td></tr><tr><td>Oligoastrocytic tumors</td><td></td><td></td><td></td><td></td></tr><tr><td>Oligoastrocytoma</td><td></td><td></td><td></td><td></td></tr><tr><td>Anaplastic oligoastrocytoma</td><td></td><td></td><td></td><td></td></tr><tr><td>Ependymal tumors</td><td></td><td></td><td colspan="2" rowspan="3"></td></tr><tr><td>Subependymoma</td><td>. .</td><td></td><td colspan="2"></td></tr><tr><td>Myxopapillary ependymoma Ependymoma</td><td></td><td></td><td colspan="2"></td></tr></table>
======================================
<table><thead><th>GRADE</th></thead><tr><td>Choroid plexus tumors</td></tr><tr><td>Choroid plexus papilloma</td></tr><tr><td>Atypical choroid plexus papilloma</td></tr><tr><td>Choroid plexus carcinoma</td></tr><tr><td>Other neuroepithelial tumors</td></tr><tr><td>Angiocentric glioma</td></tr><tr><td>Choroid glioma of the third ventricle</td><td></td></tr><tr><td>Neuronal and mixed neuronal-glial tumors</td></tr><tr><td rowspan="2">Gangliocytoma Ganglioglioma</td></tr><tr><td></td></tr><tr><td>Anaplastic ganglioglioma</td></tr><tr><td>Desmoplastic infantile astrocytoma and</td></tr><tr><td>ganglioglioma</td></tr><tr><td>Dysembryoplastic neuroepithelial tumor</td></tr><tr><td>Central</td></tr><tr><td>neurocytoma</td></tr><tr><td>Extraventricular neurocytoma</td></tr><tr><td>Cerebellar liponeurocytoma</td></tr><tr><td>Paraganglioma of the spinal cord</td></tr><tr><td>Papillary glioneuronal tumor</td></tr><tr><td>Rosette-forming glioneuronal tumor of the</td></tr><tr><td>fourth ventricle</td></tr><tr><td>Pineal tumors</td><td></td></tr><tr><td>Pineocytoma</td></tr><tr><td>Pineal parenchymal tumor of intermediate</td></tr><tr><td>differentiation</td></tr><tr><td>Pineoblastoma</td></tr><tr><td>Papillary tumor of the pineal region</td></tr><tr><td>Embryonal tumors</td></tr><tr><td>Medulloblastoma</td></tr><tr><td>CNS primitive neuroectodermal tumor (PNET)</td></tr><tr><td>Atypical teratoid/rhabdoid tumor</td></tr><tr><td>Tumors of the cranial and paraspinal nerves</td></tr><tr><td>Schwannoma</td></tr><tr><td>Neurofibroma</td></tr><tr><td>Perineurioma</td></tr><tr><td>Malignant peripheral nerve sheath tumor (MPNST)</td></tr><tr><td>Meningeal tumors</td></tr><tr><td>Meningioma</td></tr><tr><td>Atypical meningioma</td></tr><tr><td>Anaplastic/malignant meningioma</td></tr><tr><td>Hemangiopericytoma</td></tr><tr><td>Anaplastic hemangiopericytoma</td></tr><tr><td>Hemangioblastoma Tumors of the sellar</td></tr><tr><td>region</td></tr><tr><td>Craniopharyngioma</td></tr><tr><td>Granular cell tumor of the neurohypophysis</td></tr><tr><td>Pituicytoma</td></tr></table>
======================================
<table><thead><th>HORMONE</th><th>TEST</th></thead><tr><td>Prolactin</td><td>Serum prolactin level, chlorpromazine- or TRH-provocative tests, L-dopa suppression</td></tr><tr><td>Somatotropin (GH)</td><td>Serum GH level, glucagon, L-dopa, glu- cose-GH suppression, somatomicid C</td></tr><tr><td>Adrenocorticotropin</td><td>Serum cortisol, urinary steroids, metyrapone test, dexamethasone suppression</td></tr><tr><td>Gonadotropin Thyrotropin</td><td>Serum FSH, LH, estradiol, testosterone, GnRH stimulation TSH, Ty, TRH</td></tr><tr><td>Vasopressin</td><td>Urine and serum osmolality after water restriction for deficiency of hormone; without water restriction for excess of hormone</td></tr></table>
======================================
<table><tr><td>SITE OF LESION</td><td>EPONYM</td><td>CLINICAL SYMPTOMS</td><td>ETIOLOGY?</td></tr><tr><td>nterior part of the base of the skull iperior orbital fissure</td><td>| Rochon-Duvigneau; syndrome</td><td>Olfactory disturbances (uni- or bilat- eral anosmia), possibly psychiatric disturbances, seizures. Lesions of the third, fourth, sixth, and</td><td>Tumors that invade the anterior part of the base of the skull from the frontal sinus, nasal cavity, or the ethmoid bone, osteomas. Meningiomas of the olfactory groove. Tumors: meningiomas, osteomas, der-</td></tr><tr><td></td><td>of the pterygopalatine fossa (Behr) and the base of the orbit (DeJean) commencing with a lesion of the maxillary and pterygoid rami and evolving into the superior orbital fissure syndrome.</td><td>first divisions of the fifth nerves with ophthalmoplegia, pain, and sensory disturbances in the area of V1; often exophthalmos, some veg- etative disturbances.</td><td>moid cysts, giant-cell tumors, tumors of the orbit, nasopharyn- geal tumors; more rarely, optic nerve gliomas; eosinophilic granu- lomas, angiomas, local or neighbor- ing infections, trauma.</td></tr><tr><td>pex of the orbit avernous sinus</td><td>Jacod-Rollet (often combined with the syndrome of the superior orbital fissure); infra- clinoid syndrome of Dandy. Foix-Jefferson; syndrome of the sphenopetrosal fissure (Bon- net and Bonnet) correspond- ing in part to the cavernous sinus syndrome of Raeder.</td><td>Visual disturbances, central scotoma, papilledema, optic nerve atrophy; occasional exophthalmos, chemo- sis. Ophthalmoplegia caused by lesions of the third, fourth, sixth, and often fifth nerves; exophthalmos; vegeta- tive disturbances. Jefferson distin- guished three syndromes: (1) the anterior-superior, corresponding to the superior orbital fissure syn- drome; (2) the middle, causing oph-</td><td>Optic nerve glioma, infraclinoid aneu- rysm of the internal carotid artery, trauma, orbital tumors, Paget disease. Tumors of the sellar and parasellar area, infraclinoid aneurysms of the internal carotid artery, nasopharyn- geal tumors, fistulas of the sinus cavernosus and the carotid artery (traumatic), tumors of the middle cranial fossa, e.g., chondromas, meningiomas, and neurinomas.</td></tr><tr><td></td><td></td><td>thalmoplegia and lesions of V; and V5; (3) the caudal, in addition affect- ing the whole trigeminal nerve.</td><td></td></tr><tr><td>pex of the petrous temporal bone</td><td>Gradenigo-Lannois</td><td>Lesions of the fifth and sixth nerves with neuralgia, sensory, and motor disturbances, diplopia.</td><td>Inflammatory processes (otitis), tumors such as cholesteatomas, chondromas, meningiomas, neurinomas of the gasserian ganglion and trigeminal root, primary and secondary sarco-</td></tr><tr><td>»henoid and petrosal bones (petrosphe- noidal syndrome)</td><td>= Jacod</td><td>Ophthalmoplegia caused by loss of function of the third, fourth, and sixth nerves; amaurosis; trigeminal neuralgia possibly with sensory</td><td>mas at the base of the skull. Tumors of the sphenoid and petrosal bones and middle cranial fossa, nasopharyngeal tumors, metastases.</td></tr><tr><td>gular foramen</td><td>Vernet</td><td>signs. Lesions of ninth, tenth, and eleventh nerves with disturbance of degluti- tion; curtain phenomenon; sensory disturbances of the tongue, soft palate, pharynx, and larynx; hoarseness; weakness of the ster- nocleidomastoid and trapezius.</td><td>Tumors of the glomus jugulare; neuri- nomas of eighth, ninth, tenth, and eleventh nerves; chondromas, cho- lesteatomas, meningiomas, nasopharyngeal and ear tumors; infections, angiomas, rarely trauma.</td></tr><tr><td>nterior occipital condyles</td><td>Collet-Sicard (Vernet-Sargnon)</td><td>Loss of twelfth nerve function (loss of normal tongue mobility) in addi- tion to the symptoms of the jugular foramen.</td><td>Tumors of the base of the skull, ear, parotid; leukemic infiltrates; aneu- rysms, angiomas, and inflamma- tions.</td></tr><tr
======================================
><td>-troparotid space (retropharyngeal syndrome)</td><td>Villaret</td><td>Lesions of the lower group of nerves (Collet-Sicard) and Bernard-Horner syndrome with ptosis and miosis.</td><td>Tumors of the retroparotid space (car- cinomas, sarcomas), trauma, inflammations.</td></tr><tr><td>alf of the base of the skull</td><td>Garcin (Guillain-Alajouanine- Garcin); also described by Hartmann in 1904.</td><td>Loss of function of all twelve cranial nerves of one side; in many cases, iso- lated cranial nerves spared; rarely signs of raised intracranial pressure or pyramidal tract symptoms.</td><td>Nasopharyngeal tumors, primary tumors at the base of the skull, leu- kemic infiltrates of basal meninges, trauma, metastases.</td></tr><tr><td>erebellopontine angle</td><td></td><td>Loss of function of eighth nerve (hear- ing loss, vertigo, nystagmus); cere- bellar disturbances; lesions of the fifth, seventh, and possibly ninth and tenth cranial nerves. Signs of raised intracranial pressure, brain- stem symptoms.</td><td>Acoustic neuromas (raised protein in CSF), meningiomas, cholesteato- mas, metastases, cerebellar tumors, neurinomas of the caudal group of nerves and the trigeminal nerve, vascular processes such as angio- mas, basilar aneurysms.</td></tr></table>
======================================
<table><thead><th>NEUROLOGIC DISORDER</th><th>CLINICAL FEATURES</th><th>PREDOMINANT AUTOANTIBODY</th><th>TUMOR</th></thead><tr><td>Cerebellar degeneration</td><td>Ataxia, subacute</td><td>Anti-Yo (anti-Purkinje cell)</td><td>Ovary, fallopian tube, lung, Hodgkin disease (anti-Tr)</td></tr><tr><td rowspan="2">Encephalomyelitis</td><td>Subacute confusion, brainstem signs, myelitis</td><td>Anti-Hu (ANNA 1) Anti-Ma</td><td>Small cell lung, neuroblastoma, prostate, breast, Hodgkin, testicular</td></tr><tr><td></td><td>Psychosis, seizures</td><td>Anti-NMDA</td><td>(Ma) Ovarian (and other site) teratoma</td></tr><tr><td>Opsoclonus—myoclonus—ataxia</td><td>Ocular movement disorder, gait ataxia</td><td>Anti-Ri (ANNA 2)</td><td>Breast, fallopian tube, small cell jun;</td></tr><tr><td>Retinal degeneration</td><td>Scotomas, blindness, disc</td><td>Antirecoverin (Anti-CAR)</td><td>Small cell lung, thymoma, renal cell, melanoma</td></tr><tr><td>Subacute sensory neuropathy and</td><td>swelling Distal or proximal sensory loss</td><td>Anti-Hu (ANNA-1)</td><td>Small cell lung, Hodgkin, other</td></tr><tr><td>neuronopathy Lambert-Eaton myasthenic syndrome</td><td>Proximal fatiguing weakness, autonomic symptoms (dry</td><td>Anti-voltage-gated (VGCG) calcium channel</td><td>lymphomas Small cell lung, Hodgkin, other lymphomas</td></tr><tr><td>Stiff man syndrome Chorea Optic neuropathy</td><td>mouth) Muscle spasms and rigidity Bilateral choreoathetosis Blindness</td><td>Antiamphiphysin Anti-Hu, CRMP-5 Anti-CRMP-5</td><td>Breast Lung, Hodgkin, others Lung</td></tr></table>
======================================
<table><thead><th>ANTIMICROBIAL AGENT</th><th>TOTAL DAILY DOSE</th><th>DOSING INTERVAL, HOURS</th></thead><tr><td>Amikacin?</td><td>15 mg/kg</td><td>8</td></tr><tr><td>Ampicillin</td><td>1g</td><td>4</td></tr><tr><td>Cefepime</td><td>46g</td><td>8-12</td></tr><tr><td>Cefotaxime</td><td>lg</td><td>46</td></tr><tr><td>Ceftazidime</td><td>6g</td><td>8</td></tr><tr><td>Ceftriaxone</td><td>4g</td><td>12-24</td></tr><tr><td>Chloramphenicol*</td><td>6g</td><td>6</td></tr><tr><td>Ciprofloxacin</td><td>800-1,200 mg</td><td>12</td></tr><tr><td>Gentamicin’</td><td>5 mg/kg</td><td>8</td></tr><tr><td>Linezolid</td><td>1,200 mg</td><td>12</td></tr><tr><td>Meropenem'</td><td>368</td><td>8</td></tr><tr><td>Nafcillin</td><td>9-12 g</td><td>4</td></tr><tr><td>Oxacillin</td><td>9-12 g</td><td>4</td></tr><tr><td>Penicillin G</td><td>24 million units</td><td>4</td></tr><tr><td>Quinupristin-dalfopristin</td><td>22.5 mg/kg</td><td>8</td></tr><tr><td>Rifampin®</td><td>600 mg</td><td>24</td></tr><tr><td>Tobramycin</td><td>5 mg/kg</td><td>8</td></tr><tr><td>Trimethoprim- sulfamethoxazole/</td><td>20 mg/kg</td><td>6-12</td></tr><tr><td>Vancomycin?s</td><td>24g</td><td>6-12</td></tr></table>
======================================
<table><thead><th>AGE OF PATIENT</th><th>ANTIMICROBIAL THERAPY</th></thead><tr><td>0-4 wk</td><td>Cefotaxime plus ampicillin</td></tr><tr><td>4-12 wk</td><td>Third-generation cephalosporin plus ampicillin (plus dexamethasone)</td></tr><tr><td>3mo-18 y</td><td>Third-generation cephalosporin plus vancomycin (+ ampicillin)</td></tr><tr><td>18-50 y</td><td>Third-generation cephalosporin plus vancomycin ((+ ampicillin)</td></tr><tr><td>&gt;50 y</td><td>Third-generation cephalosporin plus vancomycin plus ampicillin</td></tr><tr><td>Immunocompromised state</td><td>Vancomycin plus ampicillin and ceftazidime</td></tr><tr><td>Basilar skull fracture</td><td>Third-generation cephalosporin plus vancomycin</td></tr><tr><td colspan="2">Head trauma; Vancomycin plus ceftazidime</td></tr><tr><td>neurosurgery CSF shunt</td><td>Vancomycin plus ceftazidime</td></tr></table>
======================================
<table><thead><th>MICROORGANISM</th><th>STANDARD THERAPY</th><th>ALTERNATIVE THERAPIES</th></thead><tr><td>Haemophilus influenzae Beta-lactamase-negative</td><td>Ampicillin</td><td>Third-generation cephalosporin’;</td></tr><tr><td>Beta-lactamase—positive Neisseria meningitidis</td><td>Third-generation cephalosporin® Penicillin G or third-generation cephalosporin®</td><td>chloramphenicol Chloramphenicol; cefepime Chloramphenicol</td></tr><tr><td>Streptococcus pneumoniae Penicillin MIC &lt;0.1 g/mL (sensitive)</td><td>Penicillin G or ampicillin</td><td>Third-generation cephalosporin‘; chloram-</td></tr><tr><td>Penicillin MIC 0.1-1.0 pg/mL</td><td>Third-generation cephalosporin”</td><td>phenicol; vancomycin plus rifampin Vancomycin; meropenem</td></tr><tr><td>(intermediate sensitivity) Penicillin MIC 22.0 pg/mL (highly resistant)</td><td>Vancomycin plus third-generation</td><td>Meropenem</td></tr><tr><td>Enterobacteriaceae</td><td>cephalosporin Third-generation cephalosporin*</td><td>Meropenem; fluoroquinolone; trimethoprim-</td></tr><tr><td>Pseudomonas</td><td>Ceftazidime or</td><td>sulfamethoxazole, or cefepime</td></tr><tr><td>aeruginosa Listeria monocytogenes</td><td>cefepime? Ampicillin or penicillin G?</td><td>Meropenem; fluoroquinolone®; piperacillin Trimethoprim-sulfamethoxazole</td></tr><tr><td colspan="3">Streptococcus agalactiae Ampicillin or penicillin G? Third-generation cephalosporin’; vancomycin</td></tr><tr><td>Staphylococcus aureus Methicillin-sensitive</td><td>Nafcillin or oxacillin plus third-generation</td><td>Vancomycin,</td></tr><tr><td>Methicillin-resistant?</td><td>cephalosporin Vancomycin‘ plus third-generation cephalosporin</td><td>Linezolid, quinupristin-dalfopristin, tigecycline</td></tr><tr><td>Staphylococcus epidermidis</td><td>Vancomycin®</td><td>Linezolid, tigecycline</td></tr></table>
======================================
<table><thead><th>DISEASE (ORGANISM)</th><th>CLINICAL FEATURES</th><th>RADIOGRAPHIC FEATURES</th></thead><tr><td colspan="3">Cestodes (tapeworms)</td></tr><tr><td>Cysticercosis (Taenia solium) and coenuriasis (Taenia multiceps)</td><td>Seizures with mature lesions, hydrocephalus, ventricular and multiple subarachnoid implantation Subcutaneous seizures</td><td>Cyst with scolex; late calcification</td></tr><tr><td>Sparganosis (Spirometra) Hydatid disease (Echinococcus)</td><td>nodule, Focal cerebral findings, raised intracranial pressure</td><td>Migrating granuloma or mass Large fluid-filled cyst, solid “chitinoma”</td></tr><tr><td>Nematodes (roundworms) Trichinosis</td><td>Skin lesions, severe myositis, brain lesions, eosinophilia, meningitis, encephalitis (rare)</td><td>Granuloma</td></tr><tr><td>Angiostrongyloidiasis (Angiostrongylus cantonensis) is (Gnathostoma spinigerum) is (Baylisascarus procyonis)</td><td>Meningoencephalitis, eosinophilia Eosinophilic meningoencephalitis Eosinophilic meningoencephalitis (from</td><td>Granuloma, nodule, migrating track</td></tr><tr><td></td><td>racoon bites)</td><td></td></tr><tr><td>Strongyloidiasis (Strongyloides stercoralis)</td><td>Encephalitis, myelitis, seizures</td><td>Irregular nodular enhancing lesions, may change position</td></tr><tr><td>Visceral larva migrans (Toxocara canis,</td><td>Eosinophilic meningoencephalitis</td><td></td></tr><tr><td colspan="3">T. cati)</td></tr><tr><td>Trematodes (flukes) Schistosomiasis (Schistosoma japonicum, S.</td><td>Myelopathy, seizures, tumor symptoms,</td><td>Single granuloma, may be large</td></tr><tr><td>mansoni, S. haematobium) Paragonimiasis</td><td>swimmer’s itch Seizures, meningoencephalitis, pulmonary lesions</td><td>Single granuloma</td></tr><tr><td>Other tropical and parasitic infections Toxoplasmosis (T. gondii) Amebiasis</td><td>Seizures, focal cerebral findings Colitis, liver abscess, rare brain abscess</td><td>Single or multiple enhancing lesions Abscess or encephalopathy</td></tr><tr><td>Entamoeba histolytica, N. fowleri, B. mandrallis</td><td>Primary amebic meningoencephalitis, seizures (after swimming) Granulomatous encephalitis</td><td>Multiple small abscess lesions</td></tr><tr><td>Tuberculoma (M. tuberculosis and atypical forms)</td><td>Seizure</td><td>Granuloma</td></tr></table>
======================================
<table><thead><th>SIGNS AND SYMPTOMS</th><th>STRUCTURES INVOLVED</th></thead><tr><td>Paralysis of the contralateral face, arm, and leg</td><td>Somatic motor area for face and arm and the fibers descending from. the leg area to enter the corona radiata</td></tr><tr><td>Sensory impairment over the contralateral face, arm, and leg (pinprick, cotton touch, vibration, position, two-point discrimination, stereognosis, tactile localization, baragnosis, cutaneographia) disorder</td><td>Somatosensory area for face and arm and thalamoparietal projections and of the dominant</td></tr><tr><td>Motor speech “Central” aphasia, word deafness, anomia, jargon speech, alexia, agraphia, acalculia, finger agnosia, right—left confusion (the last four comprise the Gerstmann syndrome) Apractagnosia (amorphosynthesis), anosognosia, hemiasomatognosia,</td><td>Broca adjacent motor area hemisphere Central language area and parietooccipital cortex of the dominant hemisphere Usually nondominant parietal lobe. Loss of topographic is</td></tr><tr><td>unilateral neglect, agnosia for the left half of external space, “dressing apraxia,” “constructional apraxia,” distortion of visual coordinates, inaccurate localization in the half field, impaired ability to judge distance, upside-down reading, visual illusions</td><td>memory usually caused by a nondominant lesion, occasionally by a dominant one</td></tr><tr><td>Homonymous hemianopia (often superior homonymous quadrantanopia) Paralysis of conjugate to the opposite side</td><td>Optic radiation deep to second temporal convolution Frontal contraversive field or fibers projecting therefrom</td></tr><tr><td>gaze Avoidance reaction of opposite limbs Miscellaneous:</td><td>Parietal lobe</td></tr><tr><td>Ataxia of contralateral limb(s)</td><td>Parietal lobe</td></tr><tr><td>So-called Bruns ataxia or apraxia of gait Loss or impairment of optokinetic nystagmus</td><td>Frontal lobes (bilateral) Supramarginal gyrus or inferior parietal lobe</td></tr><tr><td>Limb-kinetic apraxia Mirror movements</td><td>Premotor or parietal cortical damage Precise location of responsible lesions not known</td></tr><tr><td>Cheyne-Stokes respiration, contralateral hyperhidrosis, mydriasis (occasionally)</td><td>Precise location of responsible lesions not known</td></tr><tr><td>Pure motor hemiplegia</td><td>Upper portion of the posterior limb of the internal capsule and the adjacent corona radiata</td></tr></table>
======================================
<table><thead><th>SIGNS AND SYMPTOMS</th><th>STRUCTURES INVOLVED</th></thead><tr><td>Paralysis of opposite foot and leg A lesser degree of paresis of opposite arm</td><td>Motor leg area Involvement of arm area of cortex or fibers descending therefrom to corona radiata</td></tr><tr><td>Cortical sensory loss over toes, foot, and leg</td><td>Sensory area for foot and leg</td></tr><tr><td>Urinary incontinence Contralateral grasp reflex, sucking reflex, gegenhalten (paratonic “frontal tremor”</td><td>Posteromedial part of superior frontal gyrus (bilateral) Medial surface of the posterior frontal lobe (?)</td></tr><tr><td>rigidity), Abulia (akinetic mutism), slowness, delay, lack of spontaneity, whispering, motor inaction, reflex distraction to sights and sounds</td><td>Uncertain localization—probably superomedial lesion near subcallosum</td></tr><tr><td>Impairment of gait and stance (gait “apraxia”)</td><td>Inferomedial frontal-striatal (?)</td></tr><tr><td>Mental impairment (perseveration and amnesia)</td><td>Localization unknown</td></tr><tr><td>Miscellaneous: dyspraxia of left limbs</td><td>Corpus callosum</td></tr><tr><td>Tactile aphasia in left limbs</td><td>Corpus callosum</td></tr><tr><td>Cerebral paraplegia</td><td>Motor leg area bilaterally (because of bilateral occlusion of anterior cerebral arteries)</td></tr></table>
======================================
<table><tr><td></td><td>Figure 34-9. The posterior cerebral and basilar arteries. (Reproduced by permis-</td></tr><tr><td>A</td><td>sion from Krayenbiihl and Yasargil.)</td></tr><tr><td colspan="2">FIGURE 34-9A: POSTERIOR CEREBRAL ARTERY REGIONS OF VASCULAR SUPPLY</td><td rowspan="3">nucleus, mammillary body, oculomotor nerve, nucleus, ventrolateral nucleus of the thalamus, geniculate body, internal capsule (posterior portion)</td></tr><tr><td>A. Circular or proximal segment (1) Paramedian arteries (interpeduncular, intercrural, perforating) (2) Quadrigeminal arteries (3) Thalamic arteries (medial and lateral)</td><td></td></tr><tr><td></td><td></td></tr><tr><td>(4) Medial posterior choroidal arteries (5) Premammillary arteries (of the posterior communicating</td><td>choroid plexus, pineal gland</td></tr><tr><td>artery) (6) Peduncular artery</td><td>peduncle, ventral nuclei of the thalamus, nuclei</td></tr><tr><td>(7) Lateral posterior choroidal arteries (anterior and posterior)</td><td>optic chiasm geniculate body, pulvinar, dentate fascia, basal cortex of the temporal lobe, choroid plexus of trigone, dorsolateral nuclei of the thalamus</td></tr><tr><td rowspan="5">B. Cortical or distal segment (8) Lateral occipital artery (a) Anterior temporal arteries (b) Middle temporal arteries (c) Posterior temporal arteries (9) Medial occipital artery (a) Dorsal callosal artery (b) Posterior parietal artery (c) Occipitoparietal artery (d) Calcarine arteries (e) Occipitotemporal artery</td><td rowspan="2">temporal and occipital lobe</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td>pole</td></tr><tr><td>FIGURE 34-9B: BASILAR ARTERY</td><td></td></tr><tr><td>(Cr) Posterior communicating artery Thalamic arteries</td><td></td></tr><tr><td>artery (1) (2a) Medial posterior choroidal artery (2b) Lateral posterior choroidal artery (3) Dorsal callosal artery (4) Medial occipital artery (a) Posterior parietal arteries (b) Occipitoparietal arteries</td><td></td></tr><tr><td>(B) Basilar (c) Calcarine arteries (5a) Anterior and middle temporal arteries (5b) Posterior temporal artery</td><td></td></tr><tr><td></td><td></td></tr></table>
======================================
<table><thead><th>EPONYM?</th><th>SITE</th><th>CRANIAL NERVES INVOLVED</th><th>TRACTS INVOLVED</th><th>SIGNS</th><th>USUAL CAUSE</th></thead><tr><td>Neber syndrome</td><td>Base of midbrain</td><td>Tl</td><td>Corticospinal tract</td><td>Oculomotor palsy with crossed hemiplegia</td><td>Vascular occlusion, tumor, aneurysm.</td></tr><tr><td>“laude syndrome</td><td>Tegmentum of midbrain</td><td>Tl</td><td>Red nucleus and brachium conjunctivum</td><td>Oculomotor palsy with contralateral cerebellar ataxia and tremor</td><td>Vascular occlusion, tumor, aneurysm.</td></tr><tr><td>3enedikt syndrome</td><td>Tegmentum of midbrain</td><td>Tl</td><td>Red nucleus, corticospinal tract, and brachium conjunctivum</td><td>Oculomotor palsy with contralateral cerebellar ataxia, tremor, and corticospinal signs</td><td>Infarct, hemorrhage, tuberculoma, tumor</td></tr><tr><td>Nothnagel syndrome</td><td>Tectum of midbrain</td><td>Unilateral or bilateral III</td><td>Superior cerebellar peduncles</td><td>Ocular palsies, paralysis of gaze, and cerebellar ataxia</td><td>Tumor</td></tr><tr><td>-arinaud syndrome</td><td>Dorsal midbrain</td><td></td><td>Supranuclear mechanism for upward gaze and other structures in periaqueductal gray matter</td><td>Paralysis of upward gaze and accommodation; fixed pupils</td><td>Pinealoma, and other lesion of dorsal midbrain, hydrocephalus</td></tr><tr><td>Millard-Gubler syndrome and Raymond-Foville syndrome</td><td>Base of pons</td><td>VII and often VI</td><td>Corticospinal tract</td><td>Facial and abducens palsy and contralateral hemiplegia; sometimes gaze palsy to side of lesion</td><td>Infarct, or tumor</td></tr><tr><td>Avellis syndrome</td><td>Tegmentum of medulla</td><td></td><td>Spinothalamic tract; sometimes descending pupillary fibers, with Bernard-Horner syndrome</td><td>Paralysis of soft palate and vocal cord and contralateral hemianesthesia</td><td>Infarct, or tumor</td></tr><tr><td>ackson syndrome</td><td>Tegmentum of medulla</td><td>X, XII</td><td>Corticospinal tract</td><td>Avellis syndrome plus ipsilateral tongue paralysis</td><td>Infarct, or tumor</td></tr><tr><td>Nallenberg syndrome</td><td>Lateral tegmentum of medulla</td><td>Spinal V, IX, X, XI</td><td>Lateral spinothalamic tract Descending pupillodilator fibers Spinocerebellar and olivocerebellar tracts</td><td>Ipsilateral V, IX, X, XI palsy, Horner syndrome and cerebellar ataxia; contralateral loss of pain and temperature sense</td><td>Occlusion of vertebral or posterior—inferior cerebellar artery</td></tr></table>
======================================
<table><thead><th colspan="3">DISEASES AND THEIR FREQUENCY</th></thead><thead><th></th><th>HARVARD</th><th></th></thead><thead><th></th><th>STROKE</th><th>BCH</th></thead><thead><th></th><th>SERIES? (756</th><th>AUTOPSY</th></thead><thead><th></th><th>SUCCESSIVE</th><th>SERIES?</th></thead><thead><th></th><th>CASES)</th><th>(179 CASES)</th></thead><tr><td>Atherosclerotic thrombosis</td><td>244 (32%)</td><td>21 (12%)</td></tr><tr><td>Lacunes</td><td>129 (18%)</td><td>34 (18.5%)</td></tr><tr><td>Embolism.</td><td>244 (32%)</td><td>57 (32%)</td></tr><tr><td>Hypertensive hemorrhage</td><td>84 (11%)</td><td>28 (15.5%)</td></tr><tr><td>Ruptured aneurysms and vascular malformations</td><td>55 (7%)</td><td>8 (4.5%)</td></tr><tr><td>Indeterminate</td><td></td><td>17 (9.5%)</td></tr><tr><td>Other‘</td><td></td><td>14 (8%)</td></tr></table>
======================================
<table><thead><th>CLINICAL DEVELOPMENT</th><th>NO. OF CASES</th><th>PERCENT</th></thead><tr><td>Transient ischemic attacks progressing to a major or minor persistent deficit</td><td>53</td><td>42</td></tr><tr><td>neurologic Stepwise development of a stroke, with or without transient ischemic attacks</td><td>23</td><td>18</td></tr><tr><td>Stroke developing as a single event: Abrupt (hours), with or without fluctuations</td><td>14</td><td>1</td></tr><tr><td>Slow, gradual (a few days), with or without minor fluctuations</td><td>7</td><td>6</td></tr><tr><td>Transient ischemic attacks only</td><td>17</td><td>14</td></tr><tr><td>Development of a limited stroke followed by transient ischemic attacks</td><td>1</td><td>9</td></tr></table>
======================================
<table><thead><th>SEQUENCE</th><th>TE</th><th>TR</th><th>GOOD FOR</th><th>BRIGHT</th><th>DARK</th></thead><tr><td>Tl-weighted</td><td>&lt;50</td><td>&lt;1,000</td><td>Subacute blood, contusions, CSF disorders</td><td>CSE, bone, edema, deoxyhemoglobin mineralization</td><td></td></tr><tr><td>T2-weighted</td><td>&gt;80</td><td>&gt;2,000</td><td>Infarcts, inflammation, tumors</td><td>CSF, liquids, edema</td><td>Solids, calcium.</td></tr><tr><td>Proton (spin) density Fluid-attenuated inversion recovery (FLAIR)</td><td>&lt;50 &gt;80</td><td>&gt;2,000 &gt;10,000</td><td>Edema, inflammation</td><td>“Most pathology” Edema, inflammation, gliosis</td><td>Fat, water, acute blood CSF; otherwise like T2 Blood after several</td></tr><tr><td>Diffusion-weighted image (DWI) Susceptibility sequence Short tau inversion recovery (STIR)</td><td></td><td></td><td>Acute infarcts Hemorrhages, calcification Spine and orbit studies (eliminates fat signals)</td><td></td><td>Blood</td></tr></table>
======================================
<table><thead><th></th><th>GENE</th><th>INHERITANCE</th><th>STRUCTURES — AFFECTED</th><th>GENERAL POPULATION (%)</th><th>WITH CEREBRAL THROMBOSIS (%)</th></thead><tr><td colspan="6">s of arterial or venous infarction</td></tr><tr><td>vated protein C</td><td>Leiden factor V mutation</td><td>AR</td><td>v</td><td>2-15</td><td>5-20</td></tr><tr><td>sistance</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>hrombin 20210</td><td>Prothrombin</td><td>AR</td><td>v</td><td>0.1</td><td>145</td></tr><tr><td>ein C deficiency</td><td>Protein C gene</td><td>AR</td><td>v</td><td>0.2-0.4</td><td>3-6</td></tr><tr><td>ein S deficiency</td><td>Protein S gene</td><td>AR</td><td>v</td><td>0.03-0.13</td><td>1-5</td></tr><tr><td>eased Factor VIII</td><td>von Willebrand factor deficiency</td><td>AR</td><td>v</td><td>10</td><td>25</td></tr><tr><td>ithrombin III deficiency</td><td>Antithrombin III</td><td>AR</td><td>v</td><td>Rare</td><td>3-8</td></tr><tr><td>minogen deficiency</td><td>Plasminogen activator-1</td><td>AR</td><td>v</td><td></td><td></td></tr><tr><td></td><td></td><td>AR</td><td>v</td><td></td><td></td></tr><tr><td>yprotein (a)</td><td>Apolipoprotein (a)</td><td></td><td></td><td></td><td></td></tr><tr><td>fan syndrome</td><td>Fibrillin 1</td><td></td><td>v,h,ao</td><td>0.03</td><td></td></tr><tr><td>ry disease</td><td>Alpha-galactosidase</td><td>AR</td><td>v</td><td></td><td></td></tr><tr><td>le cell syndrome</td><td>Globin genes</td><td></td><td>va</td><td></td><td></td></tr><tr><td>arin cofactor II</td><td>Heparin cofactor II</td><td>AR</td><td>v</td><td>Rare</td><td>25</td></tr><tr><td>elet</td><td>Platelet</td><td>AR</td><td></td><td></td><td></td></tr><tr><td>collagen receptor</td><td>collagen receptor</td><td></td><td>v</td><td></td><td></td></tr><tr><td>or XII</td><td>Factor XII</td><td>AR</td><td>v</td><td></td><td></td></tr><tr><td>4D</td><td>4D</td><td></td><td>a</td><td></td><td></td></tr><tr><td>sphodiesterase</td><td>Phosphodiesterase</td><td>Complex</td><td></td><td></td><td></td></tr><tr><td>DASIL</td><td>Notch 3</td><td>AD</td><td>a</td><td></td><td></td></tr><tr><td>erhomocysteinemia</td><td>Methylene tetrahydrofolate</td><td>AR</td><td>a</td><td>Rare</td><td>20 in young</td></tr><tr><td></td><td>reductase</td><td></td><td></td><td></td><td></td></tr><tr><td>nocysteinemia</td><td>Cystathione beta-synthase</td><td>AR</td><td>a</td><td></td><td></td></tr><tr><td>nocysteinemia</td><td>Homocysteine methyl</td><td>AR</td><td>a</td><td></td><td></td></tr><tr><td colspan="6" rowspan="2">transferase rs Danlos disease a</td></tr><tr><td colspan="6"></td></tr><tr><td>_AS (mitochondrial)</td><td>mtDNA</td><td>Maternal</td><td></td><td></td><td></td></tr><tr><td>s of cerebral hemorrhage</td><td>associated with congenital diseases</td><td>AD</td><td></td><td></td><td></td></tr><tr><td>Hippel-Lindau (Chap.31)</td><td>= pVHL</td><td></td><td>hemorrhage "</td><td></td><td></td></tr><tr><td>ernous malformations</td><td>Cerebral cavernous</td><td>AD</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>malformations (CCM1)</td><td></td><td></td><td></td><td></td></tr><tr><td>»bral</td><td>E4</td><td></td><td>"</td><td></td><td></td></tr><tr><td>amyloidosis »bral with</td><td>Apolipoprotein</td><td>Complex</td><td>"</td><td></td><td></td></tr><tr><td>hemorrhage</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>myloidosis</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Dutch type</td><td>Amyloid precursor protein</td><td>AD</td><td>"</td><td></td><td></td></tr><tr><td>Icelandic type</td><td>Cystatin C</td><td>AD</td><td>"</td><td></td><td></td></tr><tr><td>editary hemorrhagic langiectasia</td><td>Endoglin</td><td>AD</td><td>"</td><td></td><td></td></tr><tr><td>editary hemorrhagic langiectasia</td><td>Activin receptor-like kinase (ALK-1)</td><td>AD</td><td>"</td><td></td><td></td></tr></table>
======================================
<table><thead><th>EYES OPEN</th><th></th></thead><thead><th>Never</th><th></th></thead><tr><td>To pain</td><td></td></tr><tr><td>To verbal stimuli</td><td>RON</td></tr><tr><td>Spontaneously</td><td></td></tr><tr><td colspan="2">BEST VERBAL RESPONSE</td></tr><tr><td>No response</td><td></td></tr><tr><td>Incomprehensible sounds</td><td></td></tr><tr><td>Inappropriate words</td><td>GROWN</td></tr><tr><td>Disoriented and converses</td><td></td></tr><tr><td>Oriented and converses</td><td></td></tr><tr><td colspan="2">BEST MOTOR RESPONSE</td></tr><tr><td>No response</td><td>1</td></tr><tr><td>Extension (decerebrate rigidity)</td><td>2</td></tr><tr><td>Flexion abnormal (decorticate rigidity)</td><td>3</td></tr><tr><td>Flexion withdrawal</td><td>4</td></tr><tr><td>Localizes pain</td><td>5</td></tr><tr><td>Obeys</td><td>6</td></tr><tr><td>Total</td><td>3-15</td></tr></table>
======================================
<table><thead><th></th><th>EPIDURAL HEMATOMA</th><th>ACUTE SUBDURAL HEMATOMA</th><th>CHRONIC SUBDURAL HEMATOMA</th><th>CONTUSION/ PARENCHYMAL HEMORRHAGE</th><th>INTRA- VENTRICULAR HEMATOMA</th><th>SUBARACHNOID HEMORRHAGE</th><th>SUBDURAL HYGROMA</th><th>DIFFUSE AXONAI INJURY</th></thead><tr><td>Causative factor</td><td>Laceration of mid- dle cerebral artery or dural sinus</td><td>Tearing of bridg- ing pial veins and arteries</td><td>Trauma (may be absent or minimal) Risk factors: coagulopathy and severe brain atrophy</td><td>Shearing of paren- chymal vessels. Risk factors: coagulopathy and amyloid vasculopathy</td><td>Shearing of paren- chymal vessels; rule out vascu- lar defects</td><td>_ Exclude underly- ing aneurysmal rupture</td><td>Arachnoid tear, following men- ingitis</td><td>Deceleration or rotational force</td></tr><tr><td>Typical location</td><td>Lateral cerebral con- vexities</td><td>Lateral cerebral convexities</td><td>Lateral cerebral convexities, may be bilateral</td><td>Inferior frontal and temporal lobes</td><td>Lateral and third ventricles blood filled</td><td>Basilar cisterns</td><td>Lateral cerebral convexities</td><td>Deep white mat- ter, corpus cal- losum, dorsolateral</td></tr><tr><td>Evolution</td><td>Hours</td><td>Many hours</td><td>Days to weeks</td><td>Expand over 12- 48h</td><td>Rapid</td><td>Minutes to hours</td><td>Days to weeks</td><td>pons From time of injury</td></tr><tr><td>Clinical profile</td><td>Classically, lucid interval then coma, but more variable; pupil- lary dilatation with contralateral then bilateral limb weakness; slowly evolving stupor then coma</td><td>Drowsiness, coma; pupillary dila- tation with con- tralateral then bilateral limb weakness; pro- gressive stupor then coma</td><td>Headache, pro- gressive alter- ation in mental status + focal neurologic signs</td><td>Stupor — coma, dilated pupil, progressive hemiplegia, spasticity</td><td>Progressive signs of hydroceph- alus</td><td>Headache, men- ingismus, delayed mani- festations, vaso- spasm</td><td>Mimics chronic subdural hema- toma</td><td>Coma, posturing, normal intra- cranial pressur</td></tr><tr><td>Age at risk</td><td>Children, young adults</td><td>Any</td><td>Elderly</td><td>Any</td><td>Any</td><td>Any</td><td>Infants, children, adults</td><td>Any</td></tr><tr><td>Radiologic features</td><td>Acute bulging epi- dural clot bounded by cra- nial sutures; len- ticular in shape</td><td>Acute blood rim- ming broad region of cere- bral convexity</td><td>Hyper- or isodense, uni- lateral or bilat- eral</td><td>Multiple, conflu- ent regions of edema inter- mixed with focal, acute blood</td><td>Focal, acute blood within ventri- cles; may layer with gravity</td><td>Acute blood lining cortex in sub- arachnoid space</td><td>Focal, CSF density, fluid collection</td><td>CT may be nor- mal; MRI show: evolving small deep contusion</td></tr><tr><td>Surgical intervention</td><td>Urgent evacuation</td><td>Urgent evacua- tion if large enough to cause symptoms</td><td>Evacuation in some circum- stances</td><td>Evacuate if large</td><td>Shunting</td><td>May cause sec- ondary vaso- spasm or late hydrocephalus</td><td>Aspiration of fluid</td><td></td></tr></table>
======================================
<table><thead><th>CLASSIFICATION OF THE INFLAMMATORY DEMYELINATIVE DISEASES</th><th></th></thead><tr><td colspan="2">I. Multiple sclerosis A. Chronic relapsing encephalomyelopathic form B. Acute multiple sclerosis (Marburg disease)</td></tr><tr><td>C. Primary and secondary progressive types D. Diffuse cerebral sclerosis (Schilder disease and</td><td>concentric</td></tr><tr><td>sclerosis of Balo) Il. Neuromyelitis optica (Devic disease) and progressive</td><td>necrotic</td></tr><tr><td>myelopathy</td><td></td></tr><tr><td>Ill. Acute disseminated encephalomyelitis A. Postinfectious: following measles, chickenpox, mumps, rubella, influenza, and other viral and</td><td>smallpox, some</td></tr><tr><td>bacterial infections (Mycoplasma, Rickettsia) B. Following rabies or smallpox and rarely other</td><td>types of</td></tr><tr><td colspan="2" rowspan="2">vaccination (postvaccinal) IV. Acute and subacute necrotizing hemorrhagic encephalitis A. Acute encephalopathic form (Hurst hemorrhagic leukoencephalitis) B. Subacute encephalitis</td><td colspan="2"></td></tr></table>
======================================
<table><thead><th colspan="2">CLINICALLY ISOLATED SYNDROME (CIS)</th></thead><thead><th>DISSEMINATION IN SPACE</th><th>DISSEMINATION IN TIME</th></thead><tr><td>21 lesion in 2 or more characteristic sites</td><td>| Any new cerebral or spinal T2 lesion on</td></tr><tr><td>(periventricular, juxtacorti- cal, posterior fossa, spinal cord) excluding symptomatic brain- stem and cord lesions</td><td>followup MRI at any time</td></tr></table>
======================================
<table><thead><th>DISORDER</th><th>TOTAL SCREENED</th><th>TOTAL DETECTED</th><th>FREQUENCY</th></thead><tr><td>Congenital hypothyroidism</td><td>3,105,000</td><td>948</td><td>1:3,300</td></tr><tr><td>Phenylketonuria</td><td>4,738,789</td><td>336</td><td>1:14,000</td></tr><tr><td>Atypical PKU</td><td>4,738,789</td><td>286</td><td>1:17,000</td></tr><tr><td>Hartnup disorder</td><td>1,028,581</td><td>46</td><td>1:22,000</td></tr><tr><td>Histidinemia</td><td>1,028,581</td><td>38</td><td>1:27,000</td></tr><tr><td>Methylmalonic acidemia</td><td>1,028,581</td><td>19</td><td>1:54,000</td></tr><tr><td>Galactosemia</td><td>3,888,716</td><td>63</td><td>1:62,000</td></tr><tr><td>Argininosuccinic acidemia</td><td>1,028,581</td><td>13</td><td>1:80,000</td></tr><tr><td>Biotinidase deficiency</td><td>1,319,123</td><td>14</td><td>1:94,000</td></tr><tr><td>Homocystinuria</td><td>3,300,000</td><td>16</td><td>1:200,000</td></tr><tr><td>Maple syrup urine disease</td><td>4,599,373</td><td>19</td><td>1:240,000</td></tr><tr><td>Prolidase deficiency</td><td>1,028,581</td><td>3</td><td>1:350,000</td></tr><tr><td>Hyperprolinemia (type II)</td><td>1,028,581</td><td>2</td><td>1:500,000</td></tr><tr><td>Short-chain acyl-CoA dehydrogenase deficiency</td><td>1,028,581</td><td>1</td><td>1:1,000,000</td></tr></table>
======================================
<table><thead><th>DISEASE</th><th>FERRIC CHLORIDE</th><th>DNPH</th><th>BENEDICT REACTION</th><th>NITROPRUSSIDE REACTION</th></thead><tr><td>Phenylketonuria</td><td>Green</td><td>+</td><td>-</td><td>-</td></tr><tr><td>Maple syrup urine disease</td><td>Navy blue</td><td>+</td><td>-</td><td>-</td></tr><tr><td>Tyrosinemia</td><td>Pale green (transient)</td><td>+</td><td>-</td><td>+</td></tr><tr><td>Histidinemia</td><td>Green-brown</td><td>+</td><td>-</td><td>-</td></tr><tr><td>Propionic acidemia</td><td>Purple</td><td>+</td><td>-</td><td>-</td></tr><tr><td>Methylmalonic aciduria</td><td>Purple</td><td>+</td><td>-</td><td>-</td></tr><tr><td>Homocystinuria</td><td>=</td><td>-</td><td></td><td>+</td></tr><tr><td>Cystinuria</td><td>-</td><td>-</td><td>-</td><td>+</td></tr><tr><td>Galactosemia</td><td>-</td><td>-</td><td>+</td><td>-</td></tr><tr><td>Fructose intolerance</td><td>-</td><td>-</td><td>+</td><td>-</td></tr></table>
======================================
<table><thead><th colspan="2">LYSOSOMAL STORAGE DISEASES</th></thead><thead><th>DISORDER</th><th>PRIMARY DEFICIENCY</th></thead><tr><td>Sphingolipidoses Gyn gangliosidosis</td><td>B-Galactosidase</td></tr><tr><td>Gy gangliosidosis Tay-Sachs disease Sandhoff disease</td><td>N-acetylhexosaminidase o subunit N-acetylhexosaminidase 8 subunit</td></tr><tr><td>Activator deficiency Metachromatic leukodystrophy</td><td>Gyp activator Arylsulfatase A (sulfatidase), sulfatide</td></tr><tr><td>Krabbe disease disease</td><td>activator (saposin B) Galactocerebrosidase a-Galactosidase A</td></tr><tr><td>Fabry Gaucher disease Niemann-Pick disease</td><td>Glucocerebrosidase</td></tr><tr><td>Types A and B Type C Farber disease</td><td>Sphingomyelinase Cholesterol esterification Ceramidase</td></tr><tr><td>Schindler disease</td><td>a-Galactosidase B</td></tr><tr><td>Neuronal ceroid lipofuscinoses Infantile form (Haltia-Santavuori) Late infantile form (Jansky-Bielschowsky)</td><td>Palmitoyl-protein thioesterase Tripeptidyl peptidase I</td></tr><tr><td>Juvenile form (Spielmeyer-Sjégren)</td><td>438-amino acid membrane protein</td></tr><tr><td>Adult form (Kufs disease)</td><td>Unknown</td></tr><tr><td>Glycoproteinoses</td><td></td></tr><tr><td>Aspartylglycosaminuria Fucosidosis</td><td>Aspartylglycosaminidase a-L-Fucosidase</td></tr><tr><td>Galactosialidosis a-Mannosidosis B-Mannosidosis</td><td>Protective protein (B-galactosidase and a-neuraminidase) a-Mannosidase B-Mannosidase</td></tr><tr><td>Mucolipidoses Sialidosis (mucolipidosis I) Mucolipidosis II (I-cell disease) Mucolipidosis III (pseudo-Hurler</td><td>a-Neuraminidase UDP-N-acetylglucosamine: lysosomal enzyme, N-acetylglucosamine-1- phosphotransferase Same phosphotransferase as above</td></tr><tr><td>polydystrophy) Mucolipidosis IV Other lysosomal diseases</td><td>Unknown</td></tr><tr><td>Acid lipase deficiency Wolman disease Cholesterol ester storage disease Glycogenosis type II (Pompe disease) Sialic acid disease</td><td>Acid lipase Acid lipase a@-Glucosidase (acid maltase)</td></tr><tr><td>storage Infantile form</td><td>Sialic acid transport</td></tr><tr><td>Salla disease</td><td>Sialic acid transport</td></tr></table>
======================================
<table><tr><td>aN Predominantly gray matter</td><td>Predominantly white matter</td></tr><tr><td>Tay-Sachs</td><td>Spongy degeneration</td></tr><tr><td>Sandhoff</td><td>(Canavan)</td></tr><tr><td>Gy; gangliosidosis</td><td>Pelizaeus-Merzbacher</td></tr><tr><td>Neuronal ceroid lipofuscinoses</td><td>Adrenoleukodystrophy</td></tr><tr><td>Leigh</td><td>Globoid-body (Krabbe)</td></tr><tr><td>Alexander</td><td>Metachromatic leukodystrop</td></tr></table>
======================================
<table><thead><th></th><th>TAY-SACHS</th><th>NIEMANN-PICK</th><th>GAUCHER</th><th>ALPERS</th><th>SUBACUTE NECROTIZING ENCEPHALOPATHY</th></thead><tr><td>Age of onset</td><td>4-6 mo</td><td>Under 6 mo</td><td>Under 6 mo</td><td>Under 1 y</td><td>Under 1 y, rarely late childhood</td></tr><tr><td>Rate of progression</td><td>— Rapid Death 2-3 y</td><td>Rapid Death before 3 y</td><td>Very rapid Death before 2 y</td><td>Rapid Death before 3 y</td><td>Usually rapid Death before 3 y</td></tr><tr><td>Ethnic group Genetic Head size Skin and/or</td><td>Almost all Jewish Recessive Enlarges late Normal</td><td>50% Jewish Recessive Normal Hepatosplenomeg-</td><td>Recessive Normal Hepatosplenomegaly</td><td>Reduces late Normal</td><td>Recessive Normal Normal</td></tr><tr><td>systemic lesions Eye</td><td>Cherry-red macula</td><td>aly xanthoma of skin, rare Cherry-red macula</td><td>Normal</td><td>Normal</td><td>Optic atrophy</td></tr><tr><td>Seizures</td><td>Optic atrophy Frequent, but late</td><td>Optic atrophy Rare</td><td>Rare</td><td>Onset with seizures</td><td>Seizures late and rare</td></tr><tr><td></td><td></td><td></td><td></td><td>Myoclonus and. other types</td><td></td></tr><tr><td>Neurologic signs</td><td>Early: flaccid paresis Late: spastic paralysis Dementia: early hyperacusis with myoclonus</td><td>Spastic paralysis _ Early: dementia</td><td>Early: retroflexion of head, dementia Strabismus Bulbar palsy Spastic paralysis</td><td>Spastic paralysis Dementia Cortical blindness and deafness</td><td>Bulbar palsy Weak, infrequent cry Flaccid paresis with immobility</td></tr><tr><td rowspan="2">Blood</td><td>Absent fructose 1-phosphate-aldo-</td><td>Tserum lipids TscoT</td><td>Total acid phospha- tase (prostatic acid</td><td>Normal</td><td>Normal</td></tr><tr><td></td><td>lase Tscor T vacuolated lym-</td><td>T vacuolated lym- phocytes</td><td>phosphatase is nor- mal)</td><td></td><td></td></tr><tr><td>Urine CSF</td><td>phocytes Normal Normal</td><td>Normal Normal</td><td>Normal</td><td>Normal Normal</td><td>Normal Normal</td></tr><tr><td>Biopsy</td><td>Rectal</td><td>“Foam cells” in bone marrow</td><td>Gaucher cells in bone marrow</td><td></td><td></td></tr><tr><td>X-ray</td><td></td><td>Diffuse pulmonary infiltrates Demineralization of bone</td><td></td><td></td><td></td></tr><tr><td>Electroretinogram: Diagnostic biochemical</td><td>normal. abnormality: see text.</td><td></td><td></td><td></td><td></td></tr></table>
======================================
<table><thead><th></th><th>KRABBE</th><th>METACHROMATIC LEUKODYSTROPHY</th><th>SPONGY DEGENERATION</th><th>PELIZAEUS- MERZBACHER</th><th>SCHILDER DISEASE; SUDANOPHILIC AND ADRENOLEUKO- DYSTROPHY</th></thead><tr><td>Age of onset</td><td>3-6 mo</td><td>1-2 y, rarely late childhood</td><td>04 mo</td><td>6-24 mo</td><td>5-10 y</td></tr><tr><td>Rate of progression</td><td>Rapid Death by 2 y Some later and slow</td><td>Slow Death by 3-5 y</td><td>Rapid Death by 3 y</td><td>Slow May survive to adult life</td><td>Abrupt onset — Death in months to years</td></tr><tr><td>Sex or ethnic group Genetic</td><td>Recessive</td><td>Recessive</td><td>Mostly Jewish Recessive</td><td>Predominantly males Sex-linked recessive</td><td>Adrenoleukodystro- phy form—x- linked recessive</td></tr><tr><td>Head size Skin or systemic lesions</td><td>Normal Normal</td><td>Enlarges late Normal</td><td>Enlarges early Normal</td><td>Normal Normal</td><td>Normal Bronzing with adrenal atrophy</td></tr><tr><td>Eye</td><td>Late: optic atrophy</td><td>Late: optic atrophy</td><td>Optic atrophy, blindness</td><td>Slow optic atrophy</td><td>Optic neuritis or optic atrophy</td></tr><tr><td>Seizures Neurologic signs</td><td>Tonic spasms Spastic paralysis Nystagmus Head retraction Bulbar palsy Dementia</td><td>Rare Changes in gait Ataxia Combined upper and lower motor neuron signs Bulbar palsy Blindness Deafness Dementia</td><td>Uncommon Hypotonia&gt; spastic diple- gia— decere- brate rigidity Late</td><td>Late Pendular nystagmus Titubation of head and other cerebel- lar signs in early childhood Spastic diplegia, late childhood Slow dementia</td><td>Rare, late _ Early spastic paralysis Dementia Late: cortical blind- ness, deafness, aphasia, pseudo- bulbar palsy</td></tr><tr><td>Miscellaneous</td><td>Slowed nerve con- duction</td><td>_ Slowed nerve</td><td></td><td></td><td>EEG diffuse delta</td></tr><tr><td>Blood</td><td>(rare) Normal</td><td>conduction Normal</td><td>LN: -acetyl-L- aspartic acid (NAA)</td><td>Normal</td><td>waves Normal or J cortisol</td></tr><tr><td>Urine</td><td>Normal</td><td>Metachromatic bodies</td><td>— Normal</td><td>Normal</td><td>Normal</td></tr><tr><td>CSF</td><td>T Protein (150-300 mg/dL)</td><td>Normal or protein up to 200 mg/dL</td><td>T Pressure Tpro- tein up to 200 mg/dL</td><td>Normal</td><td>Normal or T gamma globulin</td></tr><tr><td>Biopsy X-ray</td><td>Brain</td><td>Sural nerve Nonfilling of gallbladder</td><td>Brain Suture separation</td><td></td><td></td></tr></table>
======================================
<table><thead><th>NUMBER</th><th>EPONYM</th><th>CLINICAL MANIFESTATIONS</th><th>ENZYME DEFICIENCY</th><th>— GLYCOSAMINOGLYCAN</th></thead><tr><td>MPs I*</td><td>Hurler</td><td>Corneal clouding, severe skeletal changes and MR, organomegaly, heart disease</td><td>a-L-Iduronidase</td><td>Dermatan sulfate, heparan sulfate</td></tr><tr><td>MPS IL</td><td>Hunter</td><td>Dysostosis, normal corneas, MR, joint stiffness, hydrocephalus, short stature, organomegaly</td><td>Iduronate sulfatase</td><td>Dermatan sulfate, heparan sulfate</td></tr><tr><td>MPS III</td><td>Sanfilippo</td><td>MR, mild or absent somatic changes, hyperactivity, hepatosplenomegaly</td><td>Heparan N-sulfatase</td><td>Heparan sulfate</td></tr><tr><td>MPS IV</td><td>Morquio</td><td>Distinctive skeletal abnormalities, slight corneal clouding, odontoid hypoplasia, normal intelligence, hepatomegaly</td><td>Galactose 6-sulfatase</td><td>Keratan sulfate, chondroitin 6-sulfate</td></tr><tr><td>MPS V MPS VI</td><td>No longer used Maroteaux-Lamy</td><td>Dysostosis, corneal clouding, normal intelligence, spinal cord compression, organomegaly</td><td>N-acetylgalactosamine, 4-sulfatase (arylsulfatase B)</td><td>— Dermatan sulfate</td></tr><tr><td>MPS VIL</td><td>Sly</td><td>Dysostosis, hepatosplenomegaly, wide range of severity, corneal clouding</td><td>B-Glucuronidase</td><td>Dermatan sulfate, heparan sulfate, chondroitin 4- sulfate</td></tr></table>
======================================
<table><thead><th>SYNDROME</th><th>COMMON MITOCHONDRIAL GENE MUTATION</th><th>RAGGED RED FIBERS</th><th>LACTIC ACIDOSIS</th></thead><tr><td>Ragged red fiber polymyopathy Progressive external ophthalmoplegia (PEO) and Kearns-</td><td>Point mutation at 3250 Heteroplasmic deletions or point mutation</td><td>+ -</td><td>~ -</td></tr><tr><td>Sayre variants Leigh syndrome, fatal lactic acidosis, and neuropathy with proximal weakness, ataxia, and retinitis pigmentosa</td><td>at 3243 Point mutation at 8993</td><td>-</td><td>+</td></tr><tr><td>(NARP) Myoclonic-epilepsy and ragged red fibers in muscle</td><td>Point mutation at 8344</td><td>+ (usually)</td><td>+</td></tr><tr><td>(MERRF) Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)</td><td>Point mutation at 3243</td><td>+</td><td>+</td></tr><tr><td>Leber optic neuropathy</td><td>Point mutation at 3460, 4160, or 11778</td><td>-</td><td>-</td></tr><tr><td>Myoneural-gastrointestinal encephalopathy</td><td>Unknown (maternal inheritance)</td><td>+</td><td>-</td></tr></table>
======================================
<table><tr><td>1. Primary (vera) 2. Secondary to cerebral disease E. Combinations of cerebral, cranial, and other anomalies . Syndactylic craniocerebral anomalies</td><td>. Infantile hemiplegia, double hemiplegia, and quadriplegia . Congenital extrapyramidal disorders (double athetosis; erythroblastosis fetalis and kernicterus) . Congenital ataxias SCOSS</td></tr><tr><td></td><td>or</td></tr><tr><td>Other craniofacial anomalies</td><td>| The flaccid paralyses</td></tr><tr><td>. Oculoencephalic defects . Oculoauriculocephalic anomalies ARON</td><td>V. Prenatal and paranatal infections A. Rubella</td></tr><tr><td>. Dwarfism 6. Dermatocephalic anomalies FE. Rachischisis</td><td>B. Cytomegalic inclusion disease C. Congenital neurosyphilis D. HIV infection and AIDS</td></tr><tr><td>1. Cephalic and spinal meningocele, meningoencephalocele, Dandy-Walker syndrome, meningomyelocele Chiari malformation</td><td>E. Toxoplasmosis F. Other viral and bacterial infections of and childhood</td></tr><tr><td>2. 3. Platybasia and cervical-spinal anomalies (Chap. 45) G. Chromosomal abnormalities</td><td>VI. Epilepsies infancy VII. Mental retardation</td></tr></table>
======================================
<table><thead><th>CAUSES OF MACROCEPHALY</th></thead><tr><td>b. Canavan disease c. Tay-Sachs disease</td></tr></table>
======================================
<table><thead><th colspan="3">MUTATIONS ASSOCIATED WITH DISORDERS OF NEURONAL MIGRATION AND CORTICAL MALDEVELOPMENT</th></thead><thead><th>DISEASE</th><th>GENE</th><th>GENE FUNCTION</th></thead><tr><td>with cerebellar</td><td>RELN</td><td>Extracellular matrix</td></tr><tr><td>Lissencephaly Lissencephaly hypoplasia Lissencephaly (Miller-Dieker) or isolated lissencephaly X-linked lissencephaly with hypogonadism (Partington syndrome) Muscle-eye-brain disease Walker-Warburg Holoprosencephaly Double cortex</td><td>(reelin) LIS1 ARX (aristaless) POMGNT1 POMTI1 SHH (sonic hedgehog)</td><td>protein Microtubule regulator Transcription factor Glycosyltransferase Glycosyltransferase Transcription factor</td></tr><tr><td></td><td></td><td></td></tr><tr><td>Double-cortex or X-linked lissencephaly</td><td>DCX (doublecortin)</td><td>Microtubule-associated protein</td></tr><tr><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td></tr><tr><td>Heterotopias Periventricular nodular heterotopia Tuberous sclerosis Tuberous sclerosis muscular</td><td>FLNA (filamin A) TSC1 (hamartin) TSC2 (tuberin) FCMD</td><td>Actin-binding protein Tumor suppressor Tumor suppressor Possible</td></tr><tr><td>Fukuyama dystrophy Schizencephaly</td><td>(fukutin)</td><td>glycosyltransferase</td></tr><tr><td>Schizencephaly Microcephaly</td><td>EMX2</td><td>Transcription factor</td></tr><tr><td>Microcephaly</td><td>MCPHI (microcephalin) MCPH5 ASPM</td><td>? DNA repair Mitotic/meiotic</td></tr><tr><td>Microcephaly</td><td></td><td>spindle</td></tr></table>
======================================
<table><tr><td>True phakomatoses</td></tr><tr><td>nervous system 1. (Sturge-Weber syndrome)</td></tr><tr><td>2. Dermatomal hemangiomas and spinal vascular malformations</td></tr><tr><td>3. Epidermal nevus (linear sebaceous nevus) syndrome 4. Osler-Weber-Rendu disease</td></tr></table>
======================================
<table><thead><th>CAUSES OF CONGENITAL HYPOTONIA—THE FLOPPY INFANT SYNDROME</th></thead><tr><td>I. Cerebral A. Cerebral atonic diplegia (Foerster) B. Prader-Willi syndrome C. Idiopathic slackness</td></tr><tr><td>II. Spinal A. Werdnig-Hoffman spinal muscular atrophy B. Spinal cord natal injury</td></tr><tr><td>IV. Neuropathic A. Inflammatory demyelinating neuropathy</td></tr></table>
======================================
<table><thead><th rowspan="2">DISEASE CATEGORY</th><th colspan="2">NUMBER OF PATIENTS</th><th rowspan="2">% OF ALL PATIENTS</th></thead><thead><th></th><th>10 &lt;50</th><th>10 &gt;50</th><th></th></thead><tr><td>Acquired destructive lesions</td><td>278</td><td>79</td><td>26.0</td></tr><tr><td>Chromosomal abnormalities</td><td>247</td><td>10</td><td>18.7</td></tr><tr><td>Multiple congenital anomalies</td><td>64</td><td>16</td><td>5.8</td></tr><tr><td>Developmental abnormality of brain</td><td>49</td><td>16</td><td>47</td></tr><tr><td>Metabolic and endocrine diseases</td><td>38</td><td>5</td><td>3.1</td></tr><tr><td>Progressive degenerative disease</td><td>5</td><td>7</td><td>0.9</td></tr><tr><td>Neurocutaneous diseases</td><td>4</td><td>0</td><td>0.3</td></tr><tr><td>Psychosis</td><td>7</td><td>6</td><td>1.0</td></tr><tr><td>Cause unknown</td><td>385</td><td>156</td><td>39.5</td></tr></table>
======================================
<table><thead><th>NOTATION</th><th>— CHROMOSOME</th><th>GENE</th><th>GENETICS</th><th>AGE</th><th>CLINICAL FEATURES</th></thead><tr><td>APP</td><td>21</td><td>Amyloid precursor protein</td><td>AD</td><td>Early</td><td>Rare but clinically simulates sporadic Alzheimer disease</td></tr><tr><td>PS1</td><td>14</td><td>Presenilin 1</td><td>AD</td><td>Early</td><td>As above</td></tr><tr><td>PS2</td><td>1</td><td>Presenilin 2</td><td>AD</td><td>Early</td><td>As above</td></tr><tr><td>ApoE</td><td>19</td><td>Apolipoprotein E</td><td>Haplotype</td><td>Late</td><td>These variants modify susceptibility to typical Alzheimer disease</td></tr><tr><td>UBQLN1</td><td>9</td><td>Ubiquilin 1</td><td>SNP</td><td>Late</td><td>Familial cases only</td></tr><tr><td>Trisomy 21</td><td>21</td><td>Amyloid precursor protein</td><td>__Triploidy</td><td>Middle age</td><td>Alzheimer change is almost universal in Down syndrome</td></tr></table>
======================================
<table><thead><th>NOTATION</th><th>CHROMOSOME</th><th>GENE</th><th>GENETICS</th><th>+ AGEOFONSET</th><th>—LEWY BODIES</th><th>SPECIAL FEATURES</th></thead><tr><td>Park1</td><td>4q21</td><td>o-synu-</td><td>AD</td><td>30-40 years</td><td>+</td><td>Two main mutations—A53T, A30P—pro-</td></tr><tr><td>Park2</td><td>6q25</td><td>clein parkin</td><td>AR</td><td>20-40 years</td><td>=</td><td>mote oligomerization of @-synuclein. Accounts for 50% of early onset inherited PD; 20% of “sporadic” early onset cases.</td></tr><tr><td>Park3</td><td>2p13</td><td></td><td>AD</td><td>Late onset</td><td>=</td><td>Resembles idiopathic PD.</td></tr><tr><td>Park5</td><td>4p14</td><td>UCH-L1</td><td>AD</td><td>50’s</td><td>+</td><td>Gene is ubiquitin carboxyterminal hydrolase L1. Mutations decreased recycling of ubiquitin</td></tr><tr><td>Park6</td><td>1p35-36</td><td>PINK1</td><td>AR</td><td>varies</td><td></td><td>monomers. Mitochondrial gene.</td></tr><tr><td>Park7</td><td>1p36</td><td>DJ-1</td><td>AR</td><td>30's</td><td>?</td><td>Slow progression; gene plays role in cellu- lar to oxidative stress.</td></tr><tr><td>Park8</td><td>12 cent</td><td>LRRK2</td><td>AD</td><td>late</td><td>+</td><td>response Ashkenazic Jews. Protein is dardarin, a novel kinase.</td></tr><tr><td>NR4A2</td><td>2q22</td><td>NURR1</td><td>AD</td><td></td><td>?</td><td>Gene is implicated in the formation and identity of dopaminergic neurons.</td></tr></table>
======================================
<table><thead><th>INITIAL SYMPTOMS IN PATIENTS WITH PARKINSON DISEASE</th><th></th></thead><tr><td>Tremor</td><td>70%</td></tr><tr><td>Gait disturbance</td><td>11%</td></tr><tr><td>Stiffness</td><td>10%</td></tr><tr><td>Slowness</td><td>10%</td></tr><tr><td>Muscle aches</td><td>8%</td></tr><tr><td>Loss of dexterity</td><td>7%</td></tr><tr><td>Handwriting disturbance</td><td>5%</td></tr><tr><td>Depression, nervousness, other psychiatric disturbance</td><td>4%</td></tr><tr><td>Speech disturbance</td><td>3%</td></tr></table>
======================================
<table><thead><th colspan="5">DRUGS COMMONLY USED IN THE TREATMENT OF PARKINSON DISEASE</th></thead><thead><th>MEDICATION</th><th>STARTING DOSE</th><th>TARGET DOSE</th><th>MAIN BENEFIT</th><th>SIDE EFFECTS</th></thead><tr><td colspan="5">.-Dopa</td></tr><tr><td>Carbidopa-L-dopa (Sinemet)</td><td>25/100 mg tid</td><td>Up to 50/250 mg q3h</td><td>Reduction of tremor and bradykinesia; less effect on postural difficulties</td><td>Nausea, dyskinesias, ortho- static hypotension, halluci- nations, confusion.</td></tr><tr><td>Controlled release carbidopa-L-dopa Dopamine agonists</td><td>25/100 mg tid</td><td>Up to 50/200 mg q4h</td><td>May prolong L-dopa effects</td><td></td></tr><tr><td>Ropinirole</td><td>0.25 mg tid</td><td>9 to 24 mg/d</td><td>Moderate effects on all aspects; reduced motor fluctuations of L-dopa</td><td>Orthostatic hypotension, excessive and abrupt sleepiness, confusion, hal- lucinations</td></tr><tr><td rowspan="2">Pramipexole Glutamate antagonist Amantadine (Symmetrel)</td><td>0.125 mg tid</td><td>0.75 to 3 mg/d</td><td>As above</td><td></td></tr><tr><td></td><td>100 mg/d</td><td>100 mg bid-tid</td><td>Smoothing of motor fluctuations</td><td>Leg swelling, congestive heart failure, prostatic out- let obstruction, confusion, hallucinations, insomnia</td></tr><tr><td>Anticholinergics Benztropine (Cogentin)</td><td>0.5 mg/d</td><td>Up to4mg/d</td><td>Tremor reduction, less effect on other features</td><td>Atropinic effects: dry mouth, urinary outlet obstruction,</td></tr><tr><td>Trihexyphenidyl (Artane)</td><td>0.5 mg bid</td><td>Up to 2 mg tid</td><td>As above</td><td>confusion and psychosis As above</td></tr><tr><td>COMT inhibitors Entacapone</td><td>200 mg with L-dopa</td><td></td><td>Prolonged effect of L-dopa</td><td>Urine discoloration, diar- thea, increased dyskinesias</td></tr><tr><td>MAO-inhibitors Rasagiline</td><td>0.5 mg</td><td>1 mg daily</td><td>Reduced “off” time, potential neuroprotection</td><td>Hypertensive crisis with tyramine-rich foods and.</td></tr><tr><td>Selegiline</td><td>5mg</td><td>5 mg bid</td><td>Potential neuroprotection</td><td>sympathomimetics</td></tr></table>
======================================
<table><thead><th>NOTATION</th><th>GENE</th><th>GENETICS</th><th>AGE OF ONSET</th><th>CLINICAL AND MISCELLANEOUS FEATURES IN ADDITION TO ATAXIA</th></thead><tr><td colspan="5">rogressive</td></tr><tr><td>Dentatorubropalli- doluysian atrophy SCA1</td><td>Atrophin Ataxin-1</td><td>AD* AD*</td><td>Childhood Variable</td><td>Chorea, dystonia, seizures, dementia 10-25% of dominant ataxias; spasticity,</td></tr><tr><td>SCA2</td><td>Ataxin-2</td><td>AD*</td><td>Teens</td><td>polyneuropathy, ophthalmoparesis, dementia Neuropathy, ophthalmoparesis, extrapyramidal</td></tr><tr><td>SCA3 (Machado-</td><td>Ataxin-3</td><td>AD*</td><td>Teens</td><td>features 25% of dominant ataxias, spasticity, neuropathy,</td></tr><tr><td>Joseph) SCA6</td><td>alpha; , calcium</td><td>AD*</td><td>Adult</td><td>extrapyramidal features 20% of dominant ataxias; dysarthria, nystagmus,</td></tr><tr><td>SCA7</td><td>channel Ataxin-7</td><td>AD*</td><td>Late teens</td><td>posterior column signs Retinal degeneration, hearing loss, ophthalmoplegia,</td></tr><tr><td></td><td></td><td></td><td>Infantile</td><td>spasticity Fulminant, with large CAG expansion</td></tr><tr><td>SCA8 SCA10</td><td>CTG repeat (noncoding) ATTCT repeat</td><td>AD AD</td><td>Adult Teens-adult</td><td>Sensory neuropathy, spasticity; there is rapid infantile variant Seizures, personality change</td></tr><tr><td>SCA11</td><td>(ataxin-10) TTBK2</td><td>AD</td><td>Adult</td><td>Mild phenotype</td></tr><tr><td>SCA12</td><td>PPP2R2B,CAG</td><td>AD</td><td>Adult</td><td>Head and hand tremor</td></tr><tr><td>SCA13</td><td>repeat KCNC3</td><td>AD</td><td></td><td>Mental retardation</td></tr><tr><td>SCA14</td><td>Protein kinase C</td><td>AD</td><td>Childhood Teens-adult</td><td>Myoclonus, tremor</td></tr><tr><td>SCA16</td><td>gamma ITPR1</td><td>AD</td><td>Varies</td><td>Head and hand tremor</td></tr><tr><td>SCA17</td><td>TATA box binding</td><td>AD*</td><td>Variable</td><td>Cognitive decline, seizures, extrapyramidal features</td></tr><tr><td>SCA with tremor</td><td>protein Fibroblast growth factor 14</td><td>AD</td><td>Childhood</td><td>Tremor, cognitive defects, facial dyskinesia</td></tr><tr><td>Friedreich ataxia</td><td>Frataxin</td><td>AR</td><td>Teens</td><td>Spinocerebellar ataxia, neuropathy, cardiomyopathy, arrhythmia</td></tr><tr><td>Friedreich ataxia variant</td><td>Vitamin E transport protein</td><td>AR</td><td>Childhood</td><td>Spinocerebellar ataxia, neuropathy, cardiomyopathy, arrhythmia</td></tr><tr><td>isodic Episodic ataxia with</td><td>KCNA</td><td>AD</td><td>Teens</td><td>Limb stiffness, dizziness, visual blurring</td></tr><tr><td>myokymia Paroxysmalepisodic ataxia</td><td>alpha, calcium channel</td><td>AD</td><td>Teens</td><td>Nystagmus, vertigo, weakness</td></tr><tr><td>Episodic ataxia</td><td>CACNB4</td><td>AD</td><td>Teens</td><td>Seizures, myoclonus, nystagmus</td></tr></table>
======================================
<table><thead><th>NOTATION</th><th>CHROMOSOME</th><th>GENE</th><th>GENETICS</th><th>AGE OF ONSET</th><th>CLINICAL FEATURES</th></thead><tr><td>SOD1</td><td>21q</td><td>Superoxide dismutase</td><td>AD</td><td>Adult</td><td>Clinically and pathologically</td></tr><tr><td>DCTN</td><td>2q</td><td>Dynactin</td><td>AD</td><td>Adult</td><td>similar to sporadic ALS Slowly progressive with predominant bulbar features</td></tr><tr><td>CytoC ALS2</td><td>mtDNA 2q33</td><td>Cytochrome-c oxidase GEF/alsin</td><td>— Mitochondrial AR</td><td>Adult Juvenile</td><td>Prominent spasticity Very slowly progressive, predominantly corticospinal</td></tr><tr><td>SETX VAPB</td><td>9q34 20q</td><td>Senataxin Vesicle-associated membrane protein</td><td>AD AD</td><td>Juvenile Adult</td><td>Very slowly progressive Similar to sporadic ALS</td></tr></table>
======================================
<table><thead><th>TYPE</th><th>INHERITANCE</th><th>AGE OF ONSET</th><th>CLINICAL FEATURES</th><th>PROGNOSIS</th></thead><tr><td>SMA I (infantile, Werdnig-Hoffmann)</td><td>Autosomal recessive</td><td>Preterm to 6 months</td><td>Neonatal hypotonia (floppy baby), weakness of sucking and swallowing, may have arthrogryposis, unable to sit</td><td>Few survive 1 year</td></tr><tr><td>SMA III (Wohlfart- Kugelberg- Welander)</td><td>Autosomal recessive or dominant</td><td>1 year to adolescence</td><td>Delayed motor development, proximal leg weakness</td><td>complications Slowly progressive, variable outcome</td></tr><tr><td>Kennedy syndrome (bulbospinal atrophy)</td><td>X-linked (CAG repeat expansion), less often autosomal dominant</td><td>Early adulthood</td><td>Scapuloperoneal or distal atrophy, oropharyngeal weakness, gynecomastia, oligospermia</td><td>Slowly progressive</td></tr><tr><td>Fazio-Londe disease</td><td>Autosomal rece: rarely dominant</td><td>Childhood to early adolescence</td><td>Progressive bulbar and respiratory failure</td><td>Survival for years, respiratory failure</td></tr></table>
======================================
<table><thead><th>GENETICS</th><th>NOTATION</th><th>CHROMOSOME</th><th>GENE</th><th>AGE OF ONSET</th><th>CLINICAL AND MISCELLANEOUS FEATURES</th></thead><tr><td>AD</td><td>3A</td><td>14q11</td><td>Atlastin</td><td>Childhood</td><td>Guanylate binding protein</td></tr><tr><td>AD</td><td>4</td><td>2p22</td><td>Spastin</td><td>20s</td><td>40-50% of HSP; binds to microtubules</td></tr><tr><td>AD</td><td>6</td><td>15q11</td><td>NIPA1</td><td>Teens</td><td>Golgi membrane protein</td></tr><tr><td>AD</td><td>10</td><td>12q13</td><td>KIF5A</td><td>Childhood</td><td>Kinesin heavy chain—motor protein</td></tr><tr><td>AD</td><td>13</td><td>2q24</td><td>Heat shock protein</td><td>Adult</td><td>Located in mitochondrial matrix</td></tr><tr><td>AD</td><td>17</td><td>11q13</td><td>Seipin (BSCL2)</td><td>Variable</td><td>Silver syndrome: HSP with wasting of hands, feet</td></tr><tr><td>AR</td><td>7</td><td>16q24</td><td>Paraplegin</td><td>Adult</td><td>Mitochondrial chaperone and metalloprotease; optic atrophy,</td></tr><tr><td>AR</td><td></td><td></td><td>Spartin</td><td></td><td>neuropathy, myopathy HSP with wasting of distal limbs, hands, feet</td></tr><tr><td>AR</td><td>21</td><td>15q22</td><td>Maspardin</td><td>Late teens</td><td>Endosomal protein involved in protein</td></tr><tr><td>XR</td><td>1</td><td>Xq28</td><td>L1 cell adhesion molecule</td><td>Infancy</td><td>transport Mental retardation, hydrocephalus, callosal hypoplasia, spasticity</td></tr><tr><td>XR</td><td>2</td><td>Xq22</td><td>Proteolipid protein</td><td>Infancy</td><td>Cognitive impairment, spasticity,</td></tr></table>
======================================
<table><tr><td colspan="2">I. Metabolic diseases presenting as a syndrome of confusion,</td></tr><tr><td>. Ischemia-hypoxia TOmmMUND&gt;</td><td></td></tr><tr><td>. Hypercapnia</td><td></td></tr><tr><td>. Hypoglycemia</td><td></td></tr><tr><td>. Hyperglycemia</td><td></td></tr><tr><td>. Hepatic failure</td><td></td></tr><tr><td>Reye syndrome Azotemia</td><td></td></tr><tr><td>IL. Metabolic diseases presenting as a progressive extrapyramidal syndrome A. Acquired hepatocerebral degeneration</td><td></td></tr><tr><td>B. Hyperbilirubinemia and kernicterus C. Hypoparathyroidism</td><td></td></tr><tr><td>III. Metabolic diseases presenting as cerebellar ataxia</td><td></td></tr><tr><td>A. Hypothyroidism</td><td></td></tr><tr><td>B. Hyperthermia</td><td></td></tr><tr><td>C. Celiac sprue disease</td><td></td></tr><tr><td>IV. Metabolic diseases causing psychosis, or dementia A. Cushing disease and steroid encephalopathy B. Hyperthyroid psychosis and hypothyroidism (myxedema)</td><td></td></tr><tr><td>C. Hyperparathyroidism</td><td></td></tr><tr><td>D. Pancreatic encephalopathy</td><td></td></tr></table>
======================================
<table><thead><th>NEUROPATHIC ABNORMALITY</th><th>(189 CASES)</th><th>(57 CASES)</th></thead><tr><td>Loss of reflexes alone</td><td>45 (24)"</td><td>6 10)’</td></tr><tr><td>Loss of sensation alone</td><td>10 (5)</td><td>10 (18)</td></tr><tr><td>Weakness alone</td><td>_</td><td>5 (9)</td></tr><tr><td>Weakness and sensory loss</td><td>2(1)</td><td>10 (18)</td></tr><tr><td>Reflex and sensory loss</td><td>40 (21)</td><td>2 (3)</td></tr><tr><td>Sensory, motor, and reflex loss</td><td>66 (35)</td><td>17 (30)</td></tr><tr><td>Data incomplete</td><td>26 (14)</td><td>7 (12)</td></tr></table>
======================================
<table><thead><th>MECHANISMS WHEREBY MALABSORPTION</th><th>MAY BE RELATED TO NEUROLOGIC</th><th>DISEASE</th></thead><thead><th colspan="3">GASTROINTESTINAL DEFECT SUBSTANCE MALABSORBED ASSOCIATED NEUROLOGIC DISORDER</th></thead><tr><td colspan="3">Localized gastric lesions:</td></tr><tr><td>Pernicious anemia Congenital lack of intrinsic factor Partial gastrectomy</td><td>Vitamin By Vitamin By Vitamin By</td><td>Myelopathy, optic neuropathy, etc. Myelopathy, neuropathy, etc. Myelopathy, neuropathy, etc.</td></tr><tr><td>Lesions of small intestine: Predominantly proximal</td><td>Vitamin D ? Water-soluble vitamins Vitamin D</td><td>Osteomalacic myopathy ? Hypovitaminosis B ? Osteomalacic myopathy</td></tr><tr><td>Predominantly distal</td><td>Folic acid Vitamin By</td><td>Probably none Neuropathy, myelopathy, etc.</td></tr><tr><td>Diffuse Bacterial contamination of small bowel</td><td>Vitamin</td><td>Myoclonus, ataxia, etc. etc.</td></tr><tr><td>(jejunal diverticulosis, blind-loop syndrome, strictures)</td><td>By</td><td>Neuropathy, myelopathy,</td></tr><tr><td>Congenital absorptive defect</td><td>“Neutral” amino acids Tryptophan Methionine Folic acid</td><td>Hartnup disease “Blue diaper” syndrome “Oast-house” urine disease Mental retardation, seizures, ataxia, choreoathetosis</td></tr><tr><td>Transmucosal transport disorders associated with steatorrhea: Endocrine causes Postirradiation</td><td>Vitamin By Fat-soluble vitamins</td><td>Neuropathy, myelopathy Xerophthalmia Keratomalacia ? Osteomalacic myopathy</td></tr><tr><td>Drug-induced Defective synthesis of chylomicrons with prolonged intestinal malabsorption</td><td>Vitamin E (carrier lipoprotein not synthesized in liver)</td><td>Bassen-Kornzweig disease, spinocerebellar degeneration with polyneuropathy</td></tr><tr><td>Infiltration of villous cores Competition for essential nutrients (e.g., fish tapeworm)</td><td>Fats (defective chylomicron release) Vitamin By</td><td>Encephalopathy of Whipple disease Neuropathy, myelopathy</td></tr></table>
======================================
<table><thead><th>VITAMIN</th><th>DISORDER</th><th>THERAPEUTIC DOSE</th><th>ENZYMATIC DEFECT</th><th>NEUROLOGIC MANIFESTATIONS</th></thead><tr><td rowspan="2">Thiamine (B,)</td><td>Branched-chain ketoaciduria</td><td>5-20 mg</td><td>Branched-chain ketoacid decarboxylase</td><td>Lethargy, coma</td></tr><tr><td></td><td>Lactic acidosis Pyruvic acidemia Anemia</td><td>5-20 mg 5-20 mg 50 mg</td><td>Pyruvate carboxylase Pyruvate dehydrogenase _</td><td>Mental retardation Cerebellar ataxia Same as thiamine-deficient beriberi of infancy and childhood</td></tr><tr><td>Pyridoxine (Bg)</td><td>Homocystinuria</td><td>&gt;25 mg</td><td>Cystathionine synthase</td><td>Mental retardation, cerebrovas- cular accidents, psychoses</td></tr><tr><td>Cobalamin (Bj)</td><td>Infantile convulsions Xanthurenic aciduria | Methylmalonic aciduria</td><td>10-50 mg 5-10 mg 1,000 g</td><td>Glutamic acid decarboxylase Kynureninase Methylmalony!-CoA mutase</td><td>Seizures Mental retardation Lethargy, coma, psychomotor retardation</td></tr><tr><td></td><td>Methylmalonic aciduriaand homocystinuria</td><td>—_ &gt;500 g</td><td>apoenzyme Defects in synthesis of adenosylcobalamin and methylcobalamin</td><td>Developmental arrest, cerebellar ataxia</td></tr><tr><td rowspan="2">Folic acid</td><td>Megaloblastic anemia Formiminotransferase deficiency</td><td>&lt;0.05 mg &gt;5 mg</td><td>Folate deficiency Intestinal malabsorption of formiminotransferase</td><td>Mental retardation Mental retardation</td></tr><tr><td></td><td>Homocystinuria and</td><td>&gt;10 mg</td><td>N°, N!°-Methylenetetrahydro- folate reductase</td><td>Schizophrenic syndrome</td></tr><tr><td>Biotin</td><td>hypomethioninemia B-Methylcrotonylglycinuria</td><td>T5-10 mg</td><td>B-Methylcrotonyl-CoA carboxylase</td><td>Mental retardation</td></tr><tr><td>Nicotinamide</td><td>Propionic acidemia Hartnup disease</td><td>T5-10 mg &gt;400 mg</td><td>Propionyl-CoA carboxylase Intestinal malabsorption of tryptophan</td><td>Lethargy, coma Cerebellar ataxia</td></tr></table>
======================================
<table><tr><td>room</td></tr><tr><td>o fS</td></tr><tr><td>-r £</td></tr><tr><td>N NY</td></tr><tr><td>ef</td></tr><tr><td>Nn yet</td></tr><tr><td>©</td></tr><tr><td>t+ Ww</td></tr><tr><td>D HNMT</td></tr><tr><td>LO</td></tr></table>
======================================
<table><thead><th colspan="9">Motor Nerve Conduction Studies</th></thead><thead><th>NERVE</th><th>DISTAL STIMULATION SITE</th><th>OTHER STIMULATION SITES</th><th>RECORDING SITE</th><th>ONSET LATENCY (MS)</th><th>AMP. (MV)</th><th>cv (M/S)</th><th>DISTANCE (CM)</th><th>F-WAVE LATENCY (MS)</th></thead><tr><td>Median</td><td>Wrist</td><td>Elbow</td><td>APB</td><td>&lt;4.2</td><td>&gt;4.4</td><td>&gt;49</td><td>6-8</td><td>&lt;31</td></tr><tr><td>Ulnar</td><td>Wrist</td><td>BG, AG</td><td>ADM</td><td>&lt;3.4</td><td>&gt;6.0</td><td>&gt;49</td><td>5.5-7.5</td><td>&lt;32</td></tr><tr><td>Radial</td><td>Forearm</td><td>Elbow, SG</td><td>EIP</td><td>&lt;5.2</td><td>&gt;4.0</td><td>&gt;50</td><td>10</td><td></td></tr><tr><td>Peroneal</td><td>Ankle</td><td>BFH, AFH</td><td>EDB</td><td>&lt;5.8</td><td>&gt;2.0</td><td>&gt;42</td><td>6-11</td><td>&lt;58</td></tr><tr><td>Peroneal</td><td>BFH</td><td>AFH</td><td>TA</td><td>&lt;3.0</td><td>&gt;5.0</td><td>&gt;42</td><td>10</td><td></td></tr><tr><td>Tibial</td><td>Ankle</td><td>PF</td><td>AH</td><td>&lt;6.5</td><td>&gt;3.0</td><td>&gt;41</td><td>6-8</td><td>&lt;59"</td></tr><tr><td colspan="9">Sensory Nerve Conduction Studies?”</td></tr><tr><td>NERVE</td><td>DISTANCE STIMULATION SITES</td><td>RECORDING SITE</td><td>ONSET LATENCY (MS)</td><td>PEAK LATENCY (MS)</td><td></td><td>AMP. (MV)</td><td>cv (M/S)</td><td>DISTANCE (CM)</td></tr><tr><td>Median</td><td>Wrist</td><td>Dig2</td><td>&lt;2.5</td><td>&lt;3.5</td><td></td><td>&gt;20</td><td>&gt;52</td><td>13</td></tr><tr><td>Ulnar</td><td>Wrist</td><td>Dig5</td><td>&lt;2.1</td><td>&lt;3.0</td><td></td><td>&gt;15</td><td>&gt;52</td><td>ll</td></tr><tr><td>Radial</td><td>Forearm</td><td>Wrist</td><td>&lt;19</td><td>&lt;2.8</td><td></td><td>&gt;20</td><td>&gt;48</td><td>10</td></tr><tr><td>Sural</td><td>Calf</td><td>Ankle</td><td>&lt;3.2</td><td>&lt;44</td><td></td><td>&gt;6</td><td>&gt;42</td><td>14</td></tr></table>
======================================
<table><thead><th rowspan="2">ACTION TESTED</th><th>ROOTS?</th><th>NERVES</th><th>MUSCLES</th></thead><thead><th colspan="4">CRANIAL</th><th></th></thead><tr><td>Closure of eyes, pursing of lips, exposure of teeth</td><td>Cranial 7</td><td>Facial</td><td>Orbicularis oculi Orbicularis oris</td></tr><tr><td>Elevation of eyelids, movement of eyes</td><td>Cranial 3, 4,6</td><td>Oculomotor, trochlear, abducens</td><td>Levator palpebrae, extraocular</td></tr><tr><td>Closing and opening of jaw</td><td>Cranial 5</td><td>Motor trigeminal</td><td>Masseters Pterygoids</td></tr><tr><td>Protrusion of tongue</td><td>Cranial 12</td><td>Hypoglossal</td><td>Lingual</td></tr><tr><td>Phonation and swallowing</td><td>Cranial 9, 10</td><td>Glossopharyngeal,</td><td>Palatal, laryngeal, and pharyngeal</td></tr><tr><td colspan="4" rowspan="2">Elevation of shoulders, anteroflexion and turning of head Cranial 11 and upper cervical vagus Spinal accessory Trapezius, sternomastoid.</td><td colspan="4"></td></tr><tr><td>Adduction of extended arm</td><td>C5, C6</td><td>Brachial plexus</td><td>Pectoralis major</td></tr><tr><td>Fixation of scapula</td><td>C5, C6, C7</td><td>Brachial plexus</td><td>Serratus anterior</td></tr><tr><td>Initiation of abduction of arm</td><td>C5, C6</td><td>Brachial plexus</td><td>Supraspinatus</td></tr><tr><td>External rotation of flexed</td><td>C5, C6</td><td>Brachial</td><td></td></tr><tr><td>arm</td><td></td><td>plexus</td><td>Infraspinatus</td></tr><tr><td>Abduction and elevation of arm up to 90°</td><td>C5, C6</td><td>Axillary nerve</td><td>Deltoid</td></tr><tr><td>Flexion of forearm</td><td>C5, C6</td><td>Musculocutaneous</td><td>brachialis</td></tr><tr><td>supinated</td><td></td><td></td><td>Biceps,</td></tr><tr><td>Extension of forearm</td><td>C6, C7,C8</td><td>Radial</td><td>Triceps</td></tr><tr><td>Extension (radial) of wrist</td><td>C6</td><td>Radial</td><td>Extensor carpi radialis longus</td></tr><tr><td>Flexion of semipronated arm</td><td>C5, C6</td><td>Radial</td><td>Brachioradialis</td></tr><tr><td>Adduction of flexed arm</td><td>C6, C7,C8</td><td>Brachial plexus</td><td>Latissimus dorsi</td></tr><tr><td>Supination of forearm</td><td>C6, C7</td><td>Posterior interosseous</td><td>Supinator</td></tr><tr><td>Extension of proximal phalanges</td><td>C7,C8</td><td>Posterior interosseous</td><td>Extensor digitorum</td></tr><tr><td>Extension of wrist (ulnar side)</td><td>C7,C8</td><td>Posterior interosseous</td><td>Extensor carpi ulnaris</td></tr><tr><td>Extension of proximal phalanx of index finger</td><td>C7,C8</td><td>Posterior interosseous</td><td>Extensor indicis</td></tr><tr><td>Abduction of thumb</td><td></td><td>Posterior interosseous</td><td>Abductor and brevis</td></tr><tr><td></td><td>C7,C8</td><td></td><td>pollicis longus</td></tr><tr><td>Extension of thumb</td><td>C7,C8</td><td>Posterior interosseous</td><td>Extensor pollicis longus and brevis</td></tr><tr><td>Pronation of forearm</td><td>C6, C7</td><td>Median nerve</td><td>Pronator teres</td></tr><tr><td>Radial flexion of wrist</td><td>C6, C7</td><td>Median nerve</td><td>Flexor carpi radialis</td></tr><tr><td>Flexion of middle phalanges</td><td>C7, C8,T1</td><td>Median nerve</td><td>Flexor digitorum superficialis</td></tr><tr><td>Flexion of proximal phalanx of thumb</td><td>C8, T1</td><td>Median nerve</td><td>Flexor pollicis brevis</td></tr><tr><td>Opposition of thumb against fifth finger</td><td>C8, T1</td><td>Median nerve</td><td>Opponens pollicis</td></tr><tr><td>Extension of middle phalanges of index and middle fingers</td><td>C8, T1</td><td>Median nerve</td><td>First, second lumbricals</td></tr><tr><td>Flexion of terminal phalanx of thumb</td><td>C8,T1</td><td>Anterior interosseous nerve</td><td>Flexor pollicis longus</td></tr><tr><td>Flexion of terminal phalanx of second and third fingers</td><td>C8, T1</td><td>Anterior interosseous nerve</td><td>Flexor digitorum profundus</td></tr><tr><td>Flexion of distal phalanges of ring and little fingers</td><td>C7
======================================
, C8</td><td>Ulnar</td><td>Flexor digitorum profundus</td></tr><tr><td>Adduction and opposition of fifth finger</td><td>C8, T1</td><td>Ulnar</td><td>Hypothenar</td></tr><tr><td>Extension of middle phalanges of ring and little fingers</td><td>C8, T1</td><td>Ulnar</td><td>Third, fourth lumbricals</td></tr><tr><td>Adduction of thumb against second finger</td><td>C8, T1</td><td>Ulnar</td><td>Adductor pollicis</td></tr><tr><td>Flexion of proximal phalanx of thumb</td><td>C8, Tl</td><td>Ulnar</td><td>Flexor pollicis brevis</td></tr><tr><td>Abduction and adduction of fingers</td><td>C8, T1</td><td>Ulnar</td><td>Interossei</td></tr></table>
======================================
<table><thead><th rowspan="2">ACTION TESTED</th><th>ROOTS?</th><th>NERVES</th><th>MUSCLES</th></thead><thead><th colspan="4">CRURAL</th><th></th></thead><tr><td>Hip flexion from semiflexed position</td><td>L1, L2,L3</td><td>Femoral</td><td>Iliopsoas</td></tr><tr><td>Hip flexion from externally rotated position</td><td>L2, L3</td><td>Femoral</td><td>Sartorius</td></tr><tr><td>Extension of knee</td><td>L2, L3, L4</td><td>Femoral</td><td>Quadriceps femoris</td></tr><tr><td>Adduction of thigh</td><td>L2, 13, L4</td><td>Obturator</td><td>Adductor longus, magnus, brevis</td></tr><tr><td>Abduction and internal rotation of thigh</td><td>L4,1L5,S1</td><td>Superior gluteal</td><td>Gluteus medius</td></tr><tr><td>Extension of thigh</td><td>L5, $1, $2</td><td>Inferior gluteal</td><td>Gluteus maximus</td></tr><tr><td rowspan="3">Flexion of knee</td><td>L5, $1, S2</td><td>Sciatic</td><td>Biceps femoris</td></tr><tr><td></td><td></td><td></td><td>Semitendinosus</td></tr><tr><td></td><td></td><td></td><td>Semimembranosus</td></tr><tr><td>Dorsiflexion of foot (medial)</td><td>14,15</td><td>Peroneal (deep)</td><td>Anterior tibial</td></tr><tr><td>Dorsiflexion of toes (proximal and distal phalanges)</td><td>L5,S1</td><td>Peroneal (deep)</td><td>Extensor digitorum longus and brevis</td></tr><tr><td>Dorsiflexion of great toe</td><td>L5,S1</td><td>Peroneal (deep)</td><td>Extensor hallucis longus</td></tr><tr><td>Eversion of foot</td><td>L5,S1</td><td>Peroneal (superficial)</td><td>Peroneus longus and brevis</td></tr><tr><td>Plantar flexion of foot</td><td>$1, 52</td><td>Tibial</td><td>Gastrocnemius, soleus</td></tr><tr><td>Inversion of foot</td><td>L4,L5</td><td>Tibial</td><td>Tibialis posterior</td></tr><tr><td>Flexion of toes (distal phalanges)</td><td>L5, $1, $2</td><td>Tibial</td><td>Flexor digitorum longus</td></tr><tr><td>Flexion of toes (middle phalanges)</td><td>S1, $2</td><td>Tibial</td><td>Flexor digitorum brevis</td></tr><tr><td>Flexion of great toe (proximal phalanx)</td><td>S1,S2</td><td>Tibial</td><td>Flexor hallucis brevis</td></tr><tr><td>Flexion of great toe (distal phalanx)</td><td>L5, $1, $2</td><td>Tibial</td><td>Flexor hallucis longus</td></tr><tr><td>Contraction of anal sphincter</td><td>$2, $3, S4</td><td>Pudendal</td><td>Perineal muscles</td></tr></table>
======================================
<table><tr><td>I. Syndrome of acute motor paralysis with variable disturbance of sensory and autonomic function A. Guillain-Barré syndrome (GBS; acute inflammatory demyelinating polyneuropathy [AIDP]); see also Table 46-3 . Acute axonal form of GBS (AMAN) Acute neuropathy and neuronopathy syndrome mms</td><td>IV. Syndrome of more chronic (late) polyneuropathy, genetically determined forms (see Table 46-6) A. Inherited polyneuropathies of predominantly sensory type 1. Dominant mutilating sensory neuropathy in adults 2. Recessive mutilating sensory neuropathy of childhood 3. Congenital insensitivity pain</td></tr></table>
======================================
<table><tr><td>I. Syndrome of acute motor paralysis with variable disturbance of sensory and autonomic function A. Guillain-Barré syndrome (GBS; acute inflammatory demyelinating polyneuropathy [AIDP]); see also Table 46-3 . Acute axonal form of GBS (AMAN) Acute neuropathy and neuronopathy syndrome mms</td><td>IV. Syndrome of more chronic (late) polyneuropathy, genetically determined forms (see Table 46-6) A. Inherited polyneuropathies of predominantly sensory type 1. Dominant mutilating sensory neuropathy in adults 2. Recessive mutilating sensory neuropathy of childhood 3. Congenital insensitivity pain</td></tr></table>
======================================
<table><thead><th>a VARIANTS OF GUILLAIN-BARRE SYNDROME</th><th></th></thead><tr><td colspan="2">Regional</td></tr><tr><td>Predominant paraparesis Bilateral facial or abducens weakness with distal Ophthalmoplegia with GQ;b autoantibodies</td><td>paresthesias</td></tr><tr><td colspan="2">Generalized ataxia without dysarthria or nystagmus</td></tr><tr><td colspan="2">Pure sensory</td></tr><tr><td colspan="2">Pure motor</td></tr><tr><td colspan="2">Pandysautonomia</td></tr><tr><td>Axonal (AMAN)</td><td></td></tr></table>
======================================
<table><thead><th></th><th>PATHOLOGY</th><th>ONSET</th><th>GENE</th><th>CLINICAL AND THERAPEUTIC FEATURES</th></thead><tr><td colspan="5">I. Charcot-Marie-Tooth (CMT) and related disorders 1. CMT1 inherited</td></tr><tr><td colspan="5">(dominantly myelinopathy) CMTI1A demyelinating c Duplication of gene for Early areflexia, distal weakness, peripheral myelin protein sensory loss (PMP22)</td></tr><tr><td>CMT1B</td><td>demyelinating</td><td>Ga</td><td>Myelin protein PO</td><td>Early areflexia, distal weakness, loss</td></tr><tr><td></td><td></td><td></td><td></td><td>sensory</td></tr><tr><td>CMT1C</td><td>demyelinating</td><td>a</td><td>Lipopolysaccharide-induced TNFa</td><td></td></tr><tr><td>CMT1D, CMT4E</td><td>demyelinating</td><td>G</td><td>Transcription factor EGR2</td><td>May be severe and congenital</td></tr><tr><td>CMT1F, CMT2E Congenital hypomy-</td><td>demyelinating, axonal demyelinating</td><td>Ga c</td><td>Neurofilament light subunit Rho guanine exchange factor</td><td>Mild or asymptomatic</td></tr><tr><td colspan="5" rowspan="3">elination 2. CMT2 (dominantly inherited axonopathy)</td></tr><tr><td colspan="5"></td></tr><tr><td colspan="5"></td></tr><tr><td>CMT2A</td><td>axonal</td><td>ca</td><td>Kinesin KIF1B£ motor</td><td></td></tr><tr><td></td><td></td><td></td><td>protein</td><td></td></tr><tr><td>CMT2A (alt)</td><td>axonal</td><td>CG</td><td>Mitofusin (MFN2)</td><td></td></tr><tr><td>CMT2B</td><td>axonal</td><td>a</td><td>GTP binding protein RAB7</td><td></td></tr><tr><td>CMT2C</td><td></td><td>ca</td><td></td><td>Prominent vocal cord, dia-</td></tr><tr><td></td><td>axonal</td><td></td><td></td><td></td></tr><tr><td colspan="5" rowspan="4">phragm paralysis CMT2D axonal a Glycyl t-RNA synthetase (GARS) CMT2F 1 axonal ca Heat shock protein 27 Slow, motor predominant</td></tr><tr><td colspan="5"></td></tr><tr><td colspan="5"></td></tr><tr><td colspan="5"></td></tr><tr><td>CMT2F 2</td><td>axonal</td><td>ca</td><td>Heat shock protein 22</td><td>Slow, motor predominant</td></tr><tr><td>3. AR-CMT2 -</td><td>inherited</td><td></td><td></td><td></td></tr><tr><td>(recessively</td><td>axonopathy)</td><td></td><td></td><td></td></tr><tr><td>AR-CMT2A</td><td>axonal</td><td></td><td>Nuclear membrane lamin A/C</td><td></td></tr><tr><td>4. CMT3 (congenital</td><td>demyelinating</td><td>inf</td><td>PMP22, PO, EGR2 (above)</td><td></td></tr><tr><td colspan="5">myelinopathy) 5. CMT4 (recessively inherited myelino-axonopathy)</td></tr><tr><td colspan="5">CMT4A demyelinating Ganglioside induced differen- May be rapidly progressive</td></tr><tr><td></td><td></td><td>c</td><td>tiation protein</td><td></td></tr><tr><td>CMT4B</td><td>demyelinating</td><td></td><td>Myotubularin-related protein</td><td>Focally folded myelin</td></tr><tr><td>CMT4B 2 CMT4C</td><td>demyelinating</td><td>Ga</td><td>SET-binding factor (SBF2) Novel neural</td><td>scoliosis</td></tr><tr><td></td><td>demyelinating</td><td></td><td>protein</td><td>Early</td></tr><tr><td>CMT4D</td><td>demyelinating</td><td>c</td><td>(KIAA1985) Schwann cell protein</td><td>Neuropathy + hearing loss</td></tr><tr><td></td><td></td><td></td><td>Nm-ycDRG1</td><td></td></tr><tr><td>CMT4F</td><td>demyelinating</td><td>c</td><td>Nuclear membrane protein (periaxin)</td><td>Early onset, severe</td></tr><tr><td>plexopathy (AD) 8. HNPP</td><td>axonal</td><td>c</td><td>PMP22 gene deletion</td><td>Focal entrapments, chronic neu-</td></tr><tr><td colspan="5" rowspan="2">and Autonomic ropathy</td></tr><tr><td colspan="5"></td></tr><tr><td>Hereditary Sensory 1. HSAN1 (AD)</td><td>Neuropathy (HSAN) axonal</td><td></td><td>Serine palmitoy] transferase</td><td>Small fibersensory and distal motor deficits</td></tr><tr><td>2. HSAN2 (AR) 3. HSANS (Riley-Day, AR)</td><td>axonal axonal</td><td>inf inf</td><td>Novel neuronal protein Kinase associated protein (IKBKAP)</td><td></td></tr><tr><td>4. HSAN4 (AR)</td><td>axonal</td><td>inf</td><td>TrkA/NGF receptor</td><td>Congenital SN with anhidrosis</td></tr><
======================================
tr><td>5. HSANG6 (AR)</td><td>axonal</td><td>inf</td><td>Nerve growth factor-beta</td><td>Absent pain</td></tr><tr><td>(I. Familial Amyloid</td><td>Polyneuropathies (AD)</td><td></td><td></td><td></td></tr><tr><td>1. 1—</td><td>axonal</td><td></td><td></td><td>Liver be beneficial</td></tr><tr><td>Type Portuguese</td><td></td><td></td><td>Transthyretin</td><td>transplant may</td></tr><tr><td>2. Type 2 - Indiana/ Swiss</td><td>axonal</td><td></td><td>Transthyretin</td><td>Liver transplant may be beneficial</td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td>3. Type 3-— Van Allen</td><td>axonal</td><td></td><td>Apolipoprotein Al</td><td></td></tr><tr><td>4. Type 4—- Finnish</td><td>axonal</td><td></td><td>Gelsolin</td><td>Lax skin and “bloodhound”</td></tr></table>
======================================
<table><thead><th colspan="5">CLASSIFICATION OF THE INHERITED PERIPHERAL NEUROPATHIES? (CONTINUED)</th></thead><thead><th></th><th>PATHOLOGY</th><th>ONSET</th><th>GENE</th><th>CLINICAL AND THERAPEUTIC FEATURES</th></thead><tr><td colspan="5">Arylsulfatase A and B IV. Hereditary Disorders of Lipid Metabolism Causing Neuropathy (AR) 1. Metachromatic demyelinating inf-a</td></tr><tr><td>leukodystrophy 2. Krabbe disease</td><td>demyelinating, axonal</td><td>_inf-a</td><td>B-galactosidase</td><td>Early bone marrow transplant may be beneficial</td></tr><tr><td>3. Fabry disease 4, Adrenomyeloneuropathy</td><td>axonal demyelinating,</td><td>c inf-a</td><td>o-galactosidase ABCD! transporter</td><td>Heat-induced pain, macular rash Early bone marrow transplant</td></tr><tr><td>(XR/XD) 5. Refsum disease</td><td>axonal demyelinating</td><td>inf-a</td><td>Phytanoyl-aCoA-hydroxylase</td><td>may be beneficial Dietary restriction may amelio-</td></tr><tr><td>6. Tangier disease</td><td>axonal</td><td>a</td><td>ABC1</td><td>rate the disease Small fiber neuropathy, facial</td></tr><tr><td>7. Bassen-Kornzweig</td><td>axonal</td><td>c</td><td>MTP</td><td>weakness, very low HDL Acanthocytosis, cerebellar ataxia</td></tr><tr><td>V. Miscellaneous Inherited 1. Giant axonalneuropathy</td><td>Neuropathies axonal</td><td>c</td><td>Gigaxonin</td><td></td></tr><tr><td>(AR) 2. Porphyria (AR)</td><td>axonal</td><td>Ga</td><td>Porphobilinogen deaminase</td><td>May respond to hematin, glucose</td></tr><tr><td>3. “Mitochondrial” neuropathies (NARP)</td><td>axonal</td><td></td><td></td><td>Retinitis pigmentosa</td></tr><tr><td>4. Severe PNS, CNS demyelination (AD)</td><td>demyelinating</td><td>inf, c</td><td>Myelin transcription factor SOX10</td><td>CNS, PNS hypomyelination</td></tr></table>
======================================
<table><thead><th>NERVE</th><th>SITE OF ENTRAPMENT</th></thead><tr><td>Suprascapular Lower trunk or medial cord of branchial plexus Median</td><td>Spinoglenoid notch Cervical rib or band at thoracic outlet</td></tr><tr><td>Wrist Elbow Ulnar</td><td>Carpal tunnel Between heads of pronator teres (pronator syndrome)</td></tr><tr><td>Elbow Posterior interosseous nerve</td><td>Bicipital groove, cubital tunnel Radial tunnel—at point of entrance into supinator muscle (arcade of Frohse)</td></tr><tr><td>Lateral femoral cutaneous (meralgia paresthetica)</td><td>Inguinal ligament</td></tr><tr><td>Obturator</td><td>Obturator canal</td></tr><tr><td>Posterior tibial</td><td>Tarsal tunnel; medial malleolus— flexor retinaculum</td></tr><tr><td>Interdigital plantar (Morton metatarsalgia)</td><td>Plantar fascia: heads of third and fourth metatarsals</td></tr></table>
======================================
<table><thead><th>SITE</th><th>CRANIAL NERVES INVOLVED</th><th>EPONYMIC. SYNDROME</th><th>USUAL CAUSE</th></thead><tr><td>shenoidal fissure ateral wall of cavernous sinus</td><td>IIL, IV, ophthalmic, V, VI IIL, IV, ophthalmic (occasionally maxillary), V, VI</td><td>Foix Tolosa-Hunt</td><td>Invasive tumors of sphenoid bone, aneurysms Aneurysms or thrombosis of cavernous sinus; invasive tumors from sinuses and sella tur- cica; sometimes recurrent, benign granulo-</td></tr><tr><td>etrosphenoidal space fossa pex of petrous bone ternal auditory meatus</td><td>IL, IIL, IV, V, VI V, VI VIL, VIL</td><td>Jaccoud Gradenigo</td><td>matous reactions, responsive to steroids Large tumors of middle cranial Petrositis, tumors of petrous bone Tumors of petrous bone (dermoids, etc.), acoustic neuroma</td></tr><tr><td>ontocerebellar angle gular foramen terior laterocondylar space</td><td>V, VIL, VIII, and sometimes IX IX, X, XI IX, X, XI, XIL</td><td>Vernet Collet-Sicard</td><td>Acoustic neuromas, meningiomas Tumors and aneurysms Tumors of parotid gland, carotid body; secon- dary and lymph node tumors, tuberculous adenitis, carotid artery dissection</td></tr><tr><td>terior retroparotid space</td><td>IX, X, XI, XIL and Horner syndrome</td><td>Villaret</td><td>Same as above, and granulomatous lesions (sarcoid, fungi)</td></tr><tr><td>osterior retroparotid space</td><td>X and XII, with or without XI</td><td>Tapia</td><td>Parotid and other tumors of, or injuries to, the high neck</td></tr></table>
======================================
<table><thead><th colspan="5">JCHENNE/BECKER, EMERY-DREIFUSS, LIMB-GIRDLE, AND RELATED MAJOR MUSCULAR DYSTROPHIES</th></thead><thead><th>HERITANCE TYPE</th><th>— GENE OR CHROMOSOME</th><th>ONSET DECADE</th><th>CK ELEVATION</th><th>REGIONS AFFECTED</th></thead><tr><td colspan="5">inked recessive Juchenne/ Becker Dystrophin 1st 10-50 x Proximal, then distal muscles</td></tr><tr><td>mery-Dreifuss</td><td>Emerin</td><td>2nd-3rd</td><td>5x</td><td>Cardiac muscle Proximal muscles, joint contractures; cardiac</td></tr><tr><td>scapuloperoneal</td><td>FHL1</td><td></td><td></td><td>arrhythmias Scalpular-peroneal</td></tr><tr><td>tosomal dominant .GMD 1A</td><td>Myotilin</td><td>3rd—4th</td><td>2x</td><td>Distal greater than proximal weakness, vocal cords,</td></tr><tr><td>.GMD 1B</td><td>Lamin A/C</td><td>1st-2nd</td><td>345 x</td><td>pharynx; allelic with myofibrillar myopathy Resembles Emery-Dreifuss disease Proximal muscles and heart, contractures</td></tr><tr><td>.GMD 1C</td><td>Caveolin-3</td><td>1st decade</td><td>4-25 x</td><td>joint Proximal muscles</td></tr><tr><td>.GMD 1D _GMD 1E</td><td>6p 7q</td><td>3rd—5th 1st</td><td>24x NI</td><td>Proximal muscles; cardiomyopathy Proximal muscles</td></tr><tr><td>tosomal recessive .GMD 2A _GMD 2B</td><td>Calpain-3 Dysferlin</td><td>1st-2nd 2nd-3rd</td><td>3-15 x 10-50 x</td><td>Proximal and distal muscles Proximal and distal muscles</td></tr><tr><td>_GMD 2C-F</td><td>a, B, y, &amp;sarcoglycans</td><td>Ist-3rd</td><td>5-40 x</td><td>Allelic to Miyoshi myopathy Phenotype of Becker dystrophy</td></tr><tr><td>.GMD 2G</td><td>Telethonin</td><td>2nd.</td><td>3-17 x</td><td>Proximal greater than distal muscles</td></tr><tr><td>.GMD 2H</td><td>TRIM32</td><td>Ist-3rd</td><td>2-25 x</td><td>Proximal greater than distal muscles</td></tr><tr><td>_GMD 21</td><td>Fukutin-related protein (FKRP)</td><td>— 1st-3rd</td><td>10-30 x</td><td>Proximal greater than distal muscles FKRP defects also cause CMD</td></tr><tr><td>JGMD 2J .GMD 2M</td><td>Titin POMGNT1*</td><td>1st-3rd Birth</td><td>2x</td><td>Proximal and sometimes distal muscles Mutations also associated with muscle-eye-brain diseases</td></tr></table>
======================================
<table><thead><th>TYPE</th><th>GENE OR CHROMOSOME</th><th>ONSET DECADE</th><th>CK ELEVATION</th><th>REGIONS AFFECTED</th></thead><tr><td>yotonic dystrophy</td><td>Expanded intronic CTG repeat in</td><td>— 1st-2nd</td><td>12x</td><td>Distal weakness, myotonia, cataracts</td></tr><tr><td>(DM1) oximal myotonic myopathy (DM2)</td><td>myotonin kinase Expanded intronic CCTG repeat in zinc finger protein</td><td>Ist-2nd</td><td>12x</td><td>Testicular atrophy, balding, cardiac arrhythmias Resembles myotonic dystrophy with prominent proximal muscle weakness but less facial weakness</td></tr><tr><td>cioscapulohumeral dystrophy</td><td>Multigene dysregulation at 4q telomere</td><td>Ist-4th</td><td>12x</td><td>no infancy onset; Facial, scapular, anterior tibial muscles Hearing loss, ocular telangiectasias</td></tr><tr><td>culopharyngeal</td><td>Exonic GCG expansion (alanine) in</td><td>6th-7th</td><td>12x</td><td>Oculopharyngeal and levator palpebrae muscles</td></tr><tr><td>dystrophy thlem myopathy</td><td>poly-A binding protein Collagen VI, subunits o 1-3</td><td>Ist-3rd</td><td>14x</td><td>Proximal weakness Contractures in fingers, elbows, knees</td></tr><tr><td>yofibrillar myopathy</td><td>Myotilin, desmin, aB-crystallin</td><td>2nd—4th</td><td>1-5 x</td><td>May present as CMD Allelic with LGMD-1A</td></tr></table>
======================================
<table><thead><th>ERITANCE DISORDER</th><th>GENE OR PROTEIN DEFICIENCY</th><th>ONSET DECADE</th><th>CK ELEVATION</th><th>REGIONS AFFECTED</th></thead><tr><td>somal recessive iyoshi myopathy</td><td>Dysferlin</td><td>2nd-3rd</td><td>= 10-50 x</td><td>Begins in gastrocnemius muscles, rarely, in anterior tibial muscles Identical genetic defects may cause LGMD-2B</td></tr><tr><td rowspan="2">onaka myopathy with rimmed vacuoles (familial IBM) somal dominant elander distal dystrophy</td><td>|= GNE kinase-epimerase UDP-N-acetylglucosamine-2- epimerase / N-mannosamine kinase</td><td>2nd-3rd</td><td>3-10 x</td><td>Involves multiple muscle groups, spares heart Distal more than proximal weakness Quadriceps sparing Spares heart</td></tr><tr><td></td><td>Unknown</td><td>4th-5th</td><td>2-3 x</td><td>Weakness begins in hands Slow progression</td></tr><tr><td>bial muscular dystrophy</td><td>Titin</td><td>4th-8th</td><td>24x</td><td>Spares cardiac muscle Onset in tibial distribution No cardiac involvemet</td></tr><tr><td>apuloperoneal dystrophy</td><td>X-linked (see Table 50-1)</td><td>3rd—6th</td><td>2-10 x</td><td>Scapuloperoneal weakness Hyaline bodies in muscle</td></tr><tr><td>esmin myopathy</td><td>Desmin</td><td>3rd—4th</td><td>2-3x</td><td>Early onset of foot-drop Onset of distal weakness, slowly progressive Cardiac arrhythmias (sometimes fatal)</td></tr><tr><td rowspan="2">ower-Laing arkesbury-Griggs</td><td></td><td>MYHC-1 (MYH7)</td><td>2nd-3rd</td><td>3x</td><td>Anterior tibial (early foot-drop)</td></tr><tr><td>ZASP</td><td>2nd-3rd</td><td>2x</td><td>Anterior tibial Cardiomyopathy common</td></tr></table>
======================================
<table><thead><th>DISORDER</th><th>GENE OR PROTEIN DEFICIENCY</th><th>CK —_ ELEVATION</th><th>REGIONS AFFECTED</th></thead><tr><td>Merosin deficiency</td><td>Merosin</td><td>5-35 x</td><td>Hypotonia, diffuse weakness, slow motor development function</td></tr><tr><td>Sukutin CMD*</td><td>Fukutin</td><td>10-50 x</td><td>Cognitive largely spared Hypotonia, diffuse weakness, slow motor development Mental retardation, seizures common</td></tr><tr><td>7-KRP CMD</td><td>FKRP</td><td>10-50 x</td><td>MRI: hypomyelination, hydrocephalus Hypotonia, diffuse weakness, slow motor development Cognitive function largely spared</td></tr><tr><td>Muscle-eye brain disease</td><td>N-acetyl-glucosaminyl-transferase POMGnT1</td><td>5-20 x</td><td>Hypotonia, diffuse weakness, slow motor development Mental retardation, seizures common Cataracts, retinal dysplasias, retinitis, glaucoma Hypoplasia of optic nerve</td></tr><tr><td>Nalker-Warburg disease</td><td>O-Mannosyl]-transferase 1 POMT1</td><td>5-20 x</td><td>MRI: hypomyelination, hydrocephalus, lissencephaly Hypotonia, diffuse weakness, slow motor development Mental retardation, seizures common Cataracts, retinal dysplasias, retinitis, glaucoma</td></tr><tr><td>Rigid spine syndrome</td><td>Selenoprotein SEPNI1</td><td>NI</td><td>MRI: hypomyelination, hydrocephalus, lissencephaly Hypotonia, restricted flexion of the neck and spine Contractures at multiple joints, normal heart function</td></tr><tr><td>ntegrin CMD</td><td>Integrin @-7</td><td>12x</td><td>Cognitive largely spared Hypotonia, diffuse weakness, slow motor development Slowed motor development + mental retardation</td></tr><tr><td>.ARGE CMD</td><td>LARGE</td><td>NI</td><td>Profound mental retardation, cerebral white matter changes</td></tr></table>
======================================
<table><thead><th rowspan="8">THE GLYCOGENOSES GLYCOGENO- SIS TYPE (PROPER NAME)</th><th>AFFECTING</th><th>SKELETAL</th><th>MUSCLE?</th><th></th><th></th><th></th><th></th><th></th></thead><thead><th></th><th></th><th></th><th></th><th>EXERCISE</th><th></th><th></th><th></th><th></th></thead><thead><th></th><th></th><th></th><th></th><th>INTOLERANCE</th><th></th><th></th><th></th><th></th></thead><thead><th></th><th></th><th></th><th></th><th>(MYALGIA,</th><th>EARLY</th><th></th><th>SEVERE</th><th></th></thead><thead><th></th><th></th><th></th><th></th><th>CRAMPS,</th><th>FATIGUE</th><th></th><th>RESPIRA-</th><th></th></thead><thead><th></th><th></th><th>ONSET</th><th></th><th>STIFFNESS, +</th><th>AND</th><th></th><th>TORY</th><th>CON-</th></thead><thead><th></th><th>DEFECTIVE</th><th>OF</th><th>HYPO-</th><th>MYOGLOBIN-</th><th>SECOND</th><th>MYOPATHY</th><th>MUSCLE</th><th>TRAC-</th></thead><thead><th></th><th>ENZYME</th><th>DISEASE?</th><th>TONIA</th><th>URIA)</th><th>WIND</th><th>ATROPHY</th><th>WEAKNESS</th><th>TURES</th></thead><tr><td>II (Pompe)</td><td>Acid maltase</td><td>I</td><td>+</td><td></td><td></td><td>+</td><td>+</td><td></td></tr><tr><td>an</td><td>Acid maltase</td><td>Cc</td><td></td><td></td><td></td><td>+</td><td>+</td><td></td></tr><tr><td>anf</td><td>Acid maltase</td><td>A</td><td></td><td></td><td></td><td>+</td><td>+</td><td></td></tr><tr><td>III (Cori-</td><td>Debrancher</td><td>CA</td><td>+</td><td></td><td></td><td>+</td><td></td><td>+</td></tr><tr><td>Forbes) IV (Andersen)</td><td>—_ Branching</td><td>LC</td><td>+</td><td></td><td></td><td>+</td><td></td><td>+</td></tr><tr><td>V (McArdle)</td><td>Myophosphory- lase</td><td>—_C, Ad, A</td><td></td><td>+</td><td>+</td><td>+</td><td></td><td>+</td></tr><tr><td>VII (Tarui)</td><td>Phosphofruc- tokinase</td><td>CA</td><td></td><td>+</td><td>+</td><td>+</td><td></td><td>+</td></tr><tr><td>Vil</td><td>Phosphorylase B kinase</td><td>LC, Ad, A</td><td>+</td><td>+</td><td></td><td>+</td><td></td><td></td></tr><tr><td>Ix</td><td>Phosphoglycer- ate kinase</td><td>LCA</td><td></td><td>+</td><td></td><td>+</td><td></td><td></td></tr><tr><td>x</td><td>Phosphoglycer- ate mutase</td><td>A</td><td></td><td>+</td><td></td><td></td><td></td><td></td></tr><tr><td>XI</td><td>Lactic dehydro- genase</td><td>— Ad-A</td><td></td><td>+</td><td>+</td><td></td><td></td><td></td></tr></table>
======================================
<table><tr><td rowspan="9">ORGANO- MEGALY</td><td rowspan="8">MYOGLO- BINURIA</td><td></td><td></td><td></td><td>INCREASED</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>GLYCOGEN</td><td></td><td></td><td rowspan="7">HISTO- CHEMISTRY</td></tr><tr><td></td><td></td><td></td><td></td><td>MEM-</td><td>IN</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td>BRANE-</td><td>SUBSARCO-</td><td>INTRA- AND</td><td></td><td></td></tr><tr><td></td><td></td><td>POSITIVE</td><td></td><td>LINED</td><td>LEMMA</td><td>EXTRA-</td><td></td><td></td></tr><tr><td></td><td></td><td>ISCHEMIC</td><td>ENZYME-</td><td>VACUOLES</td><td>AND INTER-</td><td>VACUOLAR</td><td>AMYLO-</td><td></td></tr><tr><td></td><td></td><td>EXERCISE</td><td>DEFICIENT CELLS</td><td>WITH</td><td>MYOFIBRIL-</td><td>ACID PHOS-</td><td>PECTIN</td><td></td></tr><tr><td></td><td></td><td>TEST</td><td>FOR ASSAY</td><td>GLYCOGEN</td><td>LAR AREAS</td><td>PHATASE</td><td>DEPOSITS</td><td></td></tr><tr><td rowspan="3">+</td><td></td><td></td><td></td><td>Muscle, WBC, chorionic villus, amniotic fluid</td><td>+</td><td>+</td><td>+</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td>Muscle</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td>Muscle</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>He</td><td></td><td></td><td>Muscle, WBC, fibroblasts</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="3"></td><td></td><td></td><td>Muscle, WBC fibro- blasts amniotic fluid</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td>Muscle, WBC</td><td></td><td></td><td></td><td></td><td>Absence of myophos- phorylase</td></tr><tr><td></td><td></td><td></td><td>Muscle, RBC</td><td></td><td></td><td></td><td>+</td><td>Absence of phospho- fructokinase</td></tr><tr><td></td><td></td><td></td><td>Muscle</td><td></td><td>+</td><td></td><td></td><td></td></tr><tr><td rowspan="3"></td><td></td><td></td><td>Muscle, RBC</td><td></td><td>+i</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td>Muscle</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td>Muscle</td><td></td><td>+</td><td></td><td></td><td></td></tr></table>
======================================
<table><thead><th>MYOPATHIC SYNDROME</th><th>AGENT</th><th>CLINICAL FEATURES</th><th>PATHOLOGY</th><th>LABORATORY FINDING</th></thead><tr><td rowspan="4">Necrotizing myopathy (rhabdomyolysis)</td><td>. Statin drugs . Alcohol abuse . Clofibrate, gemfibrozil Amphetamine derivatives SCNATARONE</td><td>Acute/subacute painful proximal myopathy; tendon reflexes usually preserved</td><td>Necrosis, regeneration</td><td>CKTT, myoglobinuria +/</td></tr><tr><td></td><td>Hypervitaminosis E . Organophosphates</td><td>5. Painless</td><td>5. Paracrystalline inclusion bodies</td><td></td></tr><tr><td></td><td>Snake venoms . High-dose corticosteroids in critical illness</td><td>7. Severe, acute intoxication 8. Neuromuscular blockers implicated</td><td></td><td></td></tr><tr><td></td><td>9. Mushroom poisoning (Amanita phalloides) 10. Cocaine</td><td></td><td>9. Loss of myosin</td><td></td></tr><tr><td>Steroid myopathy Hypokalemic myopathy</td><td>1. Acute (high IV steroid doses, ventilated patients on pancuronium) 2. Chronic 1. Diuretics 2. Laxatives</td><td>Severe proximal and distal weakness 2. Proximal atrophy, weakness Weakness may be periodic, reflexes may be depressed or absent, rarely</td><td>1. Necrosis of mainly type 2 fibers; loss of myosin; vacuolar changes 2. Type 2 fiber atrophy Necrosis, regeneration, vacuolization</td><td>CK TT, myoglobinuria + Blood lymphocytosis CKTT, myoglobinuria +/ hypokalemia</td></tr><tr><td></td><td>3. Licorice, carbenoxolone 4. 5. . Amphotericin B, toluene . Alcohol abuse</td><td>severe myoglobinuria</td><td></td><td></td></tr><tr><td>Amphiphilic cationic drug myopathy (lysosomal storage, “lipidosis”)</td><td>1 . Chloroquine (&gt;500 mg), hydroxychloroquine, quinacrine, plasmocid 2. Amiodarone 3. Perhexiline</td><td>Proximal muscle pain and weakness, sensorimotor neuropathy, cardiomy- opathy</td><td>Chloroquine: vacuole formation, optically dense structures</td><td>CK</td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Impaired protein synthesis</td><td>Ipecac syrup, emetine</td><td>Myalgia, proximal weakness,</td><td>Focal mitochondrial loss, vacuoles</td><td>CK</td></tr><tr><td>Antimicrotubular myopathy</td><td>. Colchicine Vincristine</td><td>cardiomyopathy Proximal weakness, peripheral CK be normal</td><td>Vacuolar myopathy (rimmed</td><td>CK</td></tr><tr><td>Inflammatory myopathy</td><td>. . D-Penicillamine . Procainamide . Cimetidine? Ciguatera toxin? WNENE</td><td>neuropathy; may Proximal muscle pain, weakness, skin changes possible</td><td>vacuoles) Inflammation, necrosis, regeneration</td><td>CK T, myoglobinuria + /-</td></tr><tr><td>Fasciitis, perimyositis, microangiopathy</td><td>1. Toxic oil syndrome . Eosinophilia-myalgia syndrome N</td><td>Myalgia, skin changes, peripheral neuropathy, other systems also affected</td><td>Vasculitis, connective tissue infiltration</td><td>Eosinophilia</td></tr><tr><td>Mitochondrial myopathy Various</td><td>. Zidovudine Germanium</td><td>Proximal myalgia and weakness</td><td>Ragged red fibers, necrosis, regeneration</td><td>CK normal or T</td></tr><tr><td></td><td>Cyclosporine . Labetalol . Anthracycline antibiotics Rifampin, amiodarone PRPONPNE</td><td>3. Humans: only cardiomyopathy</td><td></td><td></td></tr><tr><td rowspan="2">Myopathy due to IM injections</td><td></td><td>Acute: IM injection of various drugs— e.g., cephalothin, lidocaine, diazepam</td><td>Local pain, swelling, sometimes abscess formation</td><td>Focal necrosis</td><td>CKT</td></tr><tr><td>. Chronic: Repeated IM injections—e.g., pethidine, pentazocine, intravenous drug N</td><td>Induration and contracture of injected muscles</td><td>Marked fibrosis and myopathic changes</td><td>Normal</td></tr></table>
======================================
<table><thead><th>TYPE</th><th>GENETICS</th><th>GENE OR CHROMOSOME</th><th>ONSET DECADE</th><th>CK ELEVATION</th><th>REGIONS AFFECTED</th></thead><tr><td>Central core disease</td><td>AD, AR</td><td>Ryanodine receptor</td><td>1st-2nd</td><td>1-10 x</td><td>Diffuse myopathy presenting in infancy Proximal myopathy beginning in adolescence Risk of malignant hyperthermia include mental retardation</td></tr><tr><td>Nemaline rod myopathy</td><td>AD, AR</td><td>o-Tropomyosin Nebulin Coflin-2 B-Tropomyosin Ryanodine receptor Troponin T1</td><td>Ist-2nd</td><td>1-2x</td><td>May Diverse phenotypes May present as severe congenital myopathy or as childhood-onset myopathy May include facial weakness, high-arched palate, and high pedal arches</td></tr><tr><td>Myotubular myopathy</td><td>X-linked AD, AR,</td><td>o-Actin Myotubularin Dynamin-2 MYF6</td><td>1st</td><td>14x</td><td>Proximal and distal weakness May include facial weakness, ophthalmoparesis, ptosis</td></tr></table>
======================================
<table><thead><th>DOSE-EQUIVALENTS TREATMENT OF</th><th>FOR DRUGS MYASTHENIA</th><th>USED IN GRAVIS</th><th>THE</th></thead><tr><td></td><td>EQUIVALENT</td><td>ONSET</td><td>RESPONSE</td></tr><tr><td>Pyridostigmine (Mestinon)</td><td>60 mg (oral)</td><td>40 min</td><td>th</td></tr><tr><td>Neostigmine oral (Prostigmin)</td><td>15mg</td><td>lh</td><td>15h</td></tr><tr><td>Neostigmine IM</td><td>1.5 mg</td><td>30 min</td><td>th</td></tr><tr><td>Neostigmine IV</td><td>0.5 mg</td><td>Immediate</td><td>20 min</td></tr></table>
======================================
<table><thead><th>MYASTHENIC SYNDROMES</th><th>CAUSAL AGENT OR GENE DEFECT</th><th>ONSET DECADE</th><th>TREATMENT</th><th>CLINICAL FEATURES</th></thead><tr><td colspan="5">ACQUIRED MYASTHENIC SYNDROMES</td></tr><tr><td>synaptic Botulism</td><td>toxin from Clostridium botulinum</td><td></td><td>ventilation</td><td>Blurred vision,</td></tr><tr><td>(Chap. 43) Lambert-Eaton myasthenic</td><td>_ Peptide Autoimmune reduction in calcium- mediated quantal release</td><td>Any Midlife</td><td>Supportive; 3,4-DAP Possibly IVIg</td><td>dysphagia, limb weakness Truncal weakness, dysau- tonomic features</td></tr><tr><td>syndrome naptic Insecticides (Chap. 43)</td><td>Organophosphates (inhibits AChE)</td><td>Any</td><td>Remove toxins Atropine</td><td>Two-thirds have cancer Miosis, diarrhea, cramps, weakness</td></tr><tr><td>stsynaptic Myasthenia gravis</td><td>Autoimmune attack on postsynaptic membrane</td><td>Adult</td><td>ACHE inhibitors, IVIg Other immunosuppres-</td><td>Delayed ropathy Diplopia, ptosis Limb weakness with exer-</td></tr><tr><td>Snake venom toxins (Chap. 43)</td><td>Antibodies to AChR or MuSK protein Multiple peptide toxins that lyse muscle, bind Na channels, K channels (acting both post- and presynaptically)</td><td>= Any</td><td>sants Supportive Possibly AChE inhibitors</td><td>tion Acute weakness</td></tr><tr><td></td><td>HEREDITARY AND CONGENITAL</td><td>MYASTHENIC</td><td>SYNDROMES</td><td></td></tr><tr><td>synaptic Episodic apnea</td><td>Choline acetyltransferase</td><td>1st</td><td>AChE inhibitors Apnea monitor</td><td>Mild episodes of weak- ness; recurrent apnea</td></tr><tr><td>Paucity of synaptic vesicles</td><td>Unknown</td><td>1st</td><td>AChE inhibitors</td><td>Ptosis common Recurrent, sometimes pro- nounced weakness</td></tr><tr><td>naptic AChE deficiency</td><td>AChE Collagen tail for AChE</td><td>1st</td><td>Avoid AChE inhibitors</td><td>Diffuse weakness, ptosis</td></tr><tr><td rowspan="2">DOK-7 “synopathy” stsynaptic Slow channel syndrome</td><td>DOK-7 mutation</td><td>1st</td><td></td><td>Limb-girdle, ptosis</td></tr><tr><td></td><td>AChR subunits</td><td>1st-6th</td><td>Quinidine, AChE inhibitors Avoid 3,4-DAP</td><td>Ptosis, diffuse weakness, delayed motor milestones Often show atrophy of dorsal forearms</td></tr><tr><td>Fast channel</td><td>AChR subunits</td><td>1st</td><td>3,4-DAP</td><td>Ptosis, recurrent weakness, motor</td></tr><tr><td>syndrome Primary AChR deficiency</td><td>AChR subunits</td><td>1st</td><td>AChE inhibitors, 3,4-DAP.</td><td>development delays Ptosis, recurrent weak- ness, motor develop- ment</td></tr><tr><td>Rapsyn deficiency Plectin deficiency</td><td>Rapsyn Plectin</td><td>1st 1st</td><td>ACHE inhibitors, 3,4-DAP. 3,4-DAP</td><td>delays Ptosis, recurrent weakness Myasthenic features,</td></tr></table>
======================================
<table><thead><th>HANNEL AFFECTED</th><th>CHLORIDE</th><th>CHLORIDE</th><th>SODIUM</th><th>SODIUM</th><th>CALCIUM</th><th>CALCIUM</th><th>POTASSIUM</th></thead><tr><td>isease</td><td>Myotoniacongenita (Thomsen’s)</td><td>_ Generalized myoto- nia (Becker)</td><td>Hyperkalemic peri- odic paralysis</td><td>Paramyotonia con- genita (Eulen- burg)</td><td>Hypokalemic peri- odic paralysis</td><td>Malignant hyper- thermia</td><td>Andersen disease</td></tr><tr><td>theritance</td><td>Dominant</td><td>Recessive</td><td>Dominant</td><td>Dominant</td><td>Dominant</td><td>Dominant</td><td>Dominant</td></tr><tr><td>ene</td><td>CLCN1</td><td>CLCN1</td><td>SCN4A</td><td>SCN4A</td><td>DHP receptor</td><td>RYRI</td><td>KCNJ2</td></tr><tr><td>hannel protein</td><td>CLC1</td><td>CLC1</td><td>Alpha subunit</td><td>Alpha subunit</td><td>Dihydropyridine receptor</td><td>Ryanodine receptor</td><td>Inward rectifying K channel</td></tr><tr><td>fyotonia (electrical)</td><td>++</td><td>++</td><td>+/-</td><td>++</td><td>—</td><td>—</td><td>—</td></tr><tr><td>fyotonia (clinical)</td><td>++</td><td>+++</td><td>+/-</td><td>—</td><td>—</td><td>—</td><td>—</td></tr><tr><td>aramyotonia (clinical)</td><td>—</td><td>—</td><td>+/-</td><td>+++</td><td>—</td><td>—</td><td>—</td></tr><tr><td>pisodic paralysis</td><td>_</td><td>_</td><td>+44</td><td>+/-</td><td>+4+</td><td>_</td><td>+</td></tr><tr><td>mset</td><td>to late</td><td>Late childhood or</td><td>First decade</td><td>at</td><td>Late childhood to</td><td>All</td><td>Childhood</td></tr><tr><td>recipitating factors</td><td>Congenital childhood</td><td>earlier</td><td></td><td>Paramyotonia birth</td><td>third decade</td><td>ages</td><td></td></tr><tr><td>Increases with exercise</td><td>_</td><td>_—</td><td>_</td><td>+44</td><td>_</td><td>_—</td><td>+</td></tr><tr><td>Appears after</td><td>++</td><td>++</td><td>++</td><td>_</td><td>++</td><td>_</td><td>_</td></tr><tr><td>exercise</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Fasting</td><td>_</td><td>—</td><td>+</td><td>—</td><td>_</td><td>—</td><td>_</td></tr><tr><td>Carbohydrate load</td><td>= —</td><td>_</td><td>_</td><td>_</td><td>+</td><td>_</td><td>_</td></tr><tr><td>Cold</td><td>+ +</td><td>+ +</td><td>+ ++</td><td>+44 ++</td><td>+ +</td><td>_— —</td><td>?</td></tr><tr><td>Pregnancy Warmup” phenom-</td><td>++</td><td>++</td><td>+</td><td>_</td><td>+</td><td>_</td><td>_</td></tr><tr><td rowspan="8">enon volvement of cra- nial muscles fuscle hypertrophy ermanent myopathy erum CK during attack erum K during attack erum K between attacks ignificant myopa- thology (vacuolar myopathy) reatment</td><td>+</td><td>+</td><td>+</td><td>++</td><td>_</td><td>_—</td><td>++</td></tr><tr><td></td><td>++</td><td>+</td><td>_</td><td>_</td><td>_</td><td>_</td><td>_</td></tr><tr><td></td><td>_</td><td>+</td><td>++</td><td>_</td><td>++</td><td>_</td><td>+</td></tr><tr><td></td><td>Normal to borderline —</td><td>Increased 2 to3 times</td><td>Increased</td><td>Increased 5 to 10 times</td><td>Normal to slightly increased</td><td>Markedly increased</td><td>Normal</td></tr><tr><td></td><td>Normal</td><td>Normal</td><td>Increased</td><td>Normal</td><td>Decreased</td><td>Normal</td><td>High, low, or norms</td></tr><tr><td></td><td>Normal</td><td>Normal</td><td>Normal</td><td>Normal</td><td>Normal</td><td>Normal</td><td>Normal</td></tr><tr><td></td><td>_</td><td>—</td><td>++</td><td>—</td><td>++</td><td>Rhabdomyolysis, cores</td><td>Tubular aggregates</td></tr><tr><td></td><td>Mexiletineifrequired for myotonia</td><td>Mexiletineifrequired for myotonia</td><td>During attack, glu- cose and calcium; for prevention, acetazolamide</td><td>Mexiletine if needed for myotonia</td><td>KCI during and ace- tazolamide between attacks</td><td>Intravenous dan- trolene</td><td>Acetazolamide</td></tr></table>
======================================
<table><thead><th>TYPE</th><th>CHARACTERISTICS</th></thead><tr><td>Paranoid</td><td>Chronic wariness, suspiciousness, litigiousness, hypersensitivity, jealousy, envy; lack of insight or humor, tendency to blame others; of and entitlement</td></tr><tr><td>Cyclothymic</td><td>sense self-importance Recurring periods of depression (low energy, pessimism, hopelessness, despair) and elation (high energy,</td></tr><tr><td>Schizoid</td><td>ambition, enthusiasm, optimism) not readily explained by circumstances Isolation, seclusiveness, secretiveness, discomfort in relationships; often eccentric and lacking in energy; few</td></tr><tr><td>Explosive</td><td>friends; detachment; inability to express ideas and feelings, especially anger Outbursts of rage and aggression not in keeping with usual personality, often in response to minor provocation;</td></tr><tr><td>Obsessive-compulsive (anankastic)</td><td>sense of loss of control followed by regret — Chronic worries about standards; excessive concern about self-image; tension in relationships, leading to isolation; inability to relax and excessive inhibitions; overly meticulous, conscientious, and perfectionist; predisposition to</td></tr><tr><td>Hysterical</td><td>depression and obsessive-compulsive neurosis Immaturity, histrionic behavior, excitability, emotional instability, sexualization of relationships, low frustration</td></tr><tr><td></td><td>tolerance, and shallow interpersonal ties; dependency</td></tr><tr><td>Asthenic</td><td>Chronic weakness, easy fatigability, sense of vulnerability, oversensitive to physically and emotionally taxing little ambition low anhedonia</td></tr><tr><td>Passive-aggressive</td><td>situations, or aggression; energy level; Obstructive behavior, stubborness, intentional errors or omissions; intolerance of authority with struggles over control, often creating difficulties in medical settings; externalization of conflicts and blaming others for untoward events</td></tr><tr><td>Inadequate</td><td>Chronic inability to meet ordinary life demands in the absence of mental retardation; severe dependency on others;</td></tr><tr><td>Antisocial</td><td>tendency to become institutionalized or to become dependent on institutions Unsocialized or antisocial behavior in conflict with society; selfishness, callousness, impulsiveness, lack of loyalty, and little guilt; low frustration tolerance; tendency to blame others, long history of interpersonal and social difficulties and arrests</td></tr><tr><td>Passive-dependent Immature</td><td>Lack of self-confidence, indecisiveness, tendency to cling to and seek support from others Ineffectual responses to social, psychologic, and physical demands; lack of stamina; poor adaptation to ordinary “loser”</td></tr><tr><td>Borderline Narcisstic</td><td>situations; a Poorly regulated emotions, self-injury, dysphoria, unstable interpersonal relationships Grandiosity, fantasies of power, success, idealized love, and belief that he or she is special or unique and can only be understood by or associate with others of high status</td></tr></table>
======================================
<table><thead><th rowspan="2">FUNCTIONAL CLASSIFICATION</th><th colspan="7">SIDE EFFECTS</th></thead><thead><th></th><th>INSOMNIA AND AGITATION</th><th>SEDATION</th><th>HYPO- TENSION</th><th>ANTI- CHOLINERGIC EFFECTS</th><th>NAUSEA OR GASTRO- INTESTINAL EFFECTS</th><th>SEXUAL DYSFUNC- TION</th><th>WEIGHT GAIN</th></thead><tr><td colspan="8">Xeuptake inhibitors</td></tr><tr><td colspan="8">Selective serotonin-reuptake inhibitors (SSRIs)</td></tr><tr><td>Fluoxetine</td><td>++</td><td>-/+</td><td>-/+</td><td>-/+</td><td>++</td><td>++</td><td>+</td></tr><tr><td>Paroxetine</td><td>++</td><td>-/+</td><td>-/+</td><td>+</td><td>++</td><td>++</td><td>+</td></tr><tr><td>Sertraline</td><td>++</td><td>-/+</td><td>-/+</td><td>-/+</td><td>++</td><td>++</td><td>+</td></tr><tr><td>Fluvoxamine</td><td>++</td><td>+</td><td>-/+</td><td>-/+</td><td>++</td><td>++</td><td>+</td></tr><tr><td>Citalopram</td><td>++</td><td>-/+</td><td>-/+</td><td>-/+</td><td>++</td><td>++</td><td>+</td></tr><tr><td>Escitalopram</td><td>++</td><td>-/+</td><td>-/+</td><td>-/+</td><td>++</td><td>++</td><td>+</td></tr><tr><td>Nonselective norepinephrine-reuptake</td><td></td><td>inhibitors</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td>-/+</td><td></td><td></td><td>-/+</td><td></td><td></td></tr><tr><td>Desipramine</td><td>+</td><td></td><td>++</td><td>+</td><td></td><td>+</td><td>+</td></tr><tr><td>Nortriptyline</td><td>+</td><td>+</td><td>+</td><td>+</td><td>-/+</td><td>+</td><td>+</td></tr><tr><td>Maprotiline</td><td>+</td><td>-/+</td><td>+</td><td>+</td><td>-/+</td><td>+</td><td>++</td></tr><tr><td>Mixed or dual-action reuptake</td><td>inhibitors</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="8">Older</td><td colspan="8" rowspan="2">agents (TCAs)</td></tr><tr><td colspan="8"></td></tr><tr><td>Amitriptyline</td><td>—/+</td><td>++</td><td>++</td><td>+44</td><td>-/+</td><td>+</td><td>++</td></tr><tr><td>Dothiepin</td><td>-/+</td><td></td><td></td><td></td><td>-/+</td><td></td><td></td></tr><tr><td></td><td>++</td><td>+</td><td>++</td><td>++</td><td>-/+</td><td>+</td><td>++</td></tr><tr><td>Imipramine</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="8">Newer agents (non-TCAs)</td></tr><tr><td>Venlafaxine</td><td>++</td><td>-/+</td><td>-/+</td><td>-/+</td><td>++</td><td>++</td><td>-/+</td></tr><tr><td>Bupropion</td><td>++</td><td>-/+</td><td>-/+</td><td>+</td><td>+</td><td>-/+</td><td>-/+</td></tr><tr><td>Duloxetine</td><td>-/+</td><td>+</td><td>—/+</td><td>+</td><td>+</td><td>-/+</td><td>-/+</td></tr><tr><td colspan="8">MAOIs</td></tr><tr><td>Phenelzine</td><td>++</td><td>+</td><td>++</td><td>+</td><td>+</td><td>++</td><td>+</td></tr><tr><td>Tranylcypromine</td><td>++</td><td>+</td><td>++</td><td>+</td><td>+</td><td>++</td><td>+</td></tr><tr><td>Isocarboxazid</td><td>++</td><td>-/+</td><td>++</td><td>+</td><td>+</td><td>++</td><td>++</td></tr><tr><td>Selegiline</td><td>+</td><td>-/+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td colspan="8">Mixed-action newer agents</td></tr><tr><td>Mirtazapine</td><td>-/+</td><td>+44</td><td>+</td><td>-/+</td><td>-/+</td><td>—/+</td><td>+++</td></tr><tr><td>Nefazodone</td><td>-/+</td><td>++</td><td>+</td><td>+</td><td>+</td><td>-/+</td><td>+</td></tr><tr><td>Trazodone</td><td>-/+</td><td>+44</td><td>+</td><td>-/+</td><td>+</td><td>++</td><td>+</td></tr></table>
======================================
<table><thead><th>REACTION</th><th>FEATURES</th><th>MAXIMUM RISK</th><th>MECHANISMS</th><th>TREATMENTS</th></thead><tr><td>Acute dystonias</td><td>Muscle spasms; tongue, face, neck, back; terrifying; rarely fatal from asphyxia</td><td>1-5 days or with each injection of decanoates</td><td>Dopamine excess?</td><td>Injected antiparkinsonism agents, then oral</td></tr><tr><td>Parkinsonism</td><td>Bradykinesia, rigidity, variable tremor, mask facies, shuffling gait</td><td>Evolves slowly in 14 weeks, often per- sists</td><td>Dopaminergic deficiency</td><td>Oral anticholinergics, aman- tadine; dopaminergics are too risky</td></tr><tr><td>Malignant syndrome</td><td>Catatonia, stupor, fever, unstable pulse, blood pressure and res- pirations, elevated serum creatine kinase and myoglo- bin; can be fatal</td><td>Days to weeks</td><td>Hypothalamic and extra- pyramidal dysfunc- tion likely; not muscle calcium influx prob- lem as in hyperther- mia of anesthesia</td><td>Stop neuroleptic; expert intensive care; dantrolene or bromocriptine may help</td></tr><tr><td>“Rabbit” syndrome</td><td>Rare perioral tremor; usually reversible</td><td>Months to years</td><td>Parkinsonism variant?</td><td>Oral anticholinergics</td></tr><tr><td>Akathisia</td><td>Motor restlessness with anxiety and agitation</td><td>Can start immediately and usually persists</td><td>| Unknown; adrenergic component?</td><td>Reduce dose or change drug propranolol; antiparkinson agents and benzodiazepines</td></tr><tr><td>Tardive dyskinesias</td><td>Oral-facial dyskinesia chore- oathetosis, variable dystonia; often slowly reversible; rarely progressive</td><td>6-120 months; worse when drug stopped</td><td>Dopaminergic excess likely</td><td>Prevention best; treatment unsatisfactory; vitamin E (400-1200 units/day) may help; slow spontaneous remission</td></tr></table>
======================================
<table><thead><th>MEDICATION</th><th>BRAND NAME</th><th>INITIAL DOSE</th><th>TARGET OR MAXIMAL DOSE</th><th>POTENTIAL SIDE EFFECTS?*</th></thead><tr><td>Olanzapine</td><td>Zyprexa</td><td>5mg</td><td>10mg</td><td>Orthostatic hypotension, transaminase elevation, hyperprolactinemia</td></tr><tr><td>Quetiapine</td><td>Seroquel</td><td>25 mg bid</td><td>300 mg</td><td>Orthostatic hypotension, cataracts, transaminase elevation</td></tr><tr><td>Clozapine</td><td>Clozaril</td><td>12.5 mg bid</td><td>300 mg</td><td>Agranulocytosis, transient fever, anticholinergic activity, hyperglycemia</td></tr><tr><td>Risperidone</td><td>Risperidol</td><td>1 mg bid</td><td>3 mg bid</td><td>Orthostatic hypotension</td></tr><tr><td>Ziprasidone</td><td>Geodon</td><td>20 mg</td><td>160 mg</td><td>Less weight gain than others in this class. Prolongation of QT interval</td></tr><tr><td>Aripiprazole</td><td>Abilify</td><td>5mg</td><td>30 mg</td><td>Less weight gain than others in this class. Prolongation of QT interval</td></tr><tr><td>Amisolpride —</td><td>Solian</td><td>100 mg</td><td>1000 mg</td><td></td></tr></table>
======================================
<table><thead><th rowspan="2">ACTION TESTED</th><th>ROOTS?</th><th>NERVES</th><th>MUSCLES</th></thead><thead><th></th><th></th><th>CRANIAL</th><th></th></thead><tr><td>Closure of eyes, pursing of lips, exposure of teeth</td><td>Cranial 7</td><td>Facial</td><td>Orbicularis oculi Orbicularis oris</td></tr><tr><td>Elevation of of</td><td>Cranial</td><td>abducens</td><td>Levator extraocular</td></tr><tr><td>eyelids, movement eyes</td><td>3, 4,6</td><td>Oculomotor, trochlear,</td><td>palpebrae,</td></tr><tr><td>Closing and opening of jaw</td><td>Cranial 5</td><td>Motor trigeminal</td><td>Masseters</td></tr><tr><td></td><td></td><td></td><td>Pterygoids</td></tr><tr><td>Protrusion of tongue</td><td>Cranial 12</td><td>Hypoglossal</td><td>Lingual</td></tr><tr><td>Phonation and swallowing</td><td>Cranial 9, 10</td><td>Glossopharyngeal, vagus</td><td>Palatal, laryngeal, and pharyngeal</td></tr><tr><td>Elevation of shoulders, anteroflexion and turning of head</td><td>Cranial 11 and upper cervical</td><td>Spinal accessory</td><td>Trapezius, sternomastoid</td></tr><tr><td></td><td></td><td>BRACHIAL</td><td></td></tr><tr><td>Adduction of extended arm</td><td>C5, C6</td><td>Brachial plexus</td><td>Pectoralis major</td></tr><tr><td>Fixation of scapula</td><td>C5, C6, C7</td><td>Brachial plexus</td><td>Serratus anterior</td></tr><tr><td>Initiation of abduction of arm</td><td>C5, C6</td><td>Brachial plexus</td><td>Supraspinatus</td></tr><tr><td>External rotation of flexed arm</td><td>C5, C6</td><td>Brachial plexus</td><td>Infraspinatus</td></tr><tr><td>Abduction and elevation of arm up to 90°</td><td>C5, C6</td><td>Axillary nerve</td><td>Deltoid</td></tr><tr><td>Flexion of supinated forearm</td><td>C5, C6</td><td>Musculocutaneous</td><td>Biceps, brachialis</td></tr><tr><td>Extension of forearm</td><td>C6, C7,C8</td><td>Radial</td><td>Triceps</td></tr><tr><td>Extension of wrist</td><td>C6</td><td></td><td>Extensor radialis</td></tr><tr><td>(radial)</td><td></td><td>Radial</td><td>carpi longus</td></tr><tr><td>Flexion of</td><td>C6</td><td></td><td>Brachioradialis</td></tr><tr><td>semipronated arm</td><td>C5,</td><td>Radial</td><td></td></tr><tr><td>Adduction of flexed arm</td><td>C6, C7,C8</td><td>Brachial plexus</td><td>Latissimus dorsi</td></tr><tr><td>of forearm</td><td>C7</td><td>Posterior interosseous</td><td></td></tr><tr><td>Supination</td><td>C6,</td><td></td><td>Supinator</td></tr><tr><td>Extension of</td><td></td><td>Posterior interosseous</td><td>Extensor</td></tr><tr><td>proximal phalanges</td><td></td><td></td><td>digitorum</td></tr><tr><td>Extension of wrist (ulnar side)</td><td></td><td>Posterior interosseous</td><td>Extensor carpi ulnaris</td></tr><tr><td>Extension of of index</td><td></td><td>Posterior interosseous</td><td>Extensor indicis</td></tr><tr><td>proximal phalanx finger</td><td></td><td></td><td></td></tr><tr><td>Abduction of thumb</td><td></td><td>Posterior interosseous</td><td>Abductor pollicis longus and brevis</td></tr><tr><td>of thumb</td><td></td><td></td><td>and brevis</td></tr><tr><td>Extension</td><td></td><td>Posterior interosseous</td><td>Extensor pollicis longus</td></tr><tr><td>Pronation of forearm</td><td></td><td>Median nerve</td><td>Pronator teres</td></tr><tr><td>Radial flexion of wrist</td><td></td><td>Median nerve</td><td>Flexor carpi radialis</td></tr><tr><td>Flexion of middle phalanges</td><td>C7, C8,T1</td><td>Median nerve</td><td>Flexor digitorum superficialis</td></tr><tr><td>Flexion of of thumb</td><td>C8, T1</td><td>Median</td><td>Flexor brevis</td></tr><tr><td>proximal phalanx of thumb fifth</td><td>T1</td><td>nerve Median</td><td>pollicis</td></tr><tr><td>Opposition against finger Extension of middle of index and middle</td><td>C8, T1</td><td>nerve Median</td><td>Opponens pollicis second lumbricals</td></tr><tr><td>phalanges fingers Flexion of terminal of thumb</td><td>C8, T1</td><td>nerve Anterior interosseous</td><td>First, Flexor</td></tr><tr><td>phalanx Flexion of terminal of second and t
======================================
hird</td><td>C8, C8, T1</td><td>nerve Anterior interosseous</td><td>pollicis longus Flexor</td></tr><tr><td>phalanx fingers Flexion of distal of and little</td><td>C8</td><td>nerve Ulnar</td><td>digitorum profundus Flexor</td></tr><tr><td>phalanges ring fingers Adduction and of fifth</td><td>C7, T1</td><td>Ulnar</td><td>digitorum profundus</td></tr><tr><td>opposition finger Extension of middle of and little</td><td>C8, T1</td><td>Ulnar</td><td>Hypothenar fourth lumbricals</td></tr><tr><td>phalanges ring fingers</td><td>C8,</td><td></td><td>Third,</td></tr><tr><td>Adduction of thumb against second finger</td><td>C8, T1</td><td>Ulnar</td><td>Adductor pollicis</td></tr><tr><td>Flexion of proximal phalanx of thumb Abduction and adduction of fingers.</td><td>C8, Tl C8. 7T1</td><td>Ulnar Ulnar</td><td>Flexor pollicis brevis Tnterossei</td></tr></table>
======================================
<table><thead><th>Hip flexion from semiflexed position</th><th>L1, L2,L3</th><th>Femoral</th><th>Iliopsoas</th></thead><tr><td>Hip flexion from externally rotated position</td><td>L2,L3</td><td>Femoral</td><td>Sartorius</td></tr><tr><td>Extension of knee</td><td>L2, L3, L4</td><td>Femoral</td><td>Quadriceps femoris</td></tr><tr><td>Adduction of thigh</td><td>L2, L3, L4</td><td>Obturator</td><td>Adductor longus, brevis</td></tr><tr><td>Abduction and internal rotation of thigh</td><td>L4,1L5,S1</td><td>Superior gluteal</td><td>magnus, Gluteus medius</td></tr><tr><td>Extension of thigh</td><td>L5, $1, S2</td><td>Inferior gluteal</td><td>Gluteus maximus</td></tr><tr><td>Flexion of knee</td><td>L5, $1,S2</td><td>Sciatic</td><td>Biceps femoris</td></tr><tr><td rowspan="2"></td><td></td><td></td><td></td><td>Semitendinosus</td></tr><tr><td></td><td></td><td>Semimembranosus</td></tr><tr><td>Dorsiflexion of foot (medial)</td><td>14,15</td><td>Peroneal (deep)</td><td>Anterior tibial</td></tr><tr><td>Dorsiflexion of toes (proximal and distal phalanges)</td><td>L5,S1</td><td>Peroneal (deep)</td><td>Extensor digitorum longus and brevis</td></tr><tr><td>Dorsiflexion of great toe</td><td>L5,S1</td><td>Peroneal (deep)</td><td>Extensor hallucis longus</td></tr><tr><td>Eversion of foot</td><td>L5,S1</td><td>Peroneal (superficial)</td><td>Peroneus longus and brevis</td></tr><tr><td>Plantar flexion of foot</td><td>$1,S2</td><td>Tibial</td><td>Gastrocnemius, soleus</td></tr><tr><td>Inversion of foot</td><td>L4,L5</td><td>Tibial</td><td>Tibialis posterior</td></tr><tr><td>Flexion of toes (distal phalanges)</td><td>L5, $1, $2</td><td>Tibial</td><td>Flexor digitorum longus</td></tr><tr><td>Flexion of toes (middle phalanges)</td><td>S1, $2</td><td>Tibial</td><td>Flexor digitorum brevis</td></tr><tr><td>Flexion of great toe (proximal phalanx)</td><td>S1,S2</td><td>Tibial</td><td>Flexor hallucis brevis</td></tr><tr><td>Flexion of great toe (distal phalanx)</td><td>L5, $1, $2</td><td>Tibial</td><td>Flexor hallucis longus</td></tr><tr><td>Contraction of anal sphincter</td><td>S2,S3, S4</td><td>Pudendal</td><td>Perineal muscles</td></tr></table>